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 Naturally occurring prodigiosenes are produced by microorganisms such as 
Streptomyces and Serratia marcescens. Prodigiosenes are fascinating for their wide 
range of biological activities in the form of anti-cancer, immunosuppressive, and 
antimicrobial agents. Some of the analogs, such as prodigiosin, are currently 
undergoing preclinical and clinical trials. Despite such widespread interest, the origin 
of prodigiosin’s biological activity has not been established unambiguously. Based on 
biological studies, it is known that prodigiosin plays a physiologically relevant role and 
has several cellular targets. The work described in this thesis explores some of the 
chemistry that may help explain prodigiosenes’ biological activity.  
 A new series of analogs of prodigiosin bearing an additional methyl and a 
carbonyl group at the C-ring were evaluated as transmembrane anion transporters. The 
effect of C-ring modifications in these new prodigiosenes on their basicity, 
transmembrane anion transport ability and their in vitro anticancer activity was 
  
assessed. The ability of prodigiosenes to facilitate co-transport of H⁺Cl⁻ leading to 
alteration of intracellular pH, and catalyze anion exchange across lipid bilayers has 
been proposed to be one of the cause of its anti-cancer activity. It has been suggested 
that the prodigiosenes bind anions in their protonated state at physiological pH. 
Prodigiosene analogs with modified B-ring demonstrated that the electronic nature of 
the substituent on the B-ring influences the basicity of these analogs, and consequently, 
their anion transport efficiency is also affected.  
 A study of the conformations of prodigiosin and its analogs was performed to 
learn about how the ligands orient in different solvents. This information could 
potentially link the preferred conformational states of these compounds and their 
observed biological activities. Lastly, we confirmed that prodigiosin binds at the 3ˈ end 
of a G-quadruplex DNA. The results from this chapter are significant as they widen the 
scope of developing prodigiosenes as G-quadruplex binding ligands or telomerase 
inhibiting agents. Further, they lead the way to revealing another possible mechanism 
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1 Chapter 1: A Background on Prodigiosenes 
 Introduction 
 The work described in this thesis centers around a natural product called 
prodigiosin 1 (Figure 1.1). Prodigiosin is the parent compound of the tripyrrolic natural 
products known as the prodigiosenes.1 It is a remarkable molecule as it has been found 
useful for its anti-cancer,2⁻4 immunosuppressive,5,6 anti-malarial,7 and antimicrobial 
activities.8 Undoubtedly, there’s a huge interest in developing synthetic analogs of 
prodigiosin for therapeutic purposes. 1,2,6,9⁻11 In fact, a few of its derivatives such as 
Obtaoclax are undergoing preclinical and clinical trials.5,12⁻15  
 
Figure 1.1. Structure of natural product prodigiosin 1.                 
 Naturally occurring prodigiosenes are produced by microorganisms such as 
Streptomyces and Serratia marcescens. They were first isolated in 1929.16 However, 
prodigiosin’s complete structure was not elucidated until the 1960s.17,18 Very soon, 
scientists realized that prodigiosin has promising biological activity. Multiple groups 
undertook the investigation of the cytotoxic and immunosuppressive properties of 






the full spectrum of the biological activities exhibited by the prodigiosenes,21⁻25 the 
origin of this activity has not been established unambiguously yet.  
 There are multiple mechanisms put forth to explain prodigiosin’s biological 
activity, such as the ability to inhibit phosphorylation and activate JAK-3, a 
cytoplasmic tyrosine kinase that may give rise to prodigiosin’s immunosuppressive 
properties.26 The ability to facilitate co-transport of HCl,10,22,27⁻30 and catalyze anion 
exchange across lipid bilayers,10,31,32 has been proposed to be the cause of prodigiosin’s 
anti-cancer activity.   Another theory attributes prodigiosin’s anti-cancer activity to the 
formation of prodigiosene-copper complexes that mediate cleavage of double stranded 
DNA.33⁻35 Obviously, the full spectrum of medicinal applications of prodigiosenes has 
ensured a steady interest in this particular group of natural products. A lot is known 
about the biological significance of prodigiosenes, whereas comparatively little is 
known about the chemistry behind these biological applications.9⁻11,24,36⁻38  In this 
thesis, I have made an effort to explore some of the chemistry that may help explain 
prodigiosin’s biological activity.  
 Thesis Organization 
 This thesis is organized into seven chapters. The initial goal of the collaborative 
research between our group and that of Dr. Alison Thompson, some of which is 
described in this thesis, was to develop synthetic analogs of prodigiosin 1 (Figure 1.2) 
that would exhibit greater efficiency in anion transport across lipid bilayers, but would 
have reduced cytotoxicity. Further, we wanted to develop analogs with properties that 






accomplished as described in the following chapters. Additionally, efforts were made 
to study some of the solution properties of prodigiosenes such as their basicity, 
conformation in solution and the modes of binding with anions (like Cl⁻, MeSO3⁻). 
Taking our studies a step further, we also explored the interactions between prodigiosin 
and another anion, DNA. There are thumbprints of prodigiosin’s biological relevance 
in the literature describing the ability of 1 to intercalate with duplex DNA.39⁻41 These 
studies point towards the possibility of an important role of prodigiosin as a therapeutic 
agent for treating cancer. We wanted to explore the possibility of prodigiosin acting as 
a ligand for G-quadruplex DNA.   
 Chapter 1 gives a description about prodigiosenes. It also describes the journey 
undertaken by scientists to elucidate the biological mechanism behind the anti-cancer 
activity observed for prodigiosin 1. The initial studies that led to the discovery of 
prodigiosin 1 being able to catalyze H⁺/Cl⁻ symport across cellular membranes are 
explained.10,22,27⁻30 A description of the work done to study the anion-exchange process 
across bilayers, as catalyzed by prodigiosin is explained as well.10,31,32 
 Chapter 2 is a description of efforts to study synthetic “C-ring” analogs of 
prodigiosin 1. Some of the analogs showed improved ability to execute anion transport 
across lipid membranes. The ester derivatives 2 (Figure 1.2), also demonstrated that 
installation of an ester group on the C-ring can allow for a greater control over the 
transmembrane anion transport activity of prodigiosenes. The last finding paved our 







                Prodigiosin 1                       Ester analog 2                      Phenyl analog 3 
Figure 1.2. Structures of natural product 1 and synthetic prodigiosenes - ester analog 
2e and phenyl analog 3.    
 In Chapter 3, a series of B-ring modified prodigiosenes 3 were designed and 
developed to study the impact of electronic effects on the basicity, and consequently, 
on the anion transport abilities of prodigiosenes (Figure 1.2). Different electron 
withdrawing and electron donating groups were installed on the prodigiosin scaffold. 
When the resultant set of new prodigiosenes 3 were tested for their anion transport 
activity, a correlation between the pKa of a prodigiosene and its ability to move anions 
across lipid membranes was found. This finding revealed the significance of 
protonation of prodigiosenes in the process of moving anions across lipid membranes, 
which led us to the research performed in Chapter 4.   
 Chapter 4 deals with studies done to investigate the conformation of 
prodigiosenes in solution (Figure 1.3). The anion binding patterns specific to different 
conformations were identified. Additionally, for the first time, it was shown that 
prodigiosenes can bind anions by using CH hydrogen (Figure 1.3). The C-H∙∙∙A⁻ 
binding is an unconventional type of H-bonding. Therefore, this result may be a 







Figure 1.3. Different conformations of the protonated form of prodigiosin 1•H⁺ - α, β, 
γ and δ are in equilibrium with each other in solution. The α conformation of 1•H⁺ 
binds MeSO3⁻ ion using a CH hydrogen.  
 DNA is a polyanion and can exist in different higher order structures - duplex, 
triplex and tetraplex forms. Since prodigiosin 1 has been shown to bind anions, 
Chapter 5 describes the experiments performed to probe the binding interactions 
between prodigiosin 1 and an anionic sequence d[TG4T] that forms a G-quadruplex 
d[TG4T]4. Results showed that prodigiosin 1 is a G-quadruplex DNA binding ligand. 
This result opens up new possibilities to develop prodigiosenes as G-quadruplex 
stabilizing ligands, and therefore, as potential telomerase inhibitors, and                        






 Chapter 6 summarizes major conclusions of this research and suggests some 
future directions, while the experimental protocols used for the research described in 
Chapters 2-5 are described in Chapter 7. 
 Introduction on Prodigiosenes 
 Prodigiosenes are a family of naturally-occurring red pigments produced by 
microorganisms such as Streptomyces and Serratia marcescens (Bacillus prodigiosis), 
a bacterium found in damp and warm conditions.9,42 These compounds are bacterial 
secondary metabolites with a characteristic pyrrolylpyrromethene skeleton, a B-ring 
methoxy group and different alkyl substituents arranged either in an acyclic or cyclic 
manner. Figure 1.4 lists some naturally-occurring prodigiosenes (1, 4 and 5) as well as 
some synthetic analogs (6-8). 






 Prodigiosin 1 was the first prodigiosene to be isolated in 1929,16  but its full 
synthesis was not elucidated until 1962.17,18 Initially, prodigiosenes were found to be 
too cytotoxic and were not pursued for any pharmacological purposes. However, over 
the last two decades, there has been a renewed interest in these natural products because 
some of the derivatives have been found to possess potent antimicrobial, antimalarial, 
anti-cancer, and immunosuppressive activities.14,24,43 At non-toxic concentrations, the 
potential immunosuppressive activity was found to be significant.44 Therefore, 
synthetic analogs of prodigiosin 1 were developed as immunosuppressive agents.5 
Prodigiosenes have been examined for their anti-cancer properties by the National 
Cancer Institute (NCI).45 These compounds induce apoptosis and are active against 
breast,21,46 haematopoietic,23,47 and colon cancer cell lines.48 They also showed activity 
in hepatocellular carcinoma xenografts and in B-cell chronic lymphocytic leukemia in 
32 patients.22,49 
 The therapeutic relevance of prodigiosenes has made sure that new, less toxic 
but more effective derivatives of prodigiosenes are pursued for treatments of various 
anomalies. In this ongoing pursuit, a number of derivatives have been selected for 
clinical and pre-clinical trials. Prodigiosin 1 is in preclinical trials for treatment of 
pancreatic cancer.14,50 The mesylate salt of obatoclax (GX15-070) 6 has undergone 
Phase I clinical trials for leukemia treatment.12,13 PNU-156804 (8) has been used as an 







 Despite the keen interest in biological activity of prodigiosenes, their main 
mechanism of action for cancer treatment has not been identified unambiguously. 
There are two proposed mechanisms to explain the anti-cancer activity shown by 
prodigiosenes that have been described in more detail in the next sections. Before 
describing my research, some background on the two proposed mechanisms used to 
explain the anti-cancer properties of prodigiosenes is provided.  
 Proposed Mechanisms for Anti-Cancer Properties of Prodigiosenes  
 For developing any compound as a potential therapeutic, it is essential to 
understand its mode of action. By knowing the details of the mechanism, one can      
fine-tune the properties of the compound to extract maximum efficacy. In this regard, 
Manderville and colleagues reported on the ability of prodigiosenes to facilitate 
cleavage of dsDNA in the presence of copper(II).51 This mechanism has been discussed 
in brief in the Section 1.4.1. In the second mechanism put forth to explain 
prodigiosenes anti-cancer activity, the research groups of Nakashima and Yamamoto 
pointed out the ability of prodigiosenes to catalyze symport of H⁺/Cl⁻ ions across 
cellular membranes. This second mechanism is described in detail in Section 1.4.2.   
 Oxidative DNA Cleavage by Prodigiosene•Cu2⁺ Complexes 
 Bipyrroles are known to undergo one-electron oxidation leading to the 
formation of a dimeric species. The resulting dimer can donate two electrons and 
trigger oxidative damage of biopolymers and cause oxidative stress.52,53 Based on this 
knowledge, Manderville et. al. rationalized that prodigiosenes, in the presence of a 






of DNA. They tested their hypothesis by monitoring mixtures of supercoiled plasmid 
DNA (Form I) with prodigiosin 1 and different metal cations, such as Cu(II), Fe(III) 
and Ni(II) by agarose gel electrophoresis.51 Following a 20-40 minute incubation time, 
the single-stranded nicked circular form of DNA was visible on the gel in the presence 
of Cu(II). This observation is classical evidence for a dsDNA cleavage event.54 Also, 
dsDNA cleavage is a known mechanism of apoptosis.55 Catalase is an enzyme that 
lowers the solution concentrations of hydrogen peroxide (H2O2). When catalase was 
added to the original mixture of dsDNA, prodigiosin and Cu(II) it completely inhibited 
the DNA cleavage reaction. This confirmed the oxidative nature of DNA cleavage as 
catalyzed by prodigiosin 1.  
 In the absence of copper(II), prodigiosin has been shown to intercalate with calf 
thymus-DNA, particularly at AT rich regions.39,40 The prodigiosin-DNA interaction 
study is discussed in more detail in Chapter 5. Collectively, these studies inspired us 
to explore the binding interactions between prodigiosin 1 and G-quadruplex DNA.       
 H⁺/Cl⁻ Co-Transport Triggers Apoptosis 
 The second mechanism proposed for prodigiosenes anti-cancer activity evolved 
out of multiple studies done by different research groups. Discussion of these studies 
is arranged into two sets. The first set involves studies done to establish the role of 
prodigiosenes in altering intracellular pH, due to the apparent movement of H⁺ and Cl⁻ 
ions across membranes. The second set of studies involves work done with 
prodigiosenes and cancer cells to confirm whether these compounds induce apoptosis 






 Prodigiosenes can Inhibit Proton Pump Activity 
 Vacuolar H⁺-ATPase (or V-ATPase) are enzymes found in eukaryotes that 
catalyze the hydrolysis of adenosine triphosphate (ATP) into adenosine diphosphate 
(ADP) and a phosphate ion. The hydrolysis reaction is an exergonic reaction and the 
energy produced by this reaction helps V-ATPase to transport protons against the 
gradient across intracellular and plasma membranes. Maintainance of intracellular pH 
is essential for smooth functioning of cells, and V-ATPase is responsible for 
maintaining a low internal pH in certain cell types and intracellular organelles such as 
Golgi apparatus, lysosomes and other vacuoles.56  
 Kataoka and colleagues published two important papers that demonstrated the 
ability of prodigiosin 25-C (undecylprodigiosin) 7 to neutralize acidic organelles in 
cytotoxic T cells and baby hamster kidney (BHK) cells (Figure 1.5).19,57  In the first 
study, the authors showed that 7 reversed the activity of V-ATPase by increasing the 
pH of certain organelles present inside T-cells.19 By neutralizing the acidic organelles, 
compound 7 also successfully negated the cytotoxicity of T cells. This result was one 
of the first studies done to explain the immunosuppressive properties of prodigiosenes.  
 In a second publication, Kataoka and group showed that even though 
prodigiosin 25-C inhibited the proton pump activity of V-ATPase with an IC50 value 
of 30 nM in BHK cells, it did not interfere with the ATP hydrolysis reaction.57 
Concentrations as high as 1 μM of prodigiosin 25-C did not affect the ATP hydrolysis 
process. Further, specific organelles such as Golgi apparatus and mitochondria in BHK 






addition of 7 was followed by swelling of these organelles. The swelling in organelles 
correlated with the initial observations. By neutralizing the acidic pH of these 
organelles, prodigiosin 25-C increased their internal pH. As a result, an osmotic 
imbalance was generated which, was rectified by inflow of water into the organelles, 
and led to the swelling of these intracellular organelles.  
 
Figure 1.5. Structures of prodigiosenes 1, 4 and 7. 
 Similar observations were made in different cell types such as osteoclasts and 
bovine cells.27,58 In both cases, metacycloprodigiosin 4 and prodigiosin 25-C 7 
inhibited the proton pump activity of V-ATPase. The study by Wasserman and 
colleagues was especially important as it helped in narrowing down the molecular 
mechanism to some extent.27 The authors first showed that prodigiosin 1, 
metacycloprodigiosin 4 and prodigiosin 25-C 7 reversed the activity of V-ATPase 
enzyme in bovine cells in the presence of chloride anion (Figure 1.5). No potential 
difference across the membranes was detected, which means that the movement of ions 
is an electroneutral process such that it involved either the symport of H⁺/Cl⁻ ions or 






 Next, to prove that the ion movement was dependent on the presence of Cl⁻, 
Wasserman and his group performed some experiments with liposomes loaded with a 
pH-sensitive fluorescent dye pyranine. Liposomes are small vesicles with a bilayer 
membrane devoid of any ion conducting proteins.27 Thus, no ions can diffuse through 
the membrane unless assisted by an ion transporter.  Activity of prodigiosenes was 
tested by changing two variables – dose and time-dependence. The general observation 
was that when the concentration of extravesicular Cl⁻ ion was in excess, as compared 
to the concentration in internal solution of liposomes, addition of prodigiosenes 
reduced the intravesicular pH (measured in terms of fluorescence of pyranine). This pH 
drop was presumably due to influx of H⁺ and Cl⁻ ions into the vesicle. In the reverse 
case, when the intravesicular concentration of Cl⁻ was increased, then the addition of 
prodigiosenes led to an increase in the intravesicular pH due to efflux of H⁺ and Cl⁻ 
ions. This was indirect evidence to indicate the involvement of Cl⁻ in the H⁺ 
translocation process catalyzed by prodigiosenes.25, 27  
 Taking their experiments a step further, the authors used radioactive 36Cl in the 
external buffer to gather direct evidence for transmembrane Cl⁻ movement.27 The 
uptake of 36Cl⁻ into the liposomes was measured by liquid-scintillation counter, while 
the changes in intravesicular pH were monitored by measuring fluorescence of 
pyranine. Initially, the extravesicular pH was lower than the pH inside the liposomes. 
It was reported that prodigiosin 1, metacycloprodigiosin 4 and prodigiosin 25-C 7  
promoted the uptake of radioactive 36Cl from the external buffer into the liposomes, 







Figure 1.6. The proposed lipophilic ion pair 1•H⁺Cl⁻ formed between prodigiosin 1 
and H⁺/Cl⁻ ions that promotes proton movement across the liposomal membrane. 
 Thus, based on the above experiments, Wasserman and colleagues proposed a 
lipophilic ion pair formation between prodigiosenes and H⁺/Cl⁻ (Figure 1.6). The 
lipophilic ion pair 1•H⁺Cl⁻ should be able to diffuse through the liposomal membrane, 
promoting H⁺ and Cl⁻ movement across the membrane.  
 There were other studies performed with plant vacuoles that further established 
that the process of alteration of pH inside cells was only possible in the presence of Cl⁻ 
and not with other anions such as the hydrophilic SO4
2⁻ anion.59,60 The next important 
development was the finding that the H⁺Cl⁻ co-transport catalyzed by prodigiosenes 
leads to apoptosis in cancer cells.  
 H⁺Cl⁻ Co-Transport by Prodigiosenes can Lead to Apoptosis  
 A few years after Kataoka and colleagues connected the ability of prodigiosenes 
to inhibit the proton pump activity of V-ATPase in presence of Cl⁻ ions,27,57 two 







Figure 1.7. Structure of cycloprodigiosin hydrochloride 9.   
 Yamamoto and colleagues found that cycloprodigiosin hydrochloride 9 can 
inhibit the growth of six different types of liver cancer cells, depending on dosage and 
duration of incubation (structure shown in Figure 1.7).22 The same effect was not 
observed on normal rat hepatocytes. When Huh-7 liver cancer cells were treated with 
9 in vitro, cell proliferation decreased drastically. By using cell cytometry, it was found 
that the intracellular pH (pHi) decreased from 7.3 to 6.8 after treatment of Huh-7 cells 
with cycloprodigiosin hydrochloride 9. A change in intracellular pH can lead to cell 
death as has been shown by different studies.62 In an in vivo study, 9 was also tested on 
mice xenografted with Huh-7 cells. In a treatment that lasted 14 days, tumor growth 
was found to be significantly reduced on day 8. Based on a histological examination, it 
was found that the tumor cells had undergone apoptosis. Although the molecular 
mechanism could not be comprehended, the authors advocated the potential application 







Figure 1.8. Effect of PG-L-1 on cellular and nuclear morphology in U937 Cells.  U937 
cells (6 × 105 cells/dish) were treated with 0 mg/ml (A, E), 0.1 mg/ml (B, F), 1.5 mg/ml 
(C, G), and 50 mg/ml (D, H) of PG-L-1 at 37 °C for 3 h. Then, the cells were observed 
under a phase contrast microscope (A, B, C, D), or a fluorescence microscope (E, F, 
G, H) after staining with Hoechst 33258 (40 mM) for 10 min. The bar indicates 10 mm. 
Reprinted with permission from Biol. Pharm. Bull. 2005, 28 (12), 2289-2295. 
Copyright (2005) Pharmaceutical Society of Japan.61 
 Another significant finding was made by Nakashima and colleagues who used 
PG-L-1, a prodigiosene extracted from a bacterial strain for in vitro studies with human 
myeloid leukemia (U937) cells.61 PG-L-1 was reported to induce apoptotic nuclear 
morphological changes in U937 cells (Figure 1.8). Further, it was found that in the 
treated U937 cells, the acidic compartment such as lysosomes disintegrated, suggesting 
that PG-L-1 induced a change in intracellular pH of these cell organelles that then 






 Some cancer cells have an alkaline intracellular pH, which is essential for the 
growth, transformation and metabolism of the cells.63 Therefore, a possible cancer 
treatment therapy can take advantage of the ability of prodigiosenes to alter pH inside 
cancer cells and trigger apoptosis.64 The research described in this section culminates 
together to provide evidence for this possibility. But, the prodigiosenes could possibly 
be used for other therapeutic purposes as well. Their ability to move anions across 
membranes might be used for treatment of abnormalities caused due to misregulation 
or malfunctioning of natural ion channels or proteins. The next section describes the 
significance of anion transport in physiological system and the work done with 
prodigiosenes to investigate their ability to catalyze anion exchange across membranes.  
 Prodigiosenes and Transmembrane Anion Transport 
 In all living organisms, movement of gases (O2, CO2, N2), polar molecules 
(amino acids, sugars) and ions (Cl⁻, K⁺, Na⁺) across the membrane of a cell and its 
organelles is an integral part of biological processes. Most hydrophobic and small 
uncharged solutes can diffuse through a lipid membrane. However, specific membrane 
proteins or ion channels are required for the movement of larger molecules and ions 
through the membrane. Nature being the original innovator, has a large array of 
ionophores in the form of ion channels,65,66 proteins,67 or ion carriers68 to move ions 
across membranes. Just like a transistor in an electronic circuit, these channels open 
and close when signaled to create a hydrophilic passage through a hydrophobic 
membrane that enables the movement of charged ions. This catalytic process is mostly 






difference on either side of the membrane, osmosis or specific messengers. Therefore, 
movement of ions becomes an important step in processes like respiration, signaling 
pathways, regulating cell pH and osmotic balance. Interestingly, ion movement across 
channels makes use of certain non-covalent interactions (such as H-bonding, 
electrostatic interactions, anion-π) that form the same foundation pillars of the 
supramolecular chemistry field.  
 One example of a membrane embedded protein is the cystic fibrosis 
transmembrane conductance regulator (CFTR) located in the epithelial tissue. This 
channel regulates the flow of Cl⁻ and HCO3⁻ ions and is controlled by protein kinase 
A. There are more than 1800 mutations that can disrupt the flow of Cl⁻, HCO3⁻ and 
water molecules across the CFTR channel.69 These mutations result in thickening of 
mucus in lungs, pancreas and intestines. The resulting condition is an autosomal 
recessive disease known as cystic fibrosis (CF). Thickened mucus in lungs leads to 
frequent respiratory infections.70 Conditions resulting due to CF can severely risk the 
health of a patient and can be fatal.  There are other diseases like Bartter syndrome and 
Dent’s disease that are also caused due to misregulation of K⁺ or Cl⁻ ions.71⁻73  
 It is widely understood that by applying supramolecular concepts of reversible 
non-covalent binding, synthetic channels or small compounds may ultimately be used 
to alleviate some of these disorders. In this regard, scientists have been actively 
working on developing anion receptors. The synthetic anion receptors should be able 
to mimic natural transport systems and be capable of moving anions across 






10 developed by Yang and colleagues (Figure 1.9). They successfully demonstrated 
the ability of 10 to form chloride channels that restore Cl⁻ movement in epithelial cells 
affected by cystic fibrosis.76 Using whole-cell patch clamp technique, currents were 
detected in CuFi-8 cells upon application of compound 10. The CuFi-8 cells were 
obtained from the bronchial epithelia of a patient suffering from CF. A gradual increase 
in whole-cell currents was observed initially, after which the currents stabilized.  
 
Figure 1.9. Compound 10 developed by Yang and her group for treatment of CF.  
 The work done by the Yang group is an important milestone in the field of anion 
transport. More and more research groups are trying to explore the biological aspects 
of their work. Similarly, a number of interesting transmembrane anion transport studies 
have been done with prodigiosin 1 and its derivatives.2,9,77 There are 3 publications that 
are most significant. Two of these studies showed that the natural product prodigiosin 
1 can transport Cl⁻, NO3⁻ and HCO3⁻ across liposomal membrane.31,32 The third study 
correlated the anion transport rates of synthetic prodigiosenes with their anti-cancer 






 Anti-Cancer Activity Correlates with the Anion Transport Rates 
 
Figure 1.10. Structure of the prodigiosenes 11 and 12. Two views of the X-ray crystal 
structure of the complex formed between protonated prodigiosin 11 and Cl⁻ ion. 
Reprinted with permission from Angew. Chem. Int. Ed. 2005, 44 (37), 5989-5992. 
Copyright © 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.10  
 Sessler’s work with synthetic prodigiosenes was an important piece of work 
that correlated the anion transport activity of synthetic prodigiosenes with their in vitro 
anti-cancer activity.10 A series of synthetic derivatives of prodigiosin 1 were 
synthesized and tested for their anion binding, transmembrane transport and in vitro 
anti-cancer activity. An X-ray crystal structure of compound 11 showed a Cl⁻ anion 
bound by the three NH protons on the pyrrole rings in solid state (Figure 1.10). After 
establishing binding interactions between prodigiosene 11 and Cl⁻, they tested these 
synthetic derivatives for their Cl⁻ transport activity using phospholipid liposomes. A 






Compound 12, with a structure closest to prodigiosin 1, was most efficient at 
transporting Cl⁻ ions out of the liposomes and into the extravesicular solution.   
  In vitro cell proliferation studies were also performed with the synthetic 
analogs.10 The compounds were tested against two cell lines – A549 human lung cancer 
and PC3 human prostate cancer cells. All of the compounds exhibited 100% inhibition 
of cell proliferation at concentrations of 40 mM. When the data from anti-cancer 
activity and transmembrane anion transport experiments were compared, it was found 
that the results from both studies correlated well. Further, this correlation supported the 
H⁺/Cl⁻ co-transport mechanism proposed by Wasserman, Ohkuma and colleagues.27 
 Prodigiosin Catalyzes Anion Exchange Across Bilayer 
 
Figure 1.11. Anion exchange mediated by prodigiosin 1•H⁺ across a lipid bilayer. 
Prodigiosin 1•H⁺ can bind Cl⁻ or NO3⁻ anions and diffuse them through the membrane.  
 Wasserman proposed a H⁺/Cl⁻ co-transport or OH⁻/Cl⁻ antiport mechanism 
while rationalizing the ability of prodigiosenes to alter intravesicular pH.27 Studies 






across lipid bilayers.31 In a study done by Seganish and Davis, it was shown that 
prodigiosin can catalyze exchange of anions – Cl⁻ and NO3⁻ across a lipid bilayer 
(Figure 1.11). The anion transport experiments were done with liposomes 
encapsulating, either NaNO3 or Na2SO4 buffer. A chloride gradient was applied by 
adding a pulse of NaCl. The internal pH of the liposomes was monitored by loading 
the vesicles with a pH sensitive fluorescent pyranine dye. Influx of Cl⁻ was measured 
by monitoring the change in fluorescence of the Cl⁻ sensitive lucigenin (LG) dye.78  
 For the first case, liposomes were loaded with Na2SO4, which is a hydrophilic 
anion (ΔGhyd = -1080 kJ/mol). Addition of prodigiosin 1 led to an immediate drop in 
the intravesicular pH (Figure 1.12B) whereas a Cl⁻ influx occurred to only 20% of the 
value that would be expected for complete equilibrium (Figure 1.12A). In the second 
case, liposomes were loaded with NaNO3 on the inside. NaNO3 is a less hydrophilic 
anion (ΔGhyd = -300 kJ/mol). When prodigiosin 1 was added to the liposome solution, 
a rapid increase in Cl⁻ influx was observed (Figure 1.12C) accompanied by no change 
in the internal pH of liposomes (Figure 1.12D). From these experiments, the authors 
concluded that prodigiosin 1 can successfully facilitate anion exchange or antiport 
mechanism between Cl⁻ and a less hydrophilic anion, NO3⁻. In contrast, in the presence 
of a more hydrophilic anion SO4
2⁻, prodigiosin 1 instead catalyzes the symport of 







Figure 1.12. Chloride gradient assays on 100 nm EYPC liposomes in 10 mM sodium 
phosphate (pH 6.4) containing either 75 mM Na2SO4 (A and B) or 100 mM NaNO3 (C 
and D). The chloride gradient was initiated by adding NaCl to give an external 
concentration of 25 mM. Chloride concentration inside the vesicles (panels A and C) 
was calculated from the fluorescence of entrapped LG dye. The pH (panels B and D) 
is calculated from the fluorescence ratio of HPTS dye emitted at 510 nm when excited 
at 403 and 460 nm in a dual wavelength assay. The trace shown in grey represents 
DMSO blanks. Reprinted with permission from Chem. Commun. 2005, (46), 5781-
5783. Copyright (2005) Royal Society of Chemistry.31 
 Another experiment using dipalmitoyl-phosphatidylcholine (DPPC) liposomes 
demonstrated that prodigiosin moves anions across membrane by an ion carrier 






reasons: a) it was the first study to show that prodigiosin 1 can facilitate anion exchange 
across lipid bilayers and b) depending on the environmental conditions, prodigiosin’s 
Cl⁻ transport mechanism can switch between H⁺/Cl⁻ co-transport or OH⁻/Cl⁻ antiport.  
 Prodigiosin Facilitates Transmembrane Movement of HCO3⁻ 
 
Figure 1.13. Proposed structure of a complex between HCO3⁻ and prodigiosin 1•H+. 
The H5 proton on ring A and the methyl group on ring C are highlighted in red.  
 Nitrate and bicarbonate anions have similar shapes and sizes, yet, it is more 
challenging to transport HCO3⁻ across lipid bilayers due to its higher hydrophilicity 
(ΔGhyd = -388 kJ/mol) as compared to the NO3⁻ ion (ΔGhyd = -300 kJ/mol).79 This study 
showed that prodigiosin 1 can transport HCO3⁻ across lipid membranes.32 The rationale 
for selecting prodigiosin as a HCO3⁻ receptor was the presence of hydrogen bond 
donors and acceptors that provide a complimentary binding site for the anion. Binding 
between prodigiosin 1 and HCO3⁻ anion was demonstrated by using NMR 
spectroscopy. In the NMR titration between prodigiosin 1 and tetraethylammonium 
bicarbonate (TEAB), the proton resonances most influenced were for the H5 proton on 






the NMR observations, a structure was proposed where all the rings were in cis 
conformation, forming a HCO3⁻ binding cleft.  
 
Figure 1.14. 13C NMR experiments demonstrate that prodigiosin 1 is able to facilitate 
Cl⁻/HCO3⁻ antiport. Titration sequence for monitoring the transmembrane transport of 
bicarbonate ions in H13CO3⁻ loaded EYPC liposomes by prodigiosin 1 and DMSO. 13C 
NMR spectra (i) before and (ii) after the addition of the 50 mM NaCl pulse to EYPC 
vesicles loaded with 100 mM NaH13CO3, 20 mM HEPES buffer, and dispersed in 75 
mM Na2SO4, 20mM HEPES buffer, pH 7.5; (iii) after the addition of prodigiosin 1 or 
DMSO (1, 0.1 mol%; DMSO, 870 mol%); (iv) after the addition of 0.5 mM Mn2+ 
(1:100 Mn2⁺/Cl⁻ ratio). Reprinted with permission from Nat. Chem. 2009, 1 (2), 138-






 Using a 13C NMR assay, Figure 1.14 shows data illustrating prodigiosin-
mediated HCO3⁻/Cl⁻ exchange. EYPC liposomes (5 mM) filled with 100 mM 
NaH13CO3 were suspended in a sulfate solution and a 50 mM NaCl pulse was added to 
this solution. A sharp 13C NMR signal for the intravesicular H13CO3⁻ was observed at 
δ 162 ppm. After addition of prodigiosin 1, a sharp 13C NMR signal for H13CO3⁻ 
appeared due to transport of bicarbonate out of the liposome mediated by 1. A 
paramagnetic ion, Mn2⁺ was added to broaden any 13C NMR signal originating from 
extravesicular H13CO3⁻ anion, whereas the 13C NMR signals for intravesicular H13CO3⁻ 
remained unaffected by the membrane-impermeable Mn2⁺. Thus, these NMR 
experiments allowed for the discrimination of extravesicular and intravesicular 
H13CO3⁻ and enabled the transmembrane movement of anion to be established. 
 The natural product prodigiosin 1 facilitated Cl⁻/HCO3⁻ anion exchange, a 
process that is typically mediated by membrane proteins. Since then the field of anion 
recognition and transport has seen the advent of many innovative receptors. The 
investigations have also paved way for new guest molecules and the study of their 
transmembrane transport properties. Scientists are become increasingly interested in 
looking at membrane transport of biologically relevant ions or small molecules other 
than chloride, nitrate and bicarbonate anions. These new molecules include 
oligonucleotides, amino acids, and less-common anions. 
 Prodigiosin 1 can Target Anions Other than Cl⁻ 
 Chloride, nitrate and bicarbonate anions are the most commonly studied anions 






looked at anions like sulfate,80 perrhenate (ReO4⁻),81 lactate, pyruvate and propionate82 
and the receptors that can selectively assist these anions to diffuse through membranes. 
Hou and group have been working with pillarenes that can transport chiral amino acids 
selectively across liposomal membranes.83 Gokel et. al. expanded their chloride 
transporting dipicolinamide derivatives into receptors that are capable of binding and 
transporting large DNA plasmids (>20 kb) across cell membranes of E. Coli.82,84 
Matile, Riezman and group have developed a library of dynamic amphiphiles that can 
help in migration of siRNA into HeLa cells and human primary fibroblasts.85  There 
are many other examples that illustrate the expansion in the field of anion transport 
with respect to the targeted anions. Even though prodigiosin 1 is one of the most 
effective anion transporters in literature,86 it has not been used for binding any anions 
other than the commonly found Cl⁻, NO3⁻ and HCO3⁻ anions. In Chapter 5, we have 
described a study involving investigation of binding interactions between prodigiosin 
1 and a polyanionic species, DNA. We found that prodigiosin 1 can end stack with a 
G-quadruplex DNA. This study is of potential significance, as it could provide another 
mechanism to explain the anti-cancer properties of prodigiosenes. Additionally, it gives 
rise to the prospect of developing prodigiosenes as telomerase inhibiting ligands.  
 Over time, groups have also become interested in developing methodologies 
that can be used to regulate ion transport across membranes, using external stimuli. The 







 Some Examples of Gating Anion Transport  
 Last decade saw a wealth of receptor molecules that were developed to 
selectively move anions across a bilayer.74,75,87,88  In most cases, the process of ion 
transport was triggered by imbalance in either ion concentration or pH across the lipid 
membrane. However, scientists have started to think a step beyond these regular ion 
transport processes. Research groups are now looking for a greater control of ion 
transport process. In nature, the conduction of ions across membranes is controlled by 
various mechanisms. One such example of ClC channel is described below.89 For this 
reason, methodologies are being developed that would allow for regulation of flow of 
ions across a membrane using an external stimuli. Some of these examples of gating of 
anion transport in natural and vesicle-like systems are discussed.  
 Gating Influenced by Conformational Changes in ClC Channel 
 Naturally-occurring ClC channel is an example of a pre-organized active site in 
an ion channel for binding chloride selectively.89 Serine (S107), tyrosine (Y445), and 
isoleucine (I356) residues form a portal to the channel opening. All these residues 
undergo hydrogen bond formation with Cl⁻ anion by using their NH and OH protons. 
A glutamate residue (E148) is present at the opening of the selectivity filter (Figure 
1.15).89,90 ClC channel makes use of the glutamate residue (E148) to control opening 
and closing of the channel, which ultimately regulates the flow of Cl⁻ ions. A 
conformational change caused due to protonation of glutamate residue can result in 
opening of the channel while, deprotonation can cause the channel to close in its resting 






across membranes. Some examples are described next, which allow for an on/off 
mechanism for transport of ions.  
 
Figure 1.15. Schematic drawing of the closed and opened conformation of a ClC 
chloride channel. In the closed conformation, the ion-binding sites Sint and Scen are 
occupied by Cl⁻ ions, and the ion-binding site Sext is occupied by the side chain of Glu 
(E148). In the opened conformation, the side chain of E148 has moved out of binding 
site Sext into the extracellular vestibule. Sext is occupied by a third Cl⁻ ion. Chloride 
ions are shown as red spheres, the E148 side chain is colored red, and hydrogen bonds 
are drawn as dashed lines. Reprinted with permission from Science 2003, 300, 108-
112. Copyright (2003) AAAS.89 
 Photoresponsive Ion Gating 
 Zhu and group designed a novel compound 13, which is a combination of a 
crown ether and a photo-responsive azobenzene group.91 Ion conduction by 13 can be 
regulated by cis-trans photoisomerization. The structural design of 13 comprises a 






azobenzene group acts as a switch to regulate ion flow (Figure 1.16). A 12-carbon 
chain helps in providing enough hydrophobicity to the molecule so that it can partition 
in and out of the membrane. There is an additional amide NH group, which contributes 
towards the supramolecular assembly via hydrogen-bonding to the target anion.  
 
Figure 1.16. Structure of compound 13. a) Schematic representation of the light-
regulated ion channel. The switching between trans and cis isomer at 365 nm and 450 
nm. Trans isomer tends to aggregate in solution and shows low transport activity, 
whereas the cis isomer forms a channel inside the membrane resulting in a high 
transport activity. b) Transport activity measured based on fluorescence of safranin O 
dye for cis and trans isomer. Adapted with permission from Chem. Commun. 2013, 
(49), 10311-10313. Copyright (2013) Royal Society of Chemistry.91 
 Patch-clamp technique and HPTS assay in liposomes were employed to monitor 
transport activity, and confirm channel formation along with cis-trans transformation. 






than partitioning into the membrane. Due to decreased partitioning ability, trans-13 
tends to precipitate out of solution, leading to low ion transport activity (Figure 1.16). 
An increase in transport activity was observed upon irradiation at 365 nm. Trans to cis 
conversion takes place at 365 nm so the increased transport activity was attributed to 
the newly formed cis conformation. Another irradiation at 450 nm switched the cis-
isomer back to trans. The photoswitching was followed by a decrease in current flow, 
which was attributed to the low transport activity exhibited by trans-isomer. 
 Voltage-Gated Anion Transport  
 Anion transport can also be regulated as a function of voltage, as illustrated in 
the work done by Hou et. al.92 Inspiration for this work came from naturally occurring 
voltage-gated K⁺ channels that contain positively charged Arg units.93 Hou and group 
had previously demonstrated that hydrazide-appended pillar[5]enes containing 
phenylalanine residues can selectively transport certain amino acids such as glycine, 
alanine, serine, etc.83 In the same scaffold, Arg units were introduced to give new 
pillarenes 14.92 Arg residues are positively charged and therefore, hydrophilic by 
nature. Due to the hydrophilic Arg units, peptide 14 is unable partition into the lipid 
bilayer of KCl encapsulated EYPC vesicles (Figure 1.17a), as determined by patch-
clamp experiments. In the patch-clamp experiment, negative potential was set to 
increase from -10 to –100 mV in ten steps, with every pulse lasting 30 s, while the 








Figure 1.17. Structure of pillarenes 14. Schematic presentation for the voltage-driven 
channel insertion and exit from the lipid bilayer. a) High hydrophilicity of arg units 
restricts the entry of pillarenes into the lipid membrane. b) Application of voltage 
polarizes the membrane which, facilitates the insertion of pillarene 14 into the 
membrane. c) The alternative negative potential (30 s) and +100 mV (90 s) potential 
pulse protocol. The negative potential (30 s) increased from -10 to -100 mV in ten steps, 
while the positive potential was kept constantly at +100 mV. d) The macroscopic 
current trace of 14 by applying the pulse in (c). Inset: The expanded current trace (30 
s) at -50 mV showing the single-channel current. Reprinted with permission from 
Angew. Chem. Int. Ed. 2014, 53 (18), 4578-4581. Copyright © 2014 Wiley-VCH 






 Negative potential facilitated the insertion of channels while a positive potential 
drove them away from the bilayer. Channel insertions were accompanied by current 
flow that was measured (Figure 1.17d). Thus, the voltage variation influenced the 
insertion and departure of channels from the bilayer and subsequently, the conduction 
of ions through the lipid membranes. 
 Inhibition of Ion Activity by Formation of Inclusion Complexes 
 Two examples have been described here that make use of inclusion complexes 
for inhibiting ion transport activity of ionophores in solution. Imidazolium salts (15) 
are a new and unexplored class of potential anion transporters (Figure 1.18).94 They 
can self-organize through H-bonds, π-stacking and electrostatic interactions. The 
resulting assemblies can insert into bilayers and act as ion channels.94 In this study, the 
authors explored the possibility of formation of inclusion complexes by imidazolium 
salt 15 in presence of α-CD or CB7, which would inhibit the anion transport activity of 
imidazolium salt 15 in aqueous conditions. The hypothesis was that both α-CD and 
CB7 would incorporate the aromatic arms of 15 into their hydrophobic cavity (Figure 
1.18b). The α-CD and CB7 are hydrophilic by nature and do not interact with the lipid 
membrane. In a liposome experiment using the LG assay, vesicles encapsulated with 
NaCl and LG were used. To initiate Cl⁻ transport, compound 15 was added along with 
1 or 2 eq of either α-CD or CB7.  It was found that 1 or 2 eq of CB7 partially inhibited 
the transport ability of 15 (Figure 1.18c). An addition of 2 eq of α-CD completely 







Figure 1.18. a) Structure of imidazolium salt 15 b) Schematic representation of the 
formation of inclusion complexes of 15 with CB7 and α-CD and displacement of the 
transporter from the bilayer. c) Relative activity of compound 15  (0.25 mM) in the 
presence of a-CD and CB7: intravesicular 100 mM NaCl, 10 mM phosphate buffer, 
extravesicular 100 mM NaNO3, 10 mM phosphate buffer (pH 6.4). Receptor 15 was 
injected at t = 35 s. Triton-X was injected at t = 500 s. Adapted and reprinted with 
permission from Chem. Commun. 2011, 47, 1788-1790. Copyright (2011) Royal 






 The formation of the inclusion complexes between 15 and α-CD or CB7 was 
confirmed by 1H NMR, UV spectroscopy studies and Jobs’ plots. The authors 
rationalized that the formation of water-soluble inclusion complexes between 15 and 
α-CD or CB7 probably reduces the chances of 15 to partition into the lipid bilayer. 
Since less self-assembled aggregates of 15 are present in the bilayer, transmembrane 
anion transport is inhibited.  
 Another example of inhibition of anion transport is of the cholic acid 
functionalized thread.95 The anion transport activity of the amphiphilic thread could be 
inhibited in solution by the assembly of a [2]-pseudorotaxane between compounds 16 
and 17 (Figure 1.19b), due to interaction between the quaternary ammonium site on 
16 and macrocycle 17, also confirmed by 1H NMR studies. Formation of the [2]-
pseudorotaxane blocks the ammonium site, which reduces Cl⁻ complexation and 
transport. Figure 1.19c shows the order of addition of 16 and 17 is not important. The 
anion transport activity of the [2]-pseudorotaxane is identical to that of free 17, as well 
as the mechanically blocked [2]-rotaxane. A sudden quenching in fluorescence is 
observed when 17 is added after 16, presumably due to formation of the 
pseudorotaxane. The residual Cl⁻ transport after formation of the [2]-pseudorotaxane 
is probably due to the complexation of Cl⁻ by the pyridinium moiety of the macrocycle 
17. Upon complexation between the quaternary ammonium site on 16, macrocycle 17 







Figure 1.19. a) Structure of amphiphilic thread 16 and pyridyl containing macrocycle 
17. b) Schematic representation of the formation of inclusion complexes between 16 
and 17. c) Relative anion transport activity of compounds 16, 17, their complex and the 
pre-formed rotaxane in the LG-based assay. Intravesicular conditions: 100 mM NaCl, 
10 mM phosphate buffer, 2 mM LG; extravesicular conditions: 100 mM NaNO3, 10 
mM phosphate buffer (pH 6.4). Adapted and reprinted with permission from Med. 








 The two examples described above successfully demonstrate that the anion 
transport properties of certain anionophores can be modulated by complexation with 
other macrocycles in solution.  
 Effect of Intramolecular Hydrogen Bonding on Anion Transport Property  
 In a series of publications including a QSAR analysis of phenylthiourea 
receptors, the authors showed that the anion transport ability of thioureas could be 
modulated by the varying lipophilicity of the receptors, triggered by substituent 
effects.96,97 Lipophilicity plays an essential role in drug design as it affects the 
membrane permeability, absorption and distribution of a drug.98 Usually, lipophilicity 
of a molecule can be enhanced by introducing lipophilic functional groups onto the 
scaffold. In this study, intramolecular hydrogen bonding and substituent effects were 
utilized to increase the lipophilic character of novel series of anion receptors 
acylthioureas.99 However, the description below focuses on a simple unsubstituted 
acylthiourea 19 and thiourea 18 (Figure 1.20). As shown in Figure 1.20b, acylthiourea 
can form six-membered intramolecular hydrogen-bonded rings that reduce the 
hydrophilicity of the receptor. As a result, acylthiourea 19 was reasoned to be more 
lipophilic than analogous thiourea 18. The intramolecular H-bonding in 19 was 
confirmed by X-ray crystal structure that showed a 6-membered hydrogen-bonded ring 







Figure 1.20. a) and b) show structures of thiourea 18 and acylthiourea 19. c) Chloride 
efflux mediated by receptors 18 and 19 (2 mol% with respect to lipid) from POPC 
vesicles containing 489 mM NaCl buffered to pH 7.2 with 5 mM sodium phosphate 
salts. The vesicles were suspended in 489 mM NaNO3 buffered to pH 7.2 with 5 mM 
sodium phosphate salts. Receptors were injected into the lipid solution. Adapted from 
Org. Biomol. Chem. 2014,12, 62-72. Copyright (2014) Royal Society of Chemistry.99 
 Anion transport activities of thiourea and acylthiourea in lipid vesicles were 
compared using a chloride selective ion electrode assay (Figure 1.20c).99 Compound 
19 was found to be more active in exchanging anions across bilayer as compared to 18. 
In conclusion, acylthioureas were found to be more efficient anion receptors as 
compared to thioureas due to higher lipophilicity caused by the formation of an 
intramolecular hydrogen bond, which shields the binding site from interactions with 






lipophilicity of the receptor, which can be varied based on different substituents added 
to the receptor scaffold.  
 Ion-Gating in Nanochannels 
 In this paper, a non-covalent approach was adopted for regulation of ion 
transport in nanochannels.100 Flow of ions through nanochannels depended on the 
surface charge inside the channels. Using two different approaches, the ion flow could 
be switched to be selective to cations, anions or ambipolar flow. The first approach 
made use of charge-transfer (C-T) supramolecular motifs between a dicationic viologen 
20 as acceptor and trianionic pyranine 21 as donor (Figure 1.21). The second approach 
depended on pH and has been explained in more detail.   
 The transport across the nanopores of viologen-modified mesoporous silica 
films (MF-V) was investigated using cyclic voltammetry with [Fe(CN)6]3⁻ and 
[Ru(NH3)6]
3⁺ as anionic and cationic electroactive probes, respectively. The viologen-
coated positively charged pores of the MF-V elicited a strong and selective 
electrochemical response for the transport of anionic [Fe(CN)6]3⁻ probe. No response 
to the cationic [Ru(NH3)6]
3⁺probe was observed owing to the unipolar environment 
inside the nanopores. To reverse the surface charge within the pores, MF-V was soaked 
in pyranine 21 solution for 16 h. This resulting MF-V incorporated non-covalent 
interactions between the positively charged viologen 20 (with a 2+ charge) and 
negatively charged pyranine 21 (with a 3- charge), showing a strong electrochemical 
response to cationic probe, [Ru(NH3)6]






the cyclic voltammogram. A complete reversal of ionic transport from anion selective 
to cation selective indicating charge-reversal inside the nanopores was observed.  
 
Figure 1.21. Non-covalent functionalization of viologen 20 modified nanopores with 
negatively charged donor, pyranine 21, to switch the gating properties of the nanopores 
from anion selective ([Fe(CN)6]3⁻) to cation selective ([Ru(NH3)6]3⁺). Reprinted with 
permission from Angew. Chem. Int. Ed. 2014, 53 (48), 13073-13077. Copyright © 2005 
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.100 
 The second approach also made use of CT-supramolecular motifs, but 
depended on pH regulation. In this case, the donor species was replaced by coronene 
tetracarboxylate (CS) 22 with four carboxylate groups whose protonation can be 
modulated with pH. The viologen containing MF-V films were soaked in CS solution 







Figure 1.22. Cyclic voltammograms corresponding to coronene tetracarboxylate 22 
bound MF-V in the presence of 1 mM [Ru(NH3)6]
3⁺ (red trace) and 1 mM [Fe(CN)6]3⁻ 
(blue trace) at different pH conditions: a) 9, c) 6 and e) 3. Scan rate: 200 mVs⁻1, 
supporting electrolyte: 0.1m KCl. The corresponding schematics are given as (b), (d) 
and (f). Reprinted with permission from Angew. Chem. Int. Ed. 2014, 53 (48), 13073-
13077. Copyright © 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.100 
 To explore pH responsive transport, ion conductance through the nanopores of 
CS bound MF-V film was investigated at pH 9, 6 and 3. At pH 9, voltammogram 
showed a high transport for positively charged [Ru(NH3)6]
3⁺ probe, suggesting 






number of deprotonated carboxylate groups of 22 at pH 9 (Figure 1.22b). At pH 6, 
voltammograms were similar for both positive and negative probes indicating 
ambipolar transport (Figure 1.22c), suggesting that probably two of the four CS 
carboxylate groups are protonated, which neutralized the dicationic viologen inside the 
pores (Figure 1.22d). At pH 3, negatively charged [Fe(CN)6]3⁻ was preferentially 
transported as most of the carboxylate groups were protonated (Figure 1.22e-f). Thus, 
a pH responsive donor facilitated the switching between selectivity towards cation, 
anion and ambipolar conductance through the nanopores. Voltammograms were 
reproducible through three cycles of pH switching, thus showing good reversibility. 
Thus, the supramolecular C-T motif allowed for a unique nanochannel system whose 
ion transport activity could be regulated by different approaches.   
 pH Tunable Thiosquaramides as Anion Transporters 
 A series of thiosquaramides were synthesized and tested for their pH-dependent 
chloride binding and anion transport behavior using 1H NMR titrations, single crystal 
X-ray diffraction and a variety of lipid vesicles-based techniques.101 Based on UV-vis 
titrations, pKa values of the thiosquaramides were found to be in the range 4.0–8.0. This 
would imply that at pH 7.2 or greater, a large proportion of the thiosquaramides will be 
deprotonated and in a negatively charged form (Figure 1.23a). Due to charge repulsion, 
the anion binding and transporting ability of squaramides will be switched OFF. 
Inversely, at pH <7, majority of the compound should be present in its neutral form and 







Figure 1.23. a) Schematic representation showing ON/OFF switching of anion 
transport by thiosquaramide 23. b) Chloride efflux from POPC vesicles at pH 7.2 and 
pH 4.0. POPC vesicles were loaded with a 489 mM NaCl solution buffered to pH 7.2 
with 5 mM phosphate salts or to pH 4.0 with 5 mM citrate salts, and were suspended 
in a 489 mM NaNO3 solution buffered to pH 7.2 with 5 mM phosphate salts or to pH 
4.0 with 5 mM citrate salts. DMSO was used as a control. Adapted from Chem. Sci. 
2014, 5, 3617-3626. Copyright (2014) Royal Society of Chemistry.101  
 This hypothesis was tested in liposomes loaded with a NaCl solution (489 mM) 
and suspended in a NaNO3 solution (489 mM) buffered to pH 7.2. Chloride efflux was 






The anion transport data is shown for thiosquaramide 23 in Figure 1.23b. At pH 7.2, 
low anion transport was reported for 23. Similar anion transport experiments were 
repeated at pH 4.0. This time, the anion transport ability of thiosquaramide 23 was 
significantly enhanced. The transport results at different pH values support the initial 
hypothesis about pH regulated anion transport ability of thiosquaramides. Similar 
results were obtained with different vesicle assays. The pH-switchable transport 
behavior gives the thiosquaramides more potential for biological significance, since the 
control of ion transport process is of utmost importance in a biological setting. 
 The examples discussed above involved regulation of ion flow through a 
phospholipid membrane under the influence of structural changes, voltage, light and 
pH. As described earlier, many of the naturally occurring chloride transporting proteins 
or channels exhibit a gating or switching mechanism (Section 1.6.1). In Section 
1.4.2.2., the correlation between HCl symport and apoptosis was also described. This 
correlation has encouraged the possibility of using ion transporters for cancer 
therapy.10,25,27 The internal and external pH of cancer cells has been shown to be 
different from that of healthy cells.63 Therefore, pH switchable chloride transporters 
have the potential to become promising leads for anti-cancer drugs. For the ion 
receptors to be biologically relevant, the pH-regulation must occur around the 
physiological pH of 7.4. Additionally, the range of pH switch should correspond to the 
pKa value of the receptor under the conditions of the anion transport experiments. In 
Chapter 2 and 3, I have described a novel set of prodigiosenes whose anion transport 






pH. Most prodigiosenes have pKa values in the range of physiological pH (6 to 8), 
therefore, improving the chances of using these analogs as anti-cancer agents. To our 
knowledge, this is the first time that a pH-regulated transmembrane anion transport 
study has been done with prodigiosenes.   
 Summary 
 Prodigiosin 1 is a natural product with three pyrrole rings. Compared to 
naturally occurring ion channels and proteins, it is a small molecule. Yet, based on 
multiple scientific undertakings, it has been shown to be an excellent transmembrane 
anion transporter in the field.86 Prodigiosenes have been identified for their different 
biological activities such as anti-cancer,2⁻4 immunosuppressive,5,6 anti-malarial,7 and 
antimicrobial8 therapeutic properties. They can also intercalate with dsDNA.39 
Naturally, the biological diversity of prodigiosenes has ensured the development and 
study of numerous synthetic analogs for ion transport or biological activities.9,10, 24,77 
Despite the large amount of work that has already been done with prodigiosenes in 
establishing their many roles as potential therapeutics, there’s still a lot more to do. For 
instance, the molecular mechanism of action for the anti-cancer properties of 
prodigiosenes still needs to be unambiguously established.     
 This chapter described two major roles of prodigiosenes – a) in the movement 
of anions across membranes and b) their potential as anti-cancer agents. The proposed 
mechanisms for anti-cancer properties of prodigiosenes were discussed. Further, some 
groups have found correlations between the in vitro anti-cancer activity of 






have been extensively tested for their anion transport properties with goal of developing 
these compounds as potential drugs for treatment of diseases like Bartter syndrome and 
cystic fibrosis. Our contribution to the field of anion transport is the identification of 
novel prodigiosenes, some of which, have shown excellent transport rates with reduced 
cytotoxicity (Chapter 2). We were also successful in manipulating the transport rates 
by changing the basicity of prodigiosin derivatives (Chapter 3). Specific chemical 
properties of prodigiosenes are explored in Chapter 4. Lastly, Chapter 5 is a 


















 Chapter 2: Synthetic Prodigiosenes and the Influence of C-Ring Substitution 
on Transmembrane Chloride Transport and Basicity 
The majority of this chapter has been published in reference 114: 
 Rastogi, S.; Marchal, E.; Uddin, I.; Groves, B.; Colpitts, J.; McFarland, S. A.; 
Davis, J. T.; Thompson, A. “Synthetic Prodigiosenes and the Influence of C-
Ring Substitution on DNA Cleavage, Transmembrane Chloride Transport and 
Basicity” Org. Biomol. Chem., 2013, 11, 3834-3845. 
Syntheses of all compounds 2a-j and 24 described in this chapter were performed by 
Dr. Alison Thompson and her group, our collaborators from Dalhousie University, 
Canada. Compounds 1, 2 and 24 were tested against 60 human cancer cell lines by the 
Developmental Therapeutic Program at NCI, NIH. 
Background 
 Introduction 
 Prodigiosin is the parent compound of the tripyrrolic natural products known as 
the prodigiosenes.1 Although the prodigiosenes possess various biological activities, 
they have also displayed high cytotoxicity in early studies.11 As a result, it becomes 
imperative to develop new synthetic analogs that share the same level of therapeutic 
efficacy as the natural products but exhibit reduced cytotoxicity. In this chapter, 
analogs of the tripyrrolic natural product prodigiosin 1 bearing an additional methyl 
and a carbonyl group at the C-ring were synthesized by our collaborators and evaluated 






transmembrane transport of chloride anions of these synthetic analogs (2a-j and 24) 
showed that the presence of the extra methyl group is not detrimental to activity. 
Furthermore, although the presence of an ester conjugated to the prodigiosene C-ring 
decreases both pKa and chloride transport efficiency, as compared to the natural product 
1, these analogs still exhibit a high rate of chloride transport. The effect of C-ring 
modifications in prodigiosenes 2a-j and 24 on their basicity, transmembrane anion 
transport ability and their in vitro anticancer activity have been described in this 
chapter. For background on C-ring modified prodigiosenes, I have given a brief account 
of the studies previously done, with particular emphasis on their biological activity.  
 
Figure 2.1. Natural product prodigiosin (1) and C-ring modified synthetic analogs – 
ester (2a-j) and 24. 
 Previous Work with C-Ring Modified Prodigiosenes 
 Prodigiosin 1 is a red tripyrrolic pigment isolated from bacteria of the Serratia 
and Streptomyces genus (Figure 2.1).6,9,42,102 This natural product and some of its 






being the ability to induce apoptosis of malignant cells. 21-23,48 Considering these 
properties, considerable effort has been directed towards the synthesis of prodigiosin 
and its analogs.5,12,103⁻107 In the next section, a few examples of the C-ring 
functionalized prodigiosin analogs have been described.  
 Earlier Examples of C-Ring Modified Prodigiosenes 
 For the goal of synthesizing prodigiosenes with enhanced cytotoxicity and 
improved toxicological profiles, derivatives with various functional groups have been 
synthesized, such that the newly introduced functional groups might help in attaching 
cell-targeting moieties.108 Discussed below are some examples of C-ring modified 
prodigiosenes and their reported biological activity.  
 Boger’s Prodigiosene 25 
 In order to investigate the effect of peripheral appendages on prodigiosin 
scaffold, Boger and Patel synthesized analog 25 (Figure 2.2).103 Compound 25 does 
not contain any functional groups on rings B and C. In an in vitro cell proliferation 
study, comprising of various cancer cell lines for melanoma (B16 mouse), leukemia 
(L1210 mouse, 9PS (P388) mouse) and human epidermoid carcinoma of the 
nasopharynx (9KB), compound 25 was found to be ineffective as compared to 
prodigiosin 1. For all cancer cell lines, prodigiosin 1 was found to have IC50 values that 
were at least 200 times lower than the values for 25. IC50 values are defined as the 
inhibitory concentration for 50% cell growth relative to untreated control. The study 
by Boger and Patel suggested that the substituents on the prodigiosin scaffold are 







Figure 2.2. Structures of prodigiosene 25 and prodigiosin 25-C (7). 
 Prodigiosin 25-C 
 Prodigiosin 25-C (undecylprodigiosin) 7 has been extensively studied for its 
biological activity (Figure 2.2).5,19,57 Compound 7 differs from prodigiosin 1 due to the 
presence of a 11 carbon aliphatic chain on its C-ring. In 1995, Kataoka and colleagues 
showed that prodigiosin 25-C could neutralize acidic organelles located within the 
cytotoxic T cells.19  By neutralizing the acidic interiors of T cells, prodigiosin C-25 
acted as an immunosuppressant and inhibited the cytotoxicity of T cells.  
 In a separate paper in 1995, Kataoka and group explained that the 
immunosuppressive properties of 7 were due to its ability to neutralize the proton-
translocation activity of V-ATPase enzyme.57 The neutralization of proton pump does 
not affect the ATP hydrolysis activity of V-ATPase. This study by Kataoka and 
colleagues further bolstered the theory about immunosuppressive properties of 
prodigiosin 25-C.  
 As described in Section 1.4.2.1, compound 7 was also used in experiments done 
to prove that prodigiosenes uncouple V-ATPase proton translocation activity by 






the first time that prodigiosenes were proposed to bind and transport anions across 
natural bilayer membranes.  
 Indole-Based Prodigiosenes by Wasserman 
 Wasserman and colleagues synthesized a library of indole-based derivatives, 
like 26, called indoloprodigiosins.110 These compounds were formed by the 
condensation of a C-10 methoxybipyrrole aldehyde with different indole derivatives. 
Some of the indoloprodigiosins contained an aromatic benzene group fused with ring 
C, while others contained a fused aliphatic group like cyclohexane. The 
indoloprodigiosins were tested and compared with prodigiosin 1 for their cytotoxicity 
towards different cancer cells (A549, DLD-1, HT29, MDA-MB-231 and NCI-
H460).110 Prodigiosin 1 was found to be most active amongst the compounds tested, 
with IC50 values in the range of 0.03 – 0.17 μM for all cancer cell lines. Amongst the 
tested indoloprodigiosins, compound 26 was found to cause maximum inhibition in 
cellular proliferation with IC50 values ranging between 0.2 to 1.3 μM (Figure 2.3). The 
significant activity shown by compound 26 was attributed to the ability of ring C to 
react as a dialkyl pyrrole, similar to prodigiosin 1. Based on the cell proliferation 
studies, Wasserman and his group concluded that the mechanism of action for 
cytotoxicity exhibited by prodigiosin and indoloprodigiosins might be related. 







Figure 2.3. Structures of indoloprodigiosin 26 and C-ring prodigiosenes 27-29. 
 C-Ring Functionalized Prodigiosenes by Thompson 
 In 2007, Thompson and group synthesized a series of prodigiosin derivatives 
with pendant functional groups such as esters (27) and ketones (28) on ring C (Figure 
2.3).2 Pendant groups like esters can help in further derivatization of the prodigiosin 
skeleton. Later on in 2013, compound 29 was tested for its antimicrobial activity and 
found to be reasonably active.8 New prodigiosene conjugates were synthesized by 
addition of tamoxifen, estrone and porphyrin moieties to 29 and analogs. These 
prodigiosene conjugates were tested for their anti-cancer activity.4,111 Some of the 
conjugates were found to be active, even at nM concentrations, thereby, paving the way 
for more investigations into these new class of compounds.  
 However, when these pendant prodigiosenes were first synthesized in 2007, it 
was essential to determine the effect of the pendant groups on the biological activity of 
these new prodigiosenes 27-29. Therefore, some of the analogs were tested against 60 
human cell lines derived from nine cancer cell types by the National Cancer Institute 
(NCI). The anti-cancer activity of the synthetic derivatives was compared with that of 






GI50, TGI and LC50 (Table 2.1). Compound 27 was found to have in vitro activity 
comparable to that of prodigiosin 1 (Table 2.1). Compound 29 exhibited sufficient 
activity to indicate potential broad spectrum growth inhibition of a variety of tumors. 
On the other hand, 28 did not exhibit any relevant anti-cancer activity. From these 
collective results of in vitro cell proliferation studies, a conclusion was made that the 
conjugated ester (27) or the pendant ester (29) did not significantly affect the activity 
of prodigiosenes because derivatives bearing these functional groups exhibited anti-
cancer activity very similar to that of prodigiosin 1.2 








Prodigiosin 1 -7.85 -5.68 -6.65 
27 -7.33 -5.96 -4.91 
28 -6.15 -4.39 -4.05 
29 -6.10 -5.49 -4.91 
aGI50 = half maximal growth inhibition concentration. 
bTGI = total growth inhibition 
concentration.   cLC50 = half maximal lethal concentration    
 
 Rationale for Studying Influence of C-Ring Substitution on 
Transmembrane Chloride Transport and Basicity  
 We have studied prodigiosin derivatives, including those with an extra methyl 
group on the C-ring (24), as well as analogs (2) that bear a C-ring conjugated 
carbonyl.2,112 These extra groups have been introduced so as to confer increased 
stability of the synthetic intermediates and facile isolation of this genre of compounds 






in conjugation of other moieties to the prodigiosene scaffold.4,8,111 In this chapter, we 
report the influence of these C-ring modifications upon the ability of the prodigiosenes 
to effect in vitro anticancer activity and their ability to catalyze transmembrane anion 
exchange. Of particular importance are the findings that: (i) the extra methyl group on 
the C-ring of 24 does not significantly diminish the in vitro anticancer activity, or the 
anion transport activities of the synthetic analogs relative to prodigiosin 1; (ii) the 
analogs generally retain the potent in vitro anticancer activities of the parent natural 
product; and (iii) the electron-withdrawing carbonyl functionality on the C-ring makes 
the synthetic esters 2 less basic than the natural product 1, which helps to rationalise 
why the ester analogs are less effective than prodigiosin 1 as transmembrane anion 
transporters at pH 7.4.  
Results 
 Study of Transmembrane Anion Transport Activity of Prodigiosin 1, Ester 
Analog 2 and 24 
 To investigate possible mechanisms that might contribute toward the anticancer 
activities of prodigiosenes, the transmembrane anion transport properties of synthetic 
prodigiosenes 2 and 24 were evaluated using an EYPC (egg-yolk l-
phosphatidylcholine) liposome model. For this assay the chloride-specific fluorescent 
dye lucigenin (LG) was used as a probe to track chloride ion export from the liposome, 
since LG fluorescence is selectively quenched by chloride, but not by nitrate anion.113 
Thus, EYPC liposomes loaded with LG and NaCl were suspended in a buffered 






of EYPC liposomes, the fluorescence of the intravesicular LG increased, indicating that 
the added transporter was catalyzing an anion exchange process between the 
intravesicular chloride anion and the extravesicular nitrate anion (Figure 2.4). Based 
on the results obtained from the liposome experiments, we were able to make some 
conclusions about the anion transport activity of prodigiosenes 2 and 24. The 
observations made from different liposome experiments and their conclusions are 
described in the following sections.  
 EC50 Values for Cl⁻/NO3⁻ Exchange Process Demonstrate the Effect of      
C-Ring Modifications in Prodigiosenes 
 Figure 2.4 shows representative LG fluorescence curves from preliminary 
screening experiments, plotted as a function of time, after addition of either the natural 
product prodigiosin 1, the methylated analog 24 or the pentyl-ester 2e (in each case the 
prodigiosene was added as a DMSO solution at a concentration that was 0.04 mol% 
ligand:lipid ratio). Under these conditions, the synthetic prodigiosene 24 had a 
qualitatively similar Cl⁻/NO3⁻ anion transport activity as did prodigiosin 1. This result 
indicates that addition of the extra methyl group to the C-ring does not diminish the 
prodigiosenes’ anion transport activity. This is a significant result since it is easier to 







Figure 2.4. Structures of compounds 1, 2e and 24. Anion exchange results for the 
natural product prodigiosin 1 relative to synthetic analogs 2e and 24. Anion exchange 
in EYPC liposomes was monitored by measuring the fluorescence of LG (λex = 372 
nm, λem = 504 nm) at 25 °C after addition of 0.04 mol% of prodigiosene transporter 
relative to EYPC lipid. The EYPC liposomes, containing 1 mM LG, 20 mM HEPES 
buffer (pH 7.4) and 100 mM NaCl were suspended in a solution of 100 mM NaNO3 
and 20 mM HEPES buffer (pH 7.4). At t = 30 s, the prodigiosene transporter in DMSO 
was added. At t = 660 s, addition of Triton-X lysed the liposomes. Traces shown are 
an average of three trials. 
 In contrast to the methylated analog 24, the pentyl-ester 2e is a less efficient 






compare the anion transport abilities of 1, 24 and the ester-containing analog 2e, the 
EC50 values for each receptor were calculated. EC50 is defined as the concentration of 
transporter needed to achieve 50 % of maximal chloride efflux at t = 150 s at 25 °C. 
The EC50 values are calculated based upon the Hill equation, which considers the 
degree of saturation (or maximal Cl⁻ efflux) as a function of ligand concentration.115 
In the experiment, a series of concentration dependent fluorescence measurements were 
performed for Cl⁻/NO3⁻ exchange catalyzed by these three analogs. For each receptor 
concentration, the LG fluorescence measurements were converted into the 
concentration of Cl⁻ ion efflux ([Cl⁻]eff) by using Stern-Volmer equation.115,116 Then, 
the EC50 values were determined from a dose-response curve plotted between the 
concentrations of a receptor and the [Cl⁻]eff facilitated by that particular receptor. More 
details on the procedure for calculating EC50 values (including dose-response curves) 
are described in Chapter 7. The calculated EC50 values for transporters 1, 2e and 24 
are recorded in Table 2.2. The increased EC50 values for ester 2e, relative to prodigiosin 
1 and the methylated analog 24, indicates that substitution of the prodigiosene C-ring 
with an electron-withdrawing ester decreases the anion transport efficiency of the 
compound, since 2e (EC50 =18.7 nM) had an EC50 value that was approximately 10-
fold higher than 24 (EC50 =1.3 nM). 
Table 2.2.  EC50 values for the transmembrane anion transport abilities of 1, 2e and 24. 
Prodigiosene 1 2e 24 
aEC50 (nM) 3.2  18.7 1.3  
aEC50 values indicate the concentration of transporter needed to achieve 50% of 







 Even though the ester 2e showed a decreased anion transport ability when 
compared to prodigiosin 1 and its methyl analog 24, it should be recognized that this 
synthetic prodigiosene remains an extremely potent anion transporter. For example, the 
experiments in Figure 2.4 were conducted using a relatively low concentration of 
prodigiosene (0.04 mol% ligand:lipid ratio). For comparison, many synthetic 
transmembrane chloride transporters described in the literature are typically used at 
concentrations as high as 1-2 mol% relative to lipid to achieve similar rates of 
transmembrane chloride transport.117 
 Ester Chain Length Affects the Ability to Transport Cl⁻ Across Bilayers 
 Having demonstrated that ester 2e was a formidable anion transporter, next, we 
investigated the influence of the alkoxy group on the transmembrane anion transport 
with same experimental conditions as before (Figure 2.4). The experiment involved 
testing ester analogs 2 of varying chain lengths as anion transporters. Receptors with 
shorter chain lengths (2a-2d) were found to be better anion transporters than 
compounds with longer chains (2g).  
 By varying the length of alkoxy chain on ring C, the lipophilicity of the 
prodigiosenes 2 was manipulated. In their publications, Quesada and Gale showed, 
based on a series of related compounds, that lipophilicity can play a vital role in the 
process of ion transport.118,119 In pharmaceutical industry, lipophilicity is an important 
parameter in drug development.98 The effective application of a therapeutic drug 
involves membrane translocation steps.120 Quesada and colleagues recently showed 






can be tuned by varying their lipophilicity.118  Gale and group studied a series of urea 
and thiourea based anion receptors.119 They varied the log P values and found that the 
change in lipophilicity had a direct impact on the transport ability of these urea and 
thiourea based receptors. Log P, the logarithm of the octanol/water partition 
coefficient, is the most widely used measure of lipophilicity.  
 
Figure 2.5.  Anion exchange results for prodigiosenes 2a-d, 2g and 2i-j, relative to 24. 
Anion exchange in EYPC liposomes was monitored by measuring the fluorescence of 
LG at 25 °C after addition of 0.04 mol% of prodigiosene transporter relative to EYPC 
lipid. The EYPC liposomes, containing 1 mM LG, 20 mM HEPES buffer (pH 7.4) and 
100 mM NaCl were suspended in a solution of 100 mM NaNO3 and 20 mM HEPES 
buffer (pH 7.4). At t = 30 s, the prodigiosene transporter was added and the change in 
fluorescence of LG was monitored (λex = 372 nm, λem = 504 nm). At t = 660 s, the 






 Figure 2.5 shows the increase in LG fluorescence after the addition of various 
prodigiosene esters at a concentration of 0.04 mol% relative to the EYPC lipid. It is 
apparent from the results that the length of the alkoxy functionality influences the 
efficiency of anion transport under these conditions. For example, the best transporters 
were the “short-chain” prodigiosene esters (methyl 2a, ethyl 2b, i-propyl 2c and butyl 
2d esters). Clearly, these short-chain alkyl esters were more effective anion transporters 
than esters that contained either a longer alkyl chain, such as the octanoate 2g, or had 
aromatic substitution like the benzyl ester 2j and the phenyl ester 2i. 
 To more clearly illustrate how the lipophilicity of the alkyl chain plays a 
significant role in the transport ability of prodigiosene esters, we carried out a set of 
comparative anion exchange assays using prodigiosenes 2f (hexanoate), 2g (octanoate) 
and 2h (tetradecanoate) with same experimental conditions as before (Figure 2.4 and 
Figure 2.5). Figure 2.6 shows that increasing the chain lengths of the C-ring ester 
alkoxy functionality results in slower rates of transmembrane anion exchange. A 
plausible reasoning for the reduced activity with long chain esters could be the more 
hydrophobic nature of the longer chains. The long alkyl chains would favor the 
formation of self-assembled aggregates such as micelles in water, thereby limiting the 







Figure 2.6. Anion exchange results for prodigiosenes 2f, 2g, 2h, relative to 24 in EYPC 
liposomes was monitored by measuring the change in the fluorescence of LG at 25 °C 
after addition of 0.04 mol% of prodigiosene transporter relative to EYPC lipid. At t = 
30 s, the prodigiosene transporter was added and the change in fluorescence of LG was 
monitored (λex = 372 nm, λem = 504 nm). At t = 660 s, the addition of Triton-X lysed 
the liposomes. Traces shown are an average of three trials. 
 Due to the long carbon chain, 2h ester prodigiosene is comparatively more 
lipophilic than an ester with a shorter chain length (say compound 2a with a methyl 
group). Our hypothesis was that for compound 2h in an aqueous solution, the 
hydrophobicity of the long alkyl chain will push the equilibrium in the direction of self-






ion carrier mechanism,31 it is essential for the aggregates to break apart so that the 
individual receptor molecules can bind and move anions across the lipid bilayer.  
 
Figure 2.7. The long C14 chain on prodigiosene 2h will tend to promote formation of 
aggregates in an aqueous solution. 
 To test our hypothesis about higher tendency of aggregate formation by 2h, we 
performed transport experiments where the compound 2h was incubated with a 
liposome sample (Figure 2.8). For this experiment, two sets of conditions were applied. 
A sample of EYPC liposomes loaded with LG and NaNO3, and suspended in a HEPES, 
NaNO3 buffer was taken. For condition I of “no incubation”, the transporter 2h was 
added at 0.04 mol% ligand:lipid ratio to the liposome sample, a pulse of  NaCl was 
then added immediately, followed by measurement of LG fluorescence. For condition 
II involving “incubation”, 2h was added to the liposome sample and allowed to 
incubate for 300 s, followed by addition of NaCl pulse and measurement of LG 








Figure 2.8. Anion exchange assay for prodigiosene 2h in EYPC liposomes was 
monitored by measuring the change in the fluorescence of LG at 25 °C after addition 
of a) 0.04 mol% of 2h relative to EYPC lipid. b) NaCl pulse was applied immediately 
(trace labeled no incubation) or after letting compound 2h incubate for 300s (trace 
labeled incubation). c) Triton-X was added at 570s to lyse the liposomes. Traces shown 
are an average of three trials.  
  The change in LG fluorescence was found to be similar for both sets of 
conditions, despite incubation of C14 ester 2h with the liposome sample. This result 






due to its hydrophobic C14 alkyl chain. Therefore, the higher lipophilicity of 2h may 
be restricting its transmembrane anion transport ability.   
 1H NMR Competition Experiment Proves that Prodigiosin 1 is More Basic 
than Ester Analog 2e 
 As illustrated in Table 2.2, the Cl⁻/NO3⁻ anion transport data indicates that 
compounds featuring a C-ring conjugated ester (2e) exhibit transmembrane transport 
activity that is about an order of magnitude lower than the natural product 1 or the 
methylated analog 24. We hypothesized that the C-ring ester derivatives are less basic 
than 1, and so the protonated form of the anionophore 2e•H⁺ would be less prevalent 
in the case of ester 2e. To investigate the effect of the ester group on the acid-base 
properties of the prodigiosenes, a simple competition NMR experiment in CD3CN was 
done (Figure 2.9). A 1:1 mixture of prodigiosin in free-base form (1) and C5 ester 
analog as an HCl salt (2e•HCl) was prepared. When the 1H NMR of this sample was 
recorded, it was found that the prodigiosin was in protonated form (1•HCl) and ester 
analog (2e) was in the free-base form (Trace c in Figure 2.9). Since prodigiosin 1 is 
more basic than the ester 2e, it is preferentially protonated in the mixture of compounds. 
Therefore, the final protonation states were reversed as compared to the initial starting 
material. These changes in protonation states were reflected by the differences in 
chemical shift for the methoxy peak of prodigiosin and ester compound. Figure 2.9 
illustrates the competition exhibited by prodigiosin 1 and ester 2e for a proton. Figure 
2.9a shows the NMR resonances for the methoxy groups of free-bases of 1 and 2e. 






of prodigiosenes 1•H⁺ and 2e•H⁺. Traces a and b in Figure 2.9 were used to assign the 
NMR resonances in trace c.  
 
Figure 2.9. A 1:1 mixture of the free-base form of prodigiosin 1 and C5 ester analog 
2e•HCl was prepared in CD3CN. The 
1H NMR of the 1:1 mixture (top trace) showed 
that prodigiosin was in the protonated form (1•HCl), while the ester was in the           
free-base form (2e).  
 Later, a 1H NMR titration was done with a mixture of free-bases of prodigiosin 
1 and ester analog 2e with MeSO3H (Figure 2.10). The NMR titration examined the 
step-by-step protonation process of both prodigiosenes, when treated with acid. 
Changes in protonation states of 1 and 2e were reflected by the chemical shifts of the 
methoxy groups of both compounds. Trace a in Figure 2.10 shows the 1H NMR spectra 
of free-base form of prodigiosin 1 and the pentyl ester prodigiosene (2e).32 The 1H 
NMR chemical shift of the methoxy group of prodigiosin 1 appeared at δ 3.86 ppm and 







Figure 2.10. 1H NMR spectra showing the B-ring -OCH3 signals during titration of a 
1:1 mixture of prodigiosin 1 and ester 2e (1 mM) with MeSO3H in CD3CN at 25 °C. 
Increments of MeSO3H were sequentially added to the equimolar mixture of the two 
prodigiosenes 1 and 2e. 
 After the addition of 0.4 eq of MeSO3H, only the methoxy peak for prodigiosin 
1 selectively broadened and decreased in relative intensity (trace c). The methoxy peak 
corresponding to the protonated species 1•H+ began to appear at δ 4.01 ppm after 
addition of 0.6 eq of MeSO3H (trace d). This peak grew and sharpened until 2 eq of 
acid had been added to the mixture (trace h). Simultaneously, the methoxy peak of ester 
2e at δ 3.88 ppm started to decrease after addition of 0.6 eq of MeSO3H (trace d), and 
a new signal ultimately appeared for 2e•H⁺Cl⁻ at δ 4.03 ppm. After the addition of 3 






NMR competition experiment clearly indicate that prodigiosin 1 is more basic than the 
prodigiosene ester 2e. 
 Determination of pKa of Ester Analog 2f and Prodigiosin 1 
 Having obtained qualitative 1H NMR evidence that the electron-withdrawing 
C-ring ester in 2 influences the proton affinity of the tripyrrolic unit, we next 
determined the apparent pKa values of prodigiosin 1•H⁺ and a C-ring hexyl ester analog 
2f•H⁺. The apparent pKa values correspond to the equilibrium mixture of and 
isomers of the B-ring prodigiosenes (Figure 2.11). As an example, the and 
isomers of compound 2f are shown in the free-base form and the protonated form in 
Figure 2.11. As the UV-vis titration progresses, prodigiosene 2f goes from protonated 
form (2f•H⁺) to the free-base form (2f). For the mixture of and isomers in free-base 
form (α2f and β2f), λmax was at 450 nm. For the mixture of and isomers in 
protonated form (α2f•H⁺ and β2f•H⁺), λmax was at 517 nm. To measure the apparent 
pKa values, we used a spectrophotometric procedure described by Manderville and 
colleagues.33 In the method used to determine apparent pKa value of prodigiosenes, a 
solution of the specific prodigiosene was prepared in a 1:1 mixture of CH3CN–H2O 
(v/v) at 25 °C (0.1 M NaCl) at a slightly acidic pH. This solution of prodigiosene (1•H⁺ 
and 2f•H⁺) was titrated with aliquots of NaOH. After each addition of NaOH, the 
absorbance of the solution containing prodigiosene was measured (Figure 2.12). The 







Figure 2.11. The and isomers of prodigiosene 2f in free-base and protonated form 
are in equilibrium with each other in solution. The apparent pKa values were calculated 
for an equilibrium mixture of and isomers of protonated prodigiosene 2f•H⁺.  
 Figure 2.12 shows UV-vis titrations for the natural prodigiosin 1 (Figure 
2.12a) and the synthetic ester 2f (Figure 2.12b) in 1:1 CH3CN /H2O. As can be seen in 
Figure 2.12a, the λmax for the protonated form of prodigiosin 1•H⁺ at 533 nm and the 
λmax for the free-base 1 at 460 nm are well separated. From this titration data, we 
determined that the natural product 1•H⁺ has an apparent pKa of 8.2. An apparent pKa 
value of 7.98 for 1•H⁺ in aqueous acetonitrile was previously reported.22 For the hexyl 
ester derivative 2f, the λmax for the protonated form 2f•H⁺ was at 517 nm and λmax for 
the free-base 2f was at 450 nm (Figure 2.12b). Based on the UV-vis spectra for the 






pKa of 6.5. These UV-vis titrations demonstrate that the electron-withdrawing carbonyl 
group on the C-ring of 2f makes the ester significantly less basic than the natural 
product 1. Relative to prodigiosin 1, the reduced basicity of ester 2f would make it more 
difficult to protonate this analog near neutral pH, which would then decrease the ability 
of the protonated esters (2•H⁺) to bind and transport anions. This hypothesis was 
demonstrated experimentally by a pH variation study, as described in the next section. 
 
Figure 2.12. UV-vis absorbance spectra for a) prodigiosin 1 and b) ester 2f as a 
function of pH in 1:1 CH3CN/H2O (v/v) at 25 °C (0.1 M NaCl). 
 Transmembrane Anion Transport as a Function of pH 
 Having shown that the differing basicities of the natural product 1 and an ester-
bearing analog 2 influence the transmembrane anion transport activity, we next 
investigated the pH dependence of Cl⁻/NO3⁻ exchange as catalyzed by these 
prodigiosenes. For these experiments, we prepared EYPC liposomes encapsulating 
NaNO3 (100 mM, pH 7.5 with 10 mM phosphate) and 1 mM of LG, the chloride-







Figure 2.13. Experimental procedure for the pH variation experiments performed with 
octyl ester analog 2g. Chloride influx promoted by 0.05 mol % of ester 2g as a function 
of extravesicular pH. At t = 30 s, a solution of 2g was added to a solution of EYPC 
vesicles, loaded with 1 mM LG and 100 mM NaNO3. The liposome sample was 
suspended in 10 mM phosphate buffer (pH 6.5, 7.5 or 8.5). At t = 60 s, NaCl solution 
was added to give a final extravesicular Cl⁻ concentration of 100 mM. At the end of 
the experiment, Triton-X detergent was added to lyse the vesicles. The faster 
fluorescence decay at pH 6.5 indicates faster anion exchange, as mediated by ester 






 The experimental procedure is depicted in Figure 2.13. At t = 30 s, the octyl-
ester prodigiosene 2g (0.05 mol % relative to EYPC lipid) was added to the liposome 
solution. Then, at t = 60 s, a pulse of 10 mM phosphate buffer (at pH 6.5, 7.5 or 8.5) 
containing 1 M NaCl and 100 mM NaNO3 was added to give an extravesicular Cl
- 
concentration of 100 mM (Figure 2.13). Figure 2.13 shows this transporter-mediated 
anion exchange as a function of extravesicular pH. The observed decrease in the LG 
fluorescence is due to influx of Cl⁻, as catalyzed by the prodigiosene ester 2g•H⁺, and 
so faster decay indicates faster anion exchange. Chloride transport by 2g•H⁺ increased 
as the pH was decreased from 8.5 to 6.5. This systematic increase in transport activity 
with decreasing pH is consistent with increased ion pairing between the target anions 
and the protonated tripyrrolic head-group of the prodigiosene 2g•H⁺, whose pKa we 
determined to be 6.5. These experiments show that transmembrane transport of anions 
by the prodigiosene ester 2g can be modulated by controlling the external pH. 
 In vitro Anticancer Activity of C-Ring Functionalized Prodigiosenes 
 The in vitro anticancer activity of some C-ring synthetic prodigiosenes was 
evaluated at the National Cancer Institute (NCI) against a standard panel of 59 human 
cell lines, derived from nine cancer cell types.121 Table 2.3 shows averaged 
concentrations for activity across all lines for prodigiosenes 1, 2 and 24. Compared to 
the natural prodigiosin 1 (Entry 1), prodigiosene 24 exhibited a slightly improved 
anticancer activity, in terms of TGI values, and a reduced toxicity (Entry 2). Some of 
the prodigiosene esters (Entries 2, 6 and 7) exhibited anticancer activities that were 






introduction of a C-ring carbonyl moiety is not detrimental to the anticancer activity of 
this series of compounds.  
Table 2.3. Mean in vitro activity of prodigiosenes over 59 cancer cell lines.121 







1 Prodigiosin 1 14 2.1 0.3 
2 24 15 0.1 1.0 
3 methyl 2a 347 6.0 49.0 
4 i-propyl 2c 59 1.0 7.9 
5 butyl 2d 117 2.0 14.5 
6 pentyl 2e 36 0.6 4.6 
7 octyl 2g 28 1.9 18.6 
8 phenyl 2i 214 2.0 14.5 
9 benzyl 2j 129 2.0 14.5 
a http://dtp.cancer.gov. b GI50 = half maximal growth inhibition concentration. 
cTGI = 
total growth inhibition concentration. dLC50 = half maximal lethal concentration. 
  
 An analysis of the data shown in Table 2.3 allows an appreciation for the 
concentrations at which in vitro activity was observed. For example, the prodigiosenes 
24 and 2e effect growth inhibition for most strains at nM concentrations, similar to the 
natural product 1. Unlike Sessler’s synthetic analogs (Section 1.5.1),10 no clear 
correlations could be made between anion transport results and the in vitro anticancer 
activity of the prodigiosenes 1, 2 and 24. Some compounds such as 2e (C5) and 24, 
with alkoxy chain lengths similar to prodigiosin 1 showed good anion transport activity, 
and also inhibited cell growth at low nM concentrations with low cytotoxicities (GI50 
and LC50 values, respectively in entries 1, 2, 6 and 7 in Table 2.3). Other compounds 
such as 2a (Me), 2c (i-Pr) and 2d (C4) also displayed good anion transport activity but 






Table 2.3). In particular, compound 24 with no ester group was the most effective at 
cell growth inhibition and as an anion transporter as well. These screening activity 
results across a range of cancer cell types demonstrate that inclusion of the extra methyl 
group on ring C is not detrimental for in vitro anticancer activity. However, the same 
cannot be said unambiguously for the ester group. Along with the ester functionality, 
the alkoxy chain length seems to play a vital role in defining the anticancer activity as 
well as the ability of prodigiosenes 2 as anion transporters. These findings are important 
given that the incorporation of the additional C-ring methyl group facilitated synthesis 
of the prodigiosene core.114 Additionally, the incorporation of the ester moiety enabled 
variation in chain lengths and a probe into the electronic effects in prodigiosenes.    
 Conclusions 
 A series of C-ring modified prodigiosenes were studied for their ability to 
transport anions across lipid bilayers and their in vitro anti-cancer activities using the 
NCI panel of 60 cancer cell lines. The methylated analog 24 exhibited very good 
anticancer activity, as compared to the natural product 1, with a decreased TGI value 
and lower toxicity. Some of the synthetic esters (2c and 2g) had similar anti-cancer 
potency as the natural product prodigiosin 1. 
 Additionally, these results based on anticancer activity of the synthetic 
prodigiosenes show that the extra methyl group added to the C-ring is not detrimental 
to the in vitro anticancer activity of these new prodigiosenes (2 and 24). Although the 
presence of an ester on the C ring decreases the pKa and the anion transport rate of 






concentrations.117 The possibility to regulate anion transport activity of prodigiosenes 
as a function of their basicity and extravesicular pH intrigued us. By manipulating the 
basicity of these synthetic prodigiosenes and variation in solution pH (2g in Figure 
2.13), the extent of protonation for the receptors (2g•H⁺) could be modulated. Since it 
is the protonated receptor that catalyzes anion transport, the process of anion binding 
and subsequently, anion transport across bilayers was also affected. With this 
information, we proceeded to study the correlation between the basicity of 
prodigiosenes and their rate of anion transport through lipid bilayers in greater detail in 


















 Chapter 3: Influence of B-Ring Modifications on Proton Affinity, 
Transmembrane Anion Transport and Anti-Cancer Properties of Synthetic 
Prodigiosenes 
The majority of this chapter has been published in reference 131: 
 Marchal, E.; Rastogi, S.; Thompson, A.; Davis, J. T. “Influence of B-Ring 
Modifications on Proton Affinity, Transmembrane Anion Transport and Anti-
Cancer Properties of Synthetic Prodigiosenes” Org. Biomol. Chem., 2014, 12, 
7515-7522. 
Syntheses of all compounds 3a-h described in this chapter were performed by Dr. 
Estelle Marchal and Dr. Alison Thompson, our collaborators from the Dalhousie 
University, Canada. Compounds 3a, 3b, 3d and 3h were tested against 60 human 
cancer cell lines by the Developmental Therapeutic Program at NCI, NIH.  
Background 
 Introduction 
 One mechanism put forth to explain the biological activities of the  
prodigiosenes is that since prodigiosenes are typically protonated at physiological pH, 
they can alter intracellular pH via H⁺Cl⁻ co-transport (or Cl⁻/OH⁻ exchange) across 
cell membranes.27,48 In this chapter, we studied a series of prodigiosene analogs 3 with 
different –O-aryl substituents attached to the B-ring of the tripyrrolic skeleton (Figure 
3.1). We found that the electronic nature of the O-aryl substituent on the B-ring 






transport, i.e. the prodigiosenes with the higher pKa had greater Cl⁻/NO3⁻ exchange 
rates. Four of the synthetic prodigiosenes were tested for their in vitro anti-cancer 
activities in the NCI60 human tumor panel. Before describing the studies done to 
correlate basicity of prodigiosenes 3 with their transmembrane anion transport 
efficiency, I first provide a brief background on work previously done with other B-
ring modified prodigiosenes. Then, I present my experimental results that show that 
anion transport ability of B-ring modified aryl prodigiosenes 3 is dependent on the 
basicity of these analogs.     
 
Figure 3.1. Structures of B-ring modified prodigiosenes 3a-h. 
 Earlier Work with B-Ring Modified Prodigiosenes 
 In the last decade various compounds that catalyze transmembrane transport of 
anions have been identified.75,79 Much of this activity has been driven by 
supramolecular chemists interested in systems that work at the water-lipid 
interface.74,122 An important factor promoting this research is the possibility that anion 
transporters might be developed into therapeutics for diseases, like cystic fibrosis, that 






 Some synthetic transporters have been developed after considering how nature 
catalyzes the process. For example, peptides that contain domains of the Cl⁻ channel 
can transport anions across lipid membranes,124,125 while modification of natural 
amphiphiles like cholic acid has provided potent anion carriers.126,127 The tripyrrolic 
prodigiosenes are known to catalyze transmembrane anion transport.31,32,77,114,128 The 
parent compound, prodigiosin (1) has much biological potential,6,129 as it is able to 
permeabilize cell membranes, alter intracellular pH and trigger apoptosis.48,27 Early 
studies indicated that prodigiosin is too cytotoxic for healthy cells and, for this reason, 
it was not initially pursued as a drug candidate.130 There has been a renewed interest in 
prodigiosenes since some synthetic analogs have promising anti-cancer,2-4 
immunosuppressive,5, 6 anti-malarial,7 and antimicrobial8 activities at concentrations 
below where they are cytotoxic to healthy cells. 
 Rationale for Studying the Anion Transport Activity by B-Ring Modified 
Aryl Prodigiosenes 
 As depicted in Figure 3.2 protonated prodigiosin 1•H⁺ has a binding pocket for 
anions, using hydrogen bonds and electrostatic interactions for anion coordination. The 
resulting amphiphilic neutral salt 1•HCl can then readily diffuse through the cell 
membrane. It has been previously shown that prodigiosin 1•HCl catalyzes the 







Figure 3.2. Protonation of prodigiosin 1 and subsequent binding of chloride anion by 
1•H⁺. The schematic at the right depicts the protonated prodigiosin 1•H⁺ catalyzing the 
exchange of anions across a lipid bilayer. 
In Chapter 2, I showed that ester 2f (Figure 3.3), with an electron-withdrawing 
carbonyl group appended to the C-ring, was less basic by two orders of magnitude than 
the parent prodigiosin 1 (prodigiosin 1•H⁺, pKa = 8.2; 2f•H⁺, pKa = 6.5) and also a 
much less effective anion transporter than 1.114 We suggested that the ease of 
protonation of the carrier and, thus, its consequent anion transport activity was 
modulated by changing the electronic properties of the C-ring substituents. Herein, I 
describe a systematic study on B-ring analogs 3 that confirms transmembrane anion 
transport rates can be modulated by tuning the pKa of the prodigiosene skeleton. I 
describe the anion transport and in vitro anti-cancer properties of prodigiosenes 3 with 
different –OAr substituents attached to the tripyrrolic B-ring. The synthetic 
prodigiosenes 3 used in this study have an A-ring pyrrole, a B-ring pyrrole substituted 
with various aryl groups (Figure 3.3) to modulate pKa, and a C-ring pyrrole that differs 







Figure 3.3. Structures of prodigiosene ester analog 2f and phenyl analog 3.  
 Examples of Previous B-Ring Modified Prodigiosenes 
There are a few reports regarding synthetic modification of the prodigiosene B-
ring, such as the compounds developed by Boger, Sessler and D’Alessio (Figure 
3.4).5,10,103 Described below are selective examples of the B-ring modified 
prodigiosenes that have shown significant biological activity.  
 
Figure 3.4. Structures of prodigiosenes 30, 31 and PNU-156804 (8). 
 Desmethoxyprodigiosin by Boger 
 Desmethoxyprodigiosin 30 was synthesized by Boger and his group (Figure 
3.4).103 There were no functional groups present on the pyrrole ring B of 30. The analog 
30 was evaluated for its in vitro cytotoxicity. The in vitro cytotoxic studies were 
comprised of assays with various cancer cell lines for melanoma (B16 mouse), 






nasopharynx (9KB) using established protocols. The IC50 values (defined as the 
inhibitory concentration for 50% cell growth relative to untreated control) of 
prodigiosin 1 and desmethoxyprodigiosin 30 were compared for the 4 cell lines 
mentioned above. For each cancer cell line, prodigiosin displayed substantial cytotoxic 
activity as compared to the analog 30 (Table 3.1).  Prodigiosin was found to be 
exceptionally potent against the P388 leukemia cell line (IC50 = 0.00037 μg/ mL) in 
comparison to the desmethoxyprodigiosin 30 (IC50 = 0.03 μg/ mL).  
Table 3.1. The in vitro cytotoxic activity (IC50) of prodigiosin 1 and 
desmethoxyprodigiosin 30 against four cancer cell lines - leukemia (L1210 mouse), 




L1210 B16 9PS (P388) 9KB 
1 0.02 0.03 0.00037 0.04 
30 12 24 0.03 0.7 
 
 The relative inactivity of desmethoxyprodigiosin 30  as an anti-cancer agent, as 
compared to the parent prodigiosin 1, was attributed to the absence of the –OMe group 
on ring B. Molecular modeling studies were done to ascertain the impact of the 
methoxy group on conformation and chemical reactivity of prodigiosenes by 
comparing structural and electronic aspects of prodigiosin 1 and 30. However, the 
theoretical studies revealed no substantial structural or electronic differences that might 






substituent. Boger et. al. concluded from this study that the presence of an –OMe group 
on the B-ring is essential for prodigiosin’s biological activity.103  
 Sessler’s B-Ring Modified Prodigiosene  
 Unlike Boger’s compound 30, compound 31  (Figure 3.4) synthesized by 
Sessler and his group demonstrated reasonable anti-cancer activity, despite the missing 
methoxy group on ring B.10 Prodigiosene 31 has an ethyl group in place of the methoxy 
group on 3-position and a methyl group on 4-position on ring B. Anti-cancer activity 
was assessed using a cell proliferation assay with two different cancer cell lines – A549 
human lung cancer and PC3 human prostate cell lines. For both cell lines, compound 
31 completely inhibited cell proliferation at 40 μM concentration. Additionally, Sessler 
et al. reported that the anti-cancer activity of 31 correlated well with its efficiency to 
catalyze Cl⁻ anion transport across liposomal membranes.   
 PNU-156804 by D’Alessio 
 PNU-156804 (8) was designed and synthesized by D’Alessio and his group 
(Figure 3.4).5 Compound 8 has a –OBn group on ring B instead of the –OMe group. 
Due to its immunosuppressive properties,5 PNU-156804 has been used as an anti-
rejection compound in organ transplants.15  For compound 8, installation of a larger –
OBn group on ring B led to a reduction in its immunosuppressive activity as compared 
to compounds with a methoxy group. However, the decrease in immunosuppressive 
activity was balanced by a significant decrease in cytotoxicity. As a result, compound 







In the study presented here, our collaborators Dr. Estelle Marchal and Dr. Alison 
Thompson prepared novel derivatives 3 substituted with different –OAr groups on the 
B-ring, alongside common features at the A and C-ring. These novel compounds 3 were 
used to probe the influence of electronic effects upon pKa values, transmembrane anion 
exchange rates and anti-cancer activity. This is, to our knowledge, the first report of 
prodigiosenes substituted with –OAr groups on the B-ring. 
Results 
 Novel Phenyl Analogs 3 and a Comparison of their Basicity 
 A series of 8 prodigiosenes with electron withdrawing or electron donating 
groups on ring B were synthesized by Dr. Estelle Marchal and Dr. Alison Thompson 
from Dalhousie University, Canada.131 These compounds are listed in Figure 3.5. 
 
Figure 3.5. Structures of B-ring modified prodigiosenes 3a-h.  
 As described below, we next conducted mechanistic studies to investigate the 
proton affinities, transmembrane anion transport activities and anti-cancer properties 






 Determination of Apparent pKa Values for Synthetic Prodigiosenes 
 We hypothesized that prodigiosene basicity would correlate with its efficiency 
as an anion transporter, since the protonated prodigiosene 3•H⁺ is the likely transporter. 
The concept that transporter efficiency can be tuned by modulating the acidity of 
hydrogen bond donors has been demonstrated with other systems. Gale and colleagues 
demonstrated that anion binding abilities of some mono-thioureas can be modulated by 
the (hydrogen bond) acidity of the thiourea NH function.96 In a separate paper, Gale et. 
al. showed that the anion transport activity of a series of easy-to-make fluorinated 
tripodal urea-based transporters could be enhanced significantly by the introduction of 
fluorinated groups. The fluorinated groups helped in increasing the acidity of anion 
binding protons as well as increasing lipophilicity of the receptor.119 
 To learn how B-ring substitution influences the acid-base properties of these 
synthetic prodigiosenes, I used a spectrophotometric method described by 
Manderville,33 to measure the apparent pKa values for five B-ring analogs: the –OPh 
derivative (3b•H⁺), two analogs with electron-donating groups on the –OAr ring 
(3d•H⁺ X = OMe, 3e•H⁺ X = NMe2), and two analogs with electron-withdrawing 
groups on the B-ring  (3f•H⁺ X = CF3, 3h•H⁺ X = Cl). The apparent pKa values 
correspond to the equilibrium mixture of and isomers of the prodigiosenes (Figure 
3.6). As an example, the and isomers of compound 3d are shown in the free-base 
form and the protonated form in Figure 3.6. As the UV-vis titration progresses, 






mixture of and isomers in free-base form (α3d and β3d), λmax was at 484 nm. For 
the mixture of isomers in protonated form (α3d•H⁺ and β3d•H⁺), λmax was at 541 nm.   
 
Figure 3.6. The and isomers of prodigiosene 3d in free-base and protonated form 
are in equilibrium with each other in solution. The apparent pKa values were calculated 
for an equilibrium mixture of and isomers of protonated prodigiosene 3d•H⁺. 
 In the method used to determine apparent pKa value of a prodigiosene 3, a 
solution of the specific prodigiosene was prepared in a 1:1 mixture of CH3CN–H2O 
(v/v) at 25 °C (0.1 M NaCl) at a slightly acidic pH. The solution of prodigiosene was 
titrated against NaOH. After each addition of NaOH, the absorbance of the solution 
containing prodigiosene 3 was measured (Figure 3.7). The apparent pKa values, which 
correspond to values for the equilibrium mixture of and isomers, for these B-ring 







Figure 3.7. UV-vis absorbance spectra for a) 3d (OMe) and b) 3f (CF3) as a function 
of pH in 1:1 CH3CN–H2O (v/v) at 25 °C (0.1 M NaCl). 
 In solution, protonated prodigiosenes are pink with absorbance maxima above 
500 nm.132 The free-base absorbs below 500 nm. Figure 3.7 shows representative pH-
dependent spectra for 3d and 3f in 1:1 acetonitrile-water at 25 °C. Absorption maxima 
for the free-base of the OMe analog 3d (λmax = 484 nm) and its protonated form 3d•H⁺ 
(λmax = 541 nm) are well separated (Figure 3.7a). The CF3 derivative showed similar 
properties, with λmax = 490 nm for the free-base 3f and λmax = 545 nm for 3f•H⁺ (Figure 
3.7b). Furthermore, the ionization states of 3d/3d•H⁺ and 3f/3f•H⁺ change smoothly as 
a function of pH, both revealing isosbestic points. As seen in Table 3.2, analogs with 
electron-donating groups on the B-ring, namely 3d•H⁺ (X = OMe, pKa = 7.3) and 3e•H⁺ 
(X = NMe2, pKa = 7.4) are weaker acids than are analogs with electron-withdrawing 
groups, 3f•H⁺ (X = CF3, pKa = 6.7) and 3h•H⁺ (X = Cl, pKa = 6.8). This means that the 






3h (X = Cl). The increased basicity of 3d and 3e means that a greater percentage of 
these analogs would be protonated at pH 7.4, which should enhance their ability to 
extract anions from water and transport these bound anions as neutral complexes 3•HA 
across lipid membrane. 
Table 3.2. The pKa values for synthetic prodigiosenes 3b, 3d-f and 3h with different –












pKa 7.3 ± 0.1 7.4 ± 0.1 7.2 ± 0.1 6.8 ± 0.1 6.7 ± 0.1 
 
 Correlation Between Anion Transport Rates and Transporter Basicity 
 Having established that B-ring substitution influences the acid-base properties 
of –OAr analogs 3b, 3d-f and 3h, I next compared the ability of these synthetic 
prodigiosenes to catalyze the exchange of anions across phospholipid vesicles. 
Transmembrane transport was evaluated with a liposome model that uses the chloride-
sensitive dye LG, to monitor anion exchange.113 This assay works because LG 
fluorescence is quenched by Cl⁻ but not by NO3⁻. Thus, egg-yolk phosphatidylcholine 
(EYPC) liposomes loaded with 1.0 mM LG and NaCl were suspended in a solution 
(pH 7.4) containing extravesicular NaNO3. Upon the addition of the synthetic 
prodigiosenes 3 the fluorescence of the intravesicular LG increases, indicating Cl⁻ 







Figure 3.8. Anion exchange assay for analogs 3b, 3d-f and 3h. Change in fluorescence 
of LG observed in EYPC liposomes at 25°C. The data was collected using 0.0008 
mol% of transporter compounds relative to EYPC lipid.  Liposomes containing 1 mM 
LG, 20 mM HEPES buffer and 100 mM NaCl (pH 7.4) were suspended in 20 mM 
HEPES and 100 mM NaNO3 solution (pH 7.4); at t = 30 s, prodigiosene transporter 
was added and the LG fluorescence monitored (λex = 372 nm, λem = 504 nm); at t = 660 
s, addition of Triton-X; traces shown are an average of three trials. 
 Figure 3.8 shows representative LG fluorescence curves, plotted as a function 
of time, after addition of analogs 3b, 3d-f and 3h. I quantified transport rates by a) 
determining the initial rate of change of the relative fluorescence of the intravesicular 






Table 3.3. The pKa values, transmembrane anion exchange rates and half-life of the 
anion transport process for prodigiosenes 3b, 3d-f and 3h with different –OAr groups 
on the B-ring. 
3•H⁺ pKa 
Initial rate for Cl⁻/NO3⁻ 
exchange (s⁻1) 
t1/2 for Cl⁻ efflux (s) 
3d (OMe) 7.3 ± 0.1 15.1 ± 0.2 65 ± 2 
3e (NMe2) 7.4 ± 0.1 10.8 ± 0.3 87 ± 3 
3b (H) 7.2 ± 0.1 10.8 ± 0.3 90 ± 5 
3h (Cl) 6.8 ± 0.1 3.4 ± 0.1 168 ± 3 
3f (CF3) 6.7 ± 0.1 1.0 ± 0.1 287 ± 2 
   
The data in Figure 3.8 and Table 3.3 contain important findings. First, these 
synthetic prodigiosenes, especially 3d and 3e, are potent anion transporters and 
relatively low transporter loadings are needed to observe significant Cl⁻ efflux from 
the liposomes. For example, only 0.0008 mol% of transporter relative to EYPC lipid 
(1 transporter for 125,000 lipid molecules or about 2.5 transporters per liposome) was 
used to generate the data in Figure 3.8. This is one of the lowest transporter loadings 
reported to date.86 Second, substitution of the B-ring with an –OAr group does not 
perturb the ability of these analogs to catalyze anion exchange. Indeed, the electron-
rich 3d•H⁺ (X = OMe) is qualitatively similar to the natural product prodigiosin 1•H⁺ 
in terms of the efficiency at which it exchanges Cl- and NO3
- anions across the EYPC 
bilayer (Figure 3.9) Most importantly, compounds substituted with electron-donating 
groups (3d and 3e) are better anion transporters than analogs containing electron-






transmembrane anion exchange correlates with how much of the prodigiosene is in its 
protonated form 3•H⁺. 
 
Figure 3.9. Anion exchange assay for prodigiosin 1 and analog 3d. Change in 
fluorescence of LG observed in EYPC liposomes at 25°C. The data was collected using 
0.004 mol% of each prodigiosene transporter relative to EYPC lipid. Liposomes 
containing 1 mM LG, 20 mM HEPES buffer, 100 mM NaCl (pH 7.4) were suspended 
in 20 mM HEPES and 100 mM NaNO3 solution (pH 7.4); at t = 30 s, prodigiosene 
transporter was added and the LG fluorescence monitored (λex = 372 nm, λem = 504 
nm); at t = 660 s, addition of Triton-X; traces shown are an average of three trials. 
 In Vitro Anti-Cancer Properties 
 The in vitro activity of some of the B-ring analogs was evaluated at the National 
Cancer Institute (NCI, http://dtp.cancer.gov) against the standard NCI60 panel of 60 
human cell lines.133 Prodigiosenes selected for testing were the benzyl (3a) and phenyl 
(3b) analogs and derivatives with an electron-donating (3d X = OMe) and an electron-






Table 3.4 as mean values averaged over all 60 cell lines; these activities are 1) the half 
maximal growth inhibition concentration, GI50, 2) the total growth inhibition 
concentration, TGI, and 3) the half maximal lethal concentration, LC50. All four 
synthetic prodigiosenes exhibited GI50 values in the nM range, indicating that 
replacement of the B-ring OMe by an O-aryl group is not universally detrimental to 
anti-cancer activity. These synthetic analogs also show LC50 values in the μM range 
that could indicate a lower toxicity compared to the natural compound 1 (LC50 = 300 
nM). The phenyl analog 3b was the most active of the derivatives with a mean GI50 
value of 18 nM. A more detailed analysis in Figure 3.10Figure 3 shows that 3b was 
also typically the most active of the four synthetic prodigiosenes against all 60 cell 
lines. 
Table 3.4. In vitro activity of prodigiosenes 1, 3a-3b, 3d and 3h over the NCI60 cancer 





(X = H) 
3d 
(X = OCH3) 
3h 
(X = Cl) 
GI50 (nM)
a 14 44 18 74 62 
TGI (M)b 2.1 0.6 0.2 0.8 1.9 
LC50 (M)
c 0.3 4.8 2.5 7.2 14.4 
a GI50 = half maximal growth inhibition concentration. 
bTGI = total growth inhibition 

























































































































































 Two questions that we sought to answer were: would the prodigiosene basicity 
1) correlate with its ability to catalyze transmembrane anion exchange and 2) correlate 
with its anti-cancer activity. The data presented herein suggest that the ease of 
protonation controls the transmembrane anion exchange. However, despite their 
significant in vitro anti-cancer activity, there is no evidence that those anti-cancer 
properties universally correlate with, or are caused by, the acid-base properties of the 
prodigiosene. Thus, the most basic prodigiosene 3d and the least basic prodigiosene 3h 
had similar mean GI50 values, 74 and 62 nM respectively, and both analogs were less 
potent than the phenyl analog 3b (GI50 = 18 nM). 
 Conclusions 
Prodigiosenes, both naturally occurring and synthetic analogs, are outstanding 
catalysts for transport of anions across lipid membranes. Being able to control the 
efficiency of this transmembrane transport of anions would be valuable for various 
reasons, such as the potential development of therapeutics or anion sensors. In this 
chapter, I studied some unique prodigiosene analogs with different –OAr substituents 
attached to the B-ring of the tripyrrolic skeleton. I measured the apparent pKa values of 
five B-ring analogs, namely the O-phenyl derivative (3b•H⁺), two O-aryl analogs with 
electron-donating groups and two O-aryl analogs with electron-withdrawing groups. 
These five derivatives were then tested for their ability to catalyze transmembrane 
exchange of Cl⁻ and NO3⁻ anions in EYPC liposomes. The data indicated that the 
efficiency of anion transport can indeed be modulated by the electronic nature of the 






and 3e (X = NMe2, pKa = 7.2) showed significantly greater Cl⁻/NO3⁻ exchange rates 
than the less basic analogs 3h (X = Cl, pKa = 6.8) and 3f (X = CF3, pKa = 6.7). This 
suggests that the key factor controlling anion transport for this family of synthetic 
analogs, and presumably for the natural product prodigiosin, is the protonation of the 
prodigiosene to give an amphiphilic cation 3•H⁺. This cation extracts anions from water 
to give a neutral complex 3•HA that then diffuses rapidly across the lipid membranes. 
In addition to the synthetic and mechanistic work, the anti-cancer activity of four 
synthetic prodigiosenes were tested at the NCI (NCI60 human tumor panel). All four 
analogs showed potent anti-cancer activities, with mean GI50 values in the nM range, 
indicating that substitution of the B-ring with OAr groups can give potent anti-cancer 
agents. Despite their promising in vitro anti-cancer activity and their excellent anion 
transport properties, there was no evidence that the anti-cancer activity is due to the 
ease of protonation of these synthetic prodigiosenes. The lack of substantive evidence 
gives rise to the issue that mechanisms other than transport of H⁺Cl⁻ across membranes 
may be responsible for the anti-cancer activities of the prodigiosenes. In Chapter 5, 
one such possible mechanism will be discussed. Based on my studies, I found that 
prodigiosin can end stack with G-quadruplex DNA. This is the first time that binding 
interactions between G-quadruplex and prodigiosin have been established. The 
relevance of G-quadruplex DNA and its binding ligands has been discussed in more 








 Chapter 4: Conformations and Anion Binding Properties of Prodigiosenes 
Some sections of this chapter have been published in reference 131: 
 Marchal, E.; Rastogi, S.; Thompson, A.; Davis, J., “Influence of B-ring 
modifications on proton affinity, transmembrane anion transport and anti-
cancer properties of synthetic prodigiosenes.” Org. Biomol. Chem. 2014, 12, 
7515-7522. 
The computational modelling and calculations for ester analog 2e, described in this 
chapter were performed by Ms. Maria Garcia Valverda and Dr. Roberto Quesada, 
collaborators from the University of Burgos, Spain. 
Background 
 Introduction 
The goal of this chapter is to explore conformational aspects of prodigiosin 1 
and its synthetic derivatives. A study of the conformations of prodigiosin and its 
analogs is important to gather in-depth knowledge about how the ligands orient 
themselves in different solvents. This information could provide an essential bridge 
between the observed biological activities of prodigiosenes and their preferred 
conformational states. Based on the research described in this chapter, I found that 1) 
both α and β isomers of prodigiosenes bind anions with distinct binding patterns 2) the 
α isomer uses a CH hydrogen to bind bidentate anions such as MeSO3⁻ 3) anions can 
influence the α/β conformational ratio for prodigiosin, but not for the ester analog 2e, 






Before describing my research, a brief background has been provided for the previous 
conformational analysis on prodigiosenes done by other groups.  
 Previous Work on Conformations of Prodigiosenes 
 
Figure 4.1. a) Structure of prodigiosene 12. Two molecules of 12 bind non-covalently 
to form a dimer. Reprinted with permission from Chem. Res. Toxicol. 2002, 15 (5), 
734-741. Copyright (2002) American Chemical Society.33 b) Perspective drawing of 
solid state structure of Zn•(1)2. Zinc atom is represented by the green sphere. c) 
Proposed ORTEP plot of solid state structure from reaction of 1 with CuCl2. Cu(II) is 
represented by the blue sphere. Reprinted with permission from Org. Lett. 2002, 5 (2), 
113-116. Copyright (2002) American Chemical Society.34  
Structurally, prodigiosin 1 appears to be a simple compound at first glance. It 






the compound can exist in multiple conformations as tautomers and rotamers. Owing 
to the versatility of possible structures and conformations, prodigiosin 1 can behave 
differently depending on solvent and other surrounding factors. Prodigiosenes can exist 
in either protonated or non-protonated states. When in its free-base form, prodigiosene 
12 can form non-covalent dimers (Figure 4.1a).33 Two molecules of prodigiosin 1, in 
its deprotonated form, can form a dimer with Zn(II) in the center (Figure 4.1b).34 
Prodigiosin 1 can also bind with Cu(II) (Figure 4.1c).34     
In both its protonated and deprotonated form, prodigiosin 1 can bind and 
transport anions (such as Cl⁻, NO3⁻ and HCO3⁻) across liposomal and cell organelle 
membranes.10,25,27 Protonation also affects the preferable conformation adopted by 
prodigiosenes. Despite the versatility of conformations and its possible impact on the 
biological properties of prodigiosenes, few in-depth studies have been done on 
prodigiosene conformations. The work done by Quesada and group in 2012 is an 
extensive NMR and computational study undertaken to learn more about the different 
conformations, their relative energies and anion binding strengths.36 Before this, Rizzo 
et. al. briefly described their work on the α and β forms of another prodigiosene 
analog.37 McNab was the first one to identify the structure of the α conformation of 
prodigiosenes.134  
 Work with α–Conformation by McNab 
In 1990, McNab described a convenient synthetic route to synthesize three-ring 
systems related to prodigiosin.134 He synthesized compound 32 with rings B and C 






methyl group at the 4-position. In the process, he obtained the crystal structure of 32 in 
a conformation that was later assigned as the α–conformation (Figure 4.2). He reported 
that the three rings in the α conformer were almost coplanar. The methoxy group was 
oriented such that it formed an intramolecular H-bond with the NH proton of ring C 
(Figure 4.2a). The α conformation owes its existence to the methoxy group on ring B. 
It has been proposed that this resulting configuration of rings could be instrumental for 
the biological activities observed for prodigiosin.134      
 
Figure 4.2. Structure of compound 32. Crystal structure of compound 32 from a) front 
and b) top. Reprinted with permission from J. Chem. Soc., Chem. Commun. 1990, (10), 
734-736. Copyright (1990) Royal Society of Chemistry.134 
 Kinetics of α,β-Rotamer Interconversion by Rizzo 
Almost a decade later, Rizzo and his group published their work on kinetics of 
α/β interconversion of a prodigiosin derivative PNU-156804 8.37 Using HPLC, they 
showed a pH-dependent separation of α and β isomers. At pH 9, the neutral form of 






At pH 2.2, two separate peaks were observed, with the minor peak assigned to the β 
conformation (Figure 4.3).  
 
Figure 4.3. The α and β conformations of (8•MeSO3H).  
The rate of interconversion between the two isomers was slow enough to allow 
calculation of pKa for the α (8.23 ± 0.03) and β (5.4 ± 0.2) forms. The protonated 
compound formed a seven-member ring stabilized by intramolecular H-bonding in the 
α conformation. The HPLC data was corroborated by UV-visible spectrophotometric 
data. In a spectrophotometric study, Rizzo and group used the absorption bands of free-
base (λmax = 460 nm) and protonated (λmax = 525 nm) forms to plot a titration curve that 
gave an apparent pKa value of 7.20 for an equilibrium mixture of the two isomers.
37  
 In order to get more structural information about α and β isomers of compound 
8, the authors performed NMR experiments using different counter-anions. The 1H 
NMR spectra of 8•HCl in CDCl3 gave a single set of resonances, consistent with the 
β-isomer, demonstrating that the Cl‾ anion could influence ligand conformation in a 
non-polar solvent. The Cl‾‾ anion can H-bond with the NH protons on the three pyrrole 






containing CD3CN/D2O (1/1, pH 1.1), NMR signals of the two conformers (α/β) were 
observed at about 2/1 ratio. The conformer ratio obtained from NMR was slightly 
different from the HPLC data where a 3/1 ratio was reported for α/β conformers. 
 
Figure 4.4. Structure of the methanesulfonate salt of PNU-156804 (8•MeSO3H) in its 
β conformation. Selective NOESY cross-peaks are indicated with blue colored double-
headed arrows. Adapted with permission from J. Pharm. Sci. 1999, 88 (1), 73-78. 
Copyright (1999) Wiley-Liss, Inc. and the American Pharmaceutical Association.37 
 On the other hand, the MeSO3⁻ salt of PNU-156804 gave a different 
conformational ratio for the mixture of conformers (= 1/2) in CDCl3. According to 
NOESY data, the two geometrical isomers of 8 have different torsion angles about the 
CB2-C1ˈˈ bonds.  In a Newman projection for 4 atoms in a chain, A-B-C-D, torsion angle 
is defined at the angle between A-B-C plane and the B-C-D plane.115 The torsion angle 
was close to 0° for β while the α conformer has an angle of 180°. An angle of 180° is 
stabilized by hydrogen bonding between the NH proton on ring C and the exocyclic 






supported by NOE experiments. NOE interactions between the three NH-exchangeable 
protons (NHA to NHB and NHB to NHC) and the HC4 to H1ˈˈ confirmed the arrangement 
for -isomer in CDCl3 (Figure 4.4). Further, an NOE cross-peak between the methyl 
group on MeSO3⁻ anion and NH and CH hydrogens on 8•H⁺ scaffold indicated ion-
pair formation and hydrogen bonding between the receptor and MeSO3⁻ ion. Thus, 
Rizzo and group were able to show specific evidence for the existence of α and β 
isomers in solution.  
 Conformational Analysis of Prodigiosene-Anion Complexes by Quesada 
Quesada and colleagues published their study of the conformational analysis of 
a synthetic prodigiosene 33.36 Their work was important as it explored the 
conformations of analog 33, and its associated anion binding affinities, in detail using 
NMR, X-ray diffraction and computational modelling along with DFT calculations.  
 Compound 33 in its neutral form, depending on the location of the unprotonated 
azafulvene nitrogen atom, can exist in three tautomeric forms: I (ring B), II (ring C) 
and III (ring A). Further, each tautomer can exist in four conformations – α, β, γ and δ. 
Three pyrrole rings are oriented cis to each other, with the nitrogen atoms forming a 
cleft at the center in the β isomer. A cis-trans isomerization around the double bond 
between rings B and C gives rise to the α isomer. The α conformation is stabilized by 
intramolecular hydrogen bonding between the NH proton on ring C and the exocyclic 
oxygen on ring B. The γ and δ isomers arise due to rotation around the single bond 






of compound 33 can exist in any of the twelve structures. The four isomers (α, β, γ and 
δ) of tautomer I are depicted in Figure 4.5.  
 
Figure 4.5. Structure of prodigiosene derivative 33. Tautomer I is shown as α, β, γ and 
δ isomers for the computational study of a neutral prodigiosene 33.  Relative energies 
are in kcal/mol for both the gas phase and in solution (in parentheses).36  
 Quesada and colleagues performed a detailed computational study of the 
equilibria in both the gas phase and in solution for the neutral form of compound 33 
(Figure 4.5). Based on DFT calculations, they found that the lowest energy isomer in 
both phases was Iβ, which was taken as an energetic reference. In general, tautomer I 
was found to have relatively low energies in comparison to the other two tautomers (II 
and III), which means that deprotonation is most preferred on ring B. As a result, 
tautomer I was chosen for further conformational analysis of a protonated 
prodigiosene. When different isomers (α, β, γ and δ) of protonated form of tautomer I 






in Figure 4.5). In order to study the anion binding affinity for different isomers, 
chloride (Cl‾) and mesylate (MeSO3‾) complexes of IVγ were studied in more detail. 
Four structures were proposed for each of the anion complexes as shown in Figure 4.6.  
    
Figure 4.6. Isomer IVγ can bind Cl‾ and MeSO3‾ anions to give four possible 
complexes each. Binding energies were calculated in kcal/mol for each mesylate 
(MeSO3‾) and chloride (Cl‾) complex in gas phase, DMSO (in brackets), and water (in 
parentheses). Reprinted with permission from J. Org. Chem. 2012, 77, 6538-6544. 
Copyright (2012) American Chemical Society.36   
DFT calculations indicated that for all the isomers in all three phases, 






complexes. This data was in agreement with a 1H NMR titration study, where Cl‾ 
displaced MeSO3⁻ anion in a solution containing 33•MeSO3H. Moreover, in both gas 
and solution phase, the β isomer of IV was found to be the most favored for binding 
anions, with lowest energies for either ions – Cl‾ (-7.3 kcal/mol) and MeSO3‾ (-5.4 
kcal/mol). This theoretical calculation agreed with NOESY experimental data. NOESY 
spectra of both the 33•HCl and 33•MeSO3H complexes in CDCl3 gave the β form as 
the predominant isomer. These NMR results and DFT calculations were supported by 
solid state structures, obtained from X-ray diffraction studies. For both anion 
complexes, receptor 33•H⁺ was found to be in β conformation. The tripyrrolic structure 
was planar, showing high conjugation within the molecule. 
The results were even more interesting for a polar solvent like DMSO. The 
anion binding energy for the β form of 33•HCl complex in DMSO was -10.9 kcal/mol. 
The binding energy for the α isomer of 33•HCl complex was 2.1 kcal/mol. For the 
33•MeSO3H complex, the β isomer was calculated to have anion binding energy of       
-8.9 kcal/mol, whereas the α isomer had a binding energy of -7.3 kcal/mol. Consistent 
with small energy difference between α and β isomers for the 33•MeSO3H complex 
(1.6 kcal/mol), both species were observed in the 1H NMR spectrum. In the NMR 
spectrum, the β conformer was identified as the major isomer while α was the minor 
isomer. Conversely, the energy difference was quite large for the α and β isomers of 
33•HCl, which was consistent with the appearance of only β form in the                             






Thus, the protonation of the prodigiosene 33 greatly affected its conformational 
equilibrium and its rate of interconversion between the α and β conformations. DFT 
calculations supported the results observed in solution and solid state. The results from 
different techniques such as NMR, X-ray crystallography and molecular modeling 
showed that prodigiosene conformation in solution is influenced by the nature of the 
solvent, the counterion as well as the compound’s protonation state.  
Results 
 Using NH Protons to Analyze Anion Binding Patterns in α and β Isomers 
Transmembrane exchange of Cl‾ and NO3‾ anions by prodigiosin (1) involves 
anion binding by the protonated transporter (1•H⁺). This is followed by diffusion of the 
neutral complex 1•HCl across the lipid membrane, and Cl‾/NO3‾ anion exchange at the 
lipid–water interface.31 The anion binding and transport processes are potentially 
complicated by the fact that protonated prodigiosenes often exist as two isomers in 
solution – the α and β conformations. This α/β conformational equilibrium can vary as 
a function of ligand structure and environmental conditions.36,37 Both α and β 
prodigiosene conformations should be able to bind anions.  
Despite the importance of prodigiosin and its biological properties, little 
conformational work has been done on this compound and its analogs. In this chapter, 
I have worked with prodigiosin (1) and its synthetic analogs (2 and 3), to investigate 
some qualitative aspects of the solution-state conformation of these                       






 NMR Titrations Reveal α,β Conformations of Phenyl Analog 3b 
Anion exchange by prodigiosin (1), ester (2e) and phenyl (3b) analogs was 
studied in detail by using NMR. These experiments also allowed us to analyze the anion 
binding pattern for the two isomers – α and β. In particular, the phenyl analog helped 
us in confirming α and β conformations in solution. The complex 3b•HCl (1 mM) 
showed one set of signals, consistent with the β conformation, when initially dissolved 
in CDCl3 (Figure 4.7).  
 
Figure 4.7. 1H NMR for the phenyl analog 3b•HCl in CDCl3 shows a single set of 
peaks belonging to the β isomer. 
However, over time, the sample in CDCl3 showed two sets of 
1H NMR signals 
in an approximate 3:1 ratio. Based on analogy with previous NMR studies of other 
prodigiosenes in CDCl3,
36,37 the major set of NMR signals was assigned to the β isomer 







Figure 4.8. β and α conformational isomers of prodigiosene 3b•H⁺. Both the major β 
and minor α isomers should be able to bind anions as indicated by H-bonds.  
Next, both conformers of 3b•H⁺ were investigated for anion binding and 
exchange in the CDCl3 solution. Thus, methanesulfonic acid (MeSO3H) was titrated 
into a solution of 3b•HCl in CDCl3 and changes in 
1H NMR signals for the pyrrolic 
NH protons (δ 12–13 ppm) were followed. The changes in this region of the spectrum 
would reflect anion binding and exchange between Cl⁻ and MeSO3⁻ anions, since it is 
the pyrrole NH atoms that should hydrogen bond with the anions. Figure 4.9 shows 
representative spectra from the titration.  
 The NH region of the 1H NMR spectrum for the 3b•HCl complex (Figure 4.9a) 
indicates a mixture of isomers, but the NMR signals were poorly resolved. However, 
this overlap for the pyrrolic NH protons was removed upon the addition of MeSO3H to 
a solution of 3b•H⁺Cl⁻ (Figure 4.9b). As shown in Figure 4.9b, I observed two 
resolved sets of three pyrrolic NH signals for the 3b•H⁺MeSO3⁻ complex. There were 
two important findings here. First, the NH chemical shifts change upon addition of the 






shifts for the six NH protons moved upfield when MeSO3H was added to a solution of 
3b•HCl (Figure 4.9b). The NH chemical shifts moved upfield as Cl‾ is replaced by the 
softer MeSO3⁻ anion in the binding site of the prodigiosene. Second, the α/β isomer 
ratio for 3b•HCl and 3b•MeSO3H did not change significantly with the change in 
bound anion (Figure 4.9c).  
 
Figure 4.9. 1H NMR spectra in CDCl3 for the pyrrolic NH region of: (a) 3b•HCl; (b) 
after addition of 6 eq of MeSO3H to sample a; two sets of NH signals were resolved 
for each α () and β (*) conformer; (c) after addition of 1 eq of tetrabutylammonium 
chloride (TBACl) to sample b.  
 NOESY Data Shows Presence of α Conformation in CDCl3 Solution 
Before proceeding to study anion binding patterns of different conformations, 
it was essential to establish the existence of α and β conformations in solution. Figure 
4.8 illustrates the two main conformations of the phenyl analog 3b•H⁺. Generally, the 
β isomer can be easily observed in solution. It is often difficult, however, to identify 







Figure 4.10. A region of the NOESY spectrum of 3b•MeSO3H in CDCl3 shows a NOE 
between one of the “minor” pyrrole NH protons and C2 methyl hydrogens. This 
correlation is consistent with the pyrrolic NH of the C-ring being involved in a solvent-
shielded intramolecular H-bond with the –OPh group of the B-ring.  
A 2D NOESY NMR experiment of the 3b•MeSO3H complex in CDCl3 allowed 
us to assign signals for the three NH protons in the major β isomer, and for the three 
NH protons in the α isomer. The NOE correlation that best supports my assignments 
can be observed between one of the minor pyrrole NH signals and the signal 
corresponding to the C2 methyl group. For the α isomer, the C-ring NH proton forms 
an intramolecular hydrogen bond with the –OPh group on the B-ring (α isomer in 
Figure 4.10). Presumably, this hydrogen-bonded NH proton exchanges much more 
slowly with residual water in the CDCl3 and, therefore, shows a NOE correlation with 
its neighboring C2-methyl group. Diagnostic NOE interactions were also observed for 
the β isomer.  These NOEs have been previously reported by Quesada and Rizzo in 






After some success in examining anion exchange with phenyl analog, my focus 
shifted to the study of anion binding patterns for α and β conformations of 
prodigiosenes. However, the NMR signals for anion binding NH protons of 3b•HCl 
were not resolved enough to provide us with information about the anion binding 
patterns (Figure 4.9b-c). Upon carrying out similar experiments, both prodigiosin 1•H⁺ 
(Figure 4.11a) and ester 2e•H⁺ (Figure 4.11b) showed presence of α and β 
conformations in CD3CN, which were consistent with the NMR signals observed for 
3b•H⁺A‾. The well-resolved signals for NH pyrrole protons of α and β isomers in 
compounds 1•H⁺ and 2e•H⁺ allowed us to clearly follow the anion binding patterns for 
the two isomers.  
 NH Protons of Prodigiosin 1 and Ester 2e Reveal Anion Binding Patterns 
Although other groups have proposed the anion binding patterns for 
prodigiosenes, no direct supporting proof has been published that both α and β 
conformers bind anions. As described below, I found that the two conformers - α and 
β, do exhibit distinct binding patterns with Cl⁻ and MeSO3⁻ anions. In the β 
conformation, all 3 NH protons bind with the anion, whereas in α conformation, only 
two NH’s are available for binding. The third NH proton in the α conformer is involved 
in intramolecular hydrogen bond with the OMe group on ring B (Figure 4.11), and thus 







Figure 4.11. Structures of α and β isomers of 1•H⁺A⁻ are illustrated at the top to show 
the interaction between NH protons and anion A⁻. 1H NMR spectra shows the changes 
in conformations for (a) prodigiosin 1•H⁺ and (b) ester 2e•H⁺ based on the chemical 
shifts of the NH protons as MeSO3H and TBACl are added to the sample in CD3CN at 
-10°C. Shifting of signals has been highlighted by red dashed lines for α isomer and 
black dashed lines for β isomer.  
Each sample containing prodigiosin 1 or ester 2e was titrated with MeSO3H. In 
both cases, the compounds underwent binding with the MeSO3⁻ anion (spectrum 
labeled 1 eq MeSO3H in Figure 4.11). Movement of signals has been highlighted by 






for α and β conformations are visible for 1•MeSO3H complex whereas only signals for 
the β isomer were observed for ester 2e•MeSO3H. Addition of increasing equivalents 
of MeSO3H led to an upfield movement in chemical shifts (5 eq MeSO3H in Figure 
4.11), due to weak binding interactions between MeSO3‾ anion and 1•H⁺ and 2e•H⁺ 
cations. Moreover at 5 eq MeSO3H, both compounds clearly show distinguishable α 
and β conformations in solution. When TBACl was added to the samples, any protons 
involved in anion binding underwent changes in chemical shifts, due to displacement 
of bound MeSO3⁻ by Cl⁻ anion. For 1•HCl and 2e•HCl, all three NH protons belonging 
to the β isomer underwent a downfield shift upon addition of 1 eq of TBACl. This 
result follows the hypothesis that β1•H⁺ and β2e•H⁺ bind chloride anion using all three 
of their pyrrole NH protons. For the minor set of peaks belonging to α1•H⁺ and α2e•H⁺, 
only 2 NH signals experienced downfield shift upon addition of Cl‾. The third NH 
signal (at approx. δ 10.5 ppm in 1 eq TBACl in Figure 4.11) remained stationary after 
addition of Cl‾. The NH proton at ~δ 10.5 ppm was identified as the NH proton on ring 
C, which is involved in hydrogen bonding with the OMe group on ring B. Thus, 
because this NH proton is involved in an intramolecular hydrogen bond, it does not 
experience any change in chemical shift as a function of Cl‾ addition. Upon addition of 
2 eq TBACl, the α isomer of prodigiosin 1•HCl was completely converted to its β form 
(spectrum labeled 2 eq TBACl in Figure 4.11a). In the case of the ester 2e•H⁺, addition 
of 2 eq of TBACl did not lead to the complete conversion of α to β isomer (spectrum 






Cl‾, these 2 NH protons keep moving downfield as more equivalents of Cl‾ are added 
to the solution (10 eq TBACl in Figure 4.12).  
 
Figure 4.12. 1H NMR spectra of α and β conformations of 2e•HCl shows the changes 
in chemical shifts of NH protons as TBACl is added to the sample in CD3CN at -10°C. 
Shifting of signals has been highlighted by red dashed lines for α isomer and black 
dashed lines for β isomer. Note that the NH proton at 10.5 ppm does not move with 
addition of TBACl.  
 The study of the chemical shifts of NH protons of the α and β isomers of ester 
analog 2e•H⁺ enabled us to assemble an equilibrium diagram for the different processes 
taking place in solution for compound 2e (Figure 4.13). The equilibrium diagram 
depicts the slow rate of interconversion between the α and β isomers of 2e•MeSO3H 
and 2e•HCl complexes. Conversely, the NMR results for prodigiosin 1 in Figure 4.11 











Figure 4.13. Structures of α and β conformations of 2e•MeSO3H and 2e•HCl 
complexes. The α and β isomers are in slow equilibrium with each other for both anion 
complexes of the ester compound (2e•MeSO3H and 2e•HCl).  
In conclusion, the assumption of assigning α and β conformations for prodigiosin 
1•H⁺ and ester 2e•H⁺ in Figure 4.11 was confirmed by the observed changes in NMR 
chemical shifts for the pyrrole NH protons. Chemical shift patterns for the pyrrole NH’s 
of α and β conformations of prodigiosin 1•H⁺ and ester 2e•H⁺ were clear and distinct 
based on their binding with anion. These NMR titrations allowed us to conclude that 






uses only two NH protons to bind anions and (3) Cl‾ interacts more strongly than 
MeSO3‾ with the receptor cations (1•H⁺, 2e•H⁺ and 3b•H⁺).  
 Evidence for CH∙∙∙Anion Hydrogen-Bonding by α-Isomer of Prodigiosenes 
In the last decade, explorations into receptors that are capable of binding anions 
using CH hydrogens have been made. The unconventional C-HA‾ interactions are a 
specific type of hydrogen-bond interactions and have found some significance in anion 
transport.135 In 2005, Hay and colleagues showed by using theoretical calculations, 
examination of crystallographic data and experimental binding energies that even in 
the absence of electron-withdrawing substituents, simple arenes like benzene can form 
hydrogen bonds with anions (such as Cl‾, NO3‾ and ClO4‾). Therefore, these moieties 
can be included in receptors to enhance their anion binding affinity and could provide 
additional binding sites within the host cavity.136  
 
Figure 4.14. Examples of receptors that can bind anions using CH and NH hydrogens.  
In 2008, Flood group introduced the macrocyclic receptor 34 (Figure 4.14).137 






positions and displayed a high affinity for anion binding using C-HCl‾ interactions. 
While macrocycle 34 based receptors were specific for binding Cl‾, there have been 
other anionophores that have been investigated for binding different anions. For 
example, Sessler and group worked with a pyrrole based triazolophane 35 that 
selectively binds pyrophosphate anion using NH and CH hydrogens in organic solvents 
(Figure 4.14).138  
 CH Hydrogen Assisted Anion Binding by Tambjamines  
 Although there are no known examples of prodigiosenes employing CH 
hydrogens to bind anions, the closest reference can be made to tambjamines. In 2014, 
Quesada and colleagues demonstrated tambjamine analog 36 utilizes CH hydrogens for 
binding anions.139 Direct proof was obtained when analog 36 was titrated with 
increasing amounts of tetrabutylammonium chloride (TBACl). Binding between 36 
and Cl⁻ ions was followed by 1H NMR spectroscopy. When TBACl was titrated into a 
solution of 36 in d6-DMSO-0.5H2O, one would expect the acidic NH pyrrole protons 
to undergo changes in chemical shifts due to binding with Cl⁻. Instead in this case, the 
chemical shift of one of the NH protons (NH1ˈ) remained unaltered whereas that of a 
CH hydrogen (H3ˈ) on the same ring shifted downfield as varying equivalents of 
chloride anion were added to the NMR sample (Figure 4.15). The downfield 
movement of H3ˈ hydrogen on ring A is evidence of its involvement in chloride binding 







Figure 4.15. Stack plot of 1H NMR titration of 36 with TBACl in d6-DMSO-0.5H2O. 
 The α-H1ˈˈ Hydrogen on Prodigiosenes 1 and 2e Binds Anions  
 
Figure 4.16. The H1ˈˈ (highlighted in red) in a2e•MeSO3H complex is involved in 
binding MeSO3⁻ anion in addition to the two NH protons on rings A and B.  
Until now, it has been widely accepted that the NH protons of prodigiosenes 
are involved in anion binding. However, for the first time, we have shown that a CH 
hydrogen belonging to the α isomer is involved in binding anion. While studying the 
CH hydrogens on pyrrole rings, I noticed a significant change in chemical shift of the 






H1ˈˈ hydrogen of α isomer of 2e•MeSO3H complex in binding with the MeSO3⁻ anion 
along with the pyrrolic NH protons on rings A and B. Due to the bidentate nature of 
the MeSO3⁻ anion, the α-H1ˈˈ hydrogen of 2e•H⁺ is able to interact with the anion. A 
monodentate anion such as Cl⁻ does not interact with the H1ˈˈ hydrogen of α isomer. In 
fact, Nager has reported that a polydentate anion such as the gluconate anion can help 
solubilize prodigiosin in aqueous solutions.140 The structure in Figure 4.16 is based on 
computational modelling and calculations performed by Ms. Maria Garcia Valverda 
and Dr. Roberto Quesada, collaborators from the University of Burgos, Spain. 
As increasing equivalents of MeSO3H were added to a NMR sample of 
prodigiosin 1, the chemical shift for the H1ˈˈ hydrogen on the α isomer shifted upfield 
indicating binding with the MeSO3‾ anion (Figure 4.17a-c). Based on my NMR results 
with prodigiosin 1•H⁺ and the computational modeling done with ester analog 2e, a 
structure has been proposed to depict the binding of MeSO3‾ anion using the H1ˈˈ and 
NH protons on rings A and B of α1•MeSO3H (Figure 4.17). Addition of MeSO3H was 
followed by TBACl addition to displace MeSO3‾ with Cl‾ anion in the binding pocket. 
Addition of Cl‾ anion caused complete conversion of α to β isomer overtime. However, 
at 1 eq TBACl in Figure 4.17d, a small signal is visible for the α-H1ˈˈ that has shifted 
downfield. The downfield shift is presumably due to the displacement of a weakly 
binding MeSO3‾ anion by a strongly binding Cl‾ anion (Figure 4.17). At 2 eq of 
TBACl, the conversion between isomers was complete and therefore, no peak for α 
isomer was observed (2 eq TBACl in Figure 4.19a). Importantly, no change in 







Figure 4.17. Proposed structure depicts the involvement of a-H1ˈˈ (highlighted in red) 
hydrogen in 1•MeSO3H complex for binding MeSO3⁻ anion, in addition to the two NH 
protons on rings A and B. 1H NMR spectra shows the changes in chemical shift for H1ˈˈ 
on α isomer of prodigiosin 1•H⁺ as MeSO3H and TBACl are titrated into the NMR 
sample in CD3CN at 25°C. When 1 eq of TBACl is added, MeSO3‾ is displaced by the 
strongly binding Cl‾ anion to give α1•HCl complex. The exchange of anions is also 
accompanied by complete conversion of α to β isomer over time. Note that the H1ˈˈ on 






 For the ester compound 2e, as equivalents of MeSO3H were added to the 
solution, the signal for α-H1ˈˈ proton grew in intensity (Figure 4.18b-c). Also, the 
signal shifted downfield with each addition of MeSO3H. Using computational 
modeling, a structure was generated to depict the binding of MeSO3‾ anion by the H1ˈˈ 
hydrogen of the α isomer of 2e•MeSO3H (Figure 4.18). As shown in Figure 4.18, the 
bidentate MeSO3‾ anion is bound using two pyrrolic NH protons on rings A and B 
along with the H1ˈˈ hydrogen of α2e•H⁺ cation. When TBACl was added to the sample, 
displacement of bound MeSO3‾ by Cl‾ anion took place. Addition of equivalents of 
TBACl led to an upfield movement of the α-H1ˈˈ resonance (1 eq TBACl NMR 
spectrum in Figure 4.18d). Moreover, no interconversion between the α and β isomers 
was observed. The resonance for α-H1ˈˈ hydrogen continued to shift upfield as more 
equivalents of chloride were added (2-10 eq TBACl in Figure 4.18e-f). According to 
the computational model of α2e•HCl in Figure 4.18, the H1ˈˈ is not involved in binding 
monodentate Cl‾ anion. Upon addition of multiple equivalents of TBACl, the weakly 
bound MeSO3‾ anion gets slowly displaced from the binding pocket by Cl‾, resulting 
in an upfield movement of the α-H1ˈˈ resonance (1-10 eq TBACl in Figure 4.18d-f). 
This behavior was in contrast to the pattern observed for α-H1ˈˈ of prodigiosin (Figure 
4.17d). No change in chemical shift for β-H1ˈˈ of 2e•H⁺ was observed.   







Figure 4.18. Structures showing the H1ˈˈ (highlighted in red) in a isomer of 
2e•MeSO3H complex, involved in binding MeSO3⁻ in addition to the two NH protons 
on rings A and B. For the a isomer of 2e•HCl complex, the H1ˈˈ is no longer involved 
in binding Cl⁻. Calculated Gibbs’ free energies for each complex are in kcal/mol, in 
gas phase and acetonitrile (in parenthesis). 1H NMR spectra shows the changes in 
chemical shift for H1ˈˈ on α isomer of ester analog 2e•H⁺ as MeSO3H and TBACl are 






 Thus, the NMR experiments described in this section provided us with 
substantial evidence for the involvement of a CH hydrogen of α isomer of 
prodigiosenes in binding anions. This data is especially exciting due to the proposed 
involvement of the α conformation in the biological activities observed for prodigiosin 
1.134 The importance of the α conformation is further elevated by the finding that 
population of α isomer of 1•H⁺ increases in solution in presence of water, as described 
in the next section.  
 Factors Affecting α/β Conformational Ratio 
After confirming the presence of α and β conformations in solution for 
prodigiosin 1 and its analogs (2e and 3b), the next step was to investigate the conditions 
under which the ratio of α/β isomers could be varied. Quesada and his group, in their 
work with synthetic prodigiosene 33, had concluded that the α/β isomer ratio could be 
manipulated by changing the counterion or solvent.36 Rizzo briefly mentioned that 
solvents such as water can drastically change the α/β ratio.37 However, none of the 
groups have studied the original natural product prodigiosin 1. We made an attempt to 
study the factors that affect conformations of 1 and a few of its synthetic analogs.  
 Anions Affect the α/β Conformational Ratio 
By looking closely at the NH pyrrole protons, I was able to ascertain the binding 
patterns adopted by α and β conformations of prodigiosenes. Similarly, by observing 
CH pyrrole protons, the role of anion in influencing α/β conformer ratio in different 
compounds was determined. In the 1H NMR experiments described below, samples of 






Figure 4.19a shows a series of NMR spectra, highlighting aromatic CH 
hydrogens of prodigiosin 1. Only one set of signals was observed for CH hydrogens 
initially (0 eq MeSO3H in Figure 4.19a). An addition of 1 eq of MeSO3H led to 
downfield movement of peaks (H3, H5 on ring A and the bridging proton H1ˈˈ) due to 
formation of 1•MeSO3H complex (1 eq MeSO3H in Figure 4.19a). Addition of excess 
acid gave rise to a second set of peaks of lower intensity (5 eq MeSO3H in Figure 
4.19a). The major set of peaks was assigned to β isomer of 1•MeSO3H while the minor 
set of peaks were assigned to α isomer. The α:β ratio was roughly 1:3 after addition of 
5 eq of MeSO3H. When 1 eq of TBACl was added to the sample, all of α isomer 
immediately converted into β form (2 eq TBACl in Figure 4.19a). Addition of excess 
equivalents of TBACl caused no other changes to the conformer ratio. The shift in 
equilibrium presumably took place because the β–isomer of 1•H⁺Cl⁻ is favored over 
the α isomer. This extra stability of β form is a result of the contribution of all 3 pyrrole 
NH protons being able to bind Cl⁻ ion. A change in binding strength owing to stronger 
association between 1•H⁺ cation and Cl⁻ anion is apparently enough to influence the 







Figure 4.19. 1H NMR spectra shows the changes in conformer ratios for (a) prodigiosin 
1•H⁺ with respect to aromatic CH hydrogens as MeSO3H and TBACl are titrated into 
the NMR sample in CD3CN at 25°C. The results for prodigiosin have been contrasted 
with results obtained from ester 2e•H⁺ (b).  
Similar to prodigiosin 1, ester 2e shows a single set of peaks for CH hydrogens 
H3, H5 on ring A and bridging hydrogen H1ˈˈ. When 1 eq of MeSO3H was added to the 
sample, peaks for β conformer were observed predominantly (1 eq MeSO3H in Figure 
4.18b). As increasing increments of acid were added to the solution, a second set of 
minor peaks appeared (5 eq MeSO3H in Figure 4.18b). The ratio of α and β conformers 






maintained and no detectable interconversion between conformations took place (2 eq 
TBACl in Figure 4.19b). When the sample was heated up to 75°C, it was found that 
the equilibrium could be pushed more toward the β conformation (2 eq TBACl, Δ in 
Figure 4.19b; NMR spectrum was recorded after cooling the sample to room 
temperature for 1 hour). However, signals for α isomer reappeared after a day, bringing 
the α:β conformation ratio back to the original ratio of 1:4 (24 hours in Figure 4.19b). 
This property shown by the ester analog was in contrast to prodigiosin 1•HCl. In order 
to understand why ester 2e•HCl maintained a α/β conformation ratio of 1:4 despite the 
addition of excess Cl‾ and a thermal push, we asked our collaborators to perform DFT 
calculations to compare and contrast the Cl‾ binding affinities of the α and β 
conformations of 2e•HCl in CH3CN. These calculations, along with molecular 
modeling, were performed by Ms. Maria Garcia Valverda and Dr. Roberto Quesada at 
the University of Burgos, Spain. 
 Binding Energies of α and β Conformations of 2e•HCl 
Since we were interested in studying the conformations of the HCl complex of 
ester 2e, we wanted to know about the relative energies of protonated species 2e•H⁺. 
Our collaborators calculated energies for both gas and solution (acetonitrile) phases. 
Based on DFT calculations, the γ isomer was found to have the minimum energy 
(Figure 4.20). Therefore, it was used as a starting point for Cl‾ binding studies. In order 
to study the Cl⁻ binding affinity for different isomers, chloride (Cl‾) complexes of 
γ2e•H⁺ were studied in more detail. Four structures were proposed for Cl‾ complexes 







Figure 4.20. The γ2e•H⁺ cation can bind Cl‾ to give four possible isomers. Binding 
energies were calculated in kcal/mol for each chloride (Cl‾) complex in gas phase and 
acetonitrile (in parentheses).  
The DFT calculations indicated that in both gas and solution phases, interaction 
energy for the β isomer was lowest (-12.3 kcal/mol). This theoretical calculation is in 
agreement with the solution NMR data, where 2e•HCl gave β form as the dominant 
isomer. Further, the anion binding energy for the β form of 2e•HCl complex in CH3CN 
was -12.3 kcal/mol, whereas the binding energy for the α isomer of 2e•HCl complex 
was -11.3 kcal/mol. The small energy difference between α and β conformers (1.0 
kcal/mol) might explain the presence of both species in the 1H NMR spectrum. Despite 
addition of excess Cl‾ anion and heating of the sample, the equilibrium ratio was 






Thus, some of the DFT calculations supported the results observed in NMR 
experiments. With the aid of NMR experiments, I was able to show that in presence of 
Cl⁻ anion, the β-conformation of prodigiosin 1•H⁺ is favored over the α-conformation. 
But the same is not true for the ester analog 2e•H⁺.  
 Water Influences Population of α Isomer in Solution 
In their 1999 publication, Rizzo et al. briefly mentioned that conformer α and 
β coexisted at about 2/1 ratio in a 1:1 CD3CN/D2O (pH 1.1) solvent system.
37 They 
provided no data, however, for this assertion. Quesada et. al. acknowledged this finding 
when they affirmed in their publication that conformation ratio was influenced by 
solvents.36 They were able to confirm solvent influence based on the studies performed 
with compound 33 in DMSO and CDCl3. However, none of the groups have looked at 
the natural product prodigiosin 1 and the influence of solvent on its conformations. 
In an aprotic solvent such as CD3CN, protonated prodigiosin 1•H⁺MeSO3⁻ 
exists in the α:β conformation ratio of 1:3 (Figure 4.21). The next goal was to evaluate 
the conformation ratio of prodigiosin in aqueous solution, a more biologically relevant 
system. However, prodigiosin has a low solubility (18 μM) in water at pH 7.0 at 25 
⁰C.141 Therefore, a 1:1 mixture of CD3CN and D2O was used for NMR studies. A 1H 
NMR spectrum of prodigiosin 1•H⁺MeSO3⁻ (2 mM) in presence of 3 eq of 
methanesulfonic acid was recorded in CD3CN:D2O (1:1) at 25 C (Figure 4.21). This 
aqueous solvent system gave a higher population of α conformer (1:2), in contrast to 







Figure 4.21. Structures of the α and β conformations of 1•MeSO3H. 1H NMR spectra 
of prodigiosin 1•MeSO3H in presence of 3 equivalents of MeSO3H in CD3CN (bottom) 
and 1:1 mixture of CD3CN:D2O (top) at 25 C.  
The higher ratio of α was evident based on the aromatic protons between 6-8 
ppm (Figure 4.21). The higher population of α isomer indicates the extra stabilization 
of the structure in water. The α isomer is characterized by intramolecular hydrogen 
bonding between the NH proton on ring C and the exocyclic oxygen on ring B (Figure 
4.21). As a solvent, water may provide a network of H-bonds to stabilize the flipping 






In Section 4.2, I described the ability of analog 12 to form non-covalent dimers 
in absence or presence of metal ions.33, 34 The change in 1H NMR spectrum of 
1•MeSO3H in presence of water could be due to the formation of dimeric and 
monomeric species.142 The possibility of dimer formation by 1•MeSO3H in 
CD3CN:D2O was examined by performing a dilution experiment and DOSY NMR. No 
changes in chemical shifts were observed throughout the dilution experiment.  
 
Figure 4.22. DOSY NMR of prodigiosin 1•MeSO3H with 3 equivalents of MeSO3H 
in a 1:1 mixture of CD3CN:D2O at 25 C. Only one set of DOSY signals were observed 
for all aromatic protons.  
DOSY NMR of 1•MeSO3H in CD3CN:D2O showed a single set of peaks for 
all aromatic protons in the two isomers (Figure 4.22), which indicates that the sample 
contains different species of similar molecular weight. Thus, diffusion NMR data 






Other 2D NMR experiments such as NOESY and ROESY were attempted to 
assign the various peaks to α or β isomer in the 1:1 CD3CN:D2O solution. NOESY and 
ROESY experiments were ineffective in gathering any details about the isomers. Based 
on COSY NMR, the resonances were separated into two sets (Figure 4.23). This 
separation was based on the knowledge that three protons from ring A (H3, H4 and H5) 
and H4 proton from ring B will show COSY correlation. As expected, three signals in 
each set showed correlation that allowed us to segregate the signals for two isomers.  
 
Figure 4.23. 2D COSY NMR of prodigiosin 1•MeSO3H with 3 equivalents of 
MeSO3H in a 1:1 mixture of CD3CN:D2O at 25 C. The signals for aromatic protons 
could be segregated for the two isomers.  
The results obtained in this section are quite interesting, when combined with 
Rizzo’s findings.37 According to my results, 1•MeSO3H exists in an α/β 
conformational ratio of 1:2 in a 1:1 mixture of CD3CN:D2O. The population of α isomer 
of 1•MeSO3H increases by 17% in presence of D2O. Although similar experiments 
were not attempted with 1•HCl complex, Rizzo’s findings with 8•HCl salt give insight 






CD3CN:D2O (1/1, pH 1.1) gave a ratio of 2:1 for the α/β isomers in an NMR experiment 
(Section 4.2.2). One common observation in both set of results is the increase in 
population of α isomer in presence of water, possibly due to the stabilizing effect of 
water on the structure of the α form. Therefore, leading us to questions, regarding the 
relevance of α conformation in biological systems where water is the major solvent.  
Chapter 2 and 3 explored the ability of prodigiosin 1 and its analogs (2, 3) to 
bind and transport anions in aqueous buffers. Multiple research groups have suggested 
that the β–isomer exhibits stronger anion binding due to the tridentate binding motif 
and therefore, must be the major conformer responsible for anion transport.33, 36-38 But 
these observations were mostly based on binding studies done in organic solvents. 
Moreover, the experiments with 1•MeSO3H have shown that depending on the 
counter-anion, the CH hydrogen in α–isomer can also be involved in anion binding, 
thus, giving rise to a tridentate motif (Section 4.5.1). Based on the above arguments, it 
is possible that the α–isomer also plays an important role, like the β–isomer in the 
process of anion transport. 
Prodigiosin 1 can intercalate with dsDNA, as illustrated by Manderville, Perez-
Tomas and Zhou.39⁻41 Prodigiosin’s ability to interact with DNA has been suggested as 
possible mechanism for explaining its anticancer activity. However, the existing studies 
do not explore the conformation adopted by prodigiosin while binding with DNA. In 
1990, McNab made an interesting correlation.134 In his paper, he wrote “...the 
configuration of the methoxy group is particularly noteworthy, allowing a seven-






configuration of the rings defined by hydrogen bonding in this way may be associated 
with the biological activity of prodigiosins, which is known to be dependent on the 
presence of the ring B methoxy group”. The last sentence highlights the dependence of 
biological activity of prodigiosenes on the methoxy group on ring B. At the same time, 
the arrangement of rings in α conformer is also a result of the methoxy group. 
Therefore, the arguments put forth suggest a larger role for the α conformation in 
biological systems. More in-depth studies need to be pursued to realize the complete 
contribution of α–isomer in the observed biological activities of prodigiosenes. The 
NMR results described in this chapter are a stepping stone in realizing this goal. 
 Conclusions 
The work presented in this chapter was inspired by the transport mechanism 
proposed by Davis and colleagues.31, 32 Davis and group proposed that prodigiosin 1•H⁺ 
is protonated at physiological pH of 7.4. In its protonated state, prodigiosin 1•H⁺ binds 
chloride and transports it as 1•H⁺Cl⁻ across liposomal membrane. In this chapter, 
binding of anions by prodigiosin 1•H⁺ and its analogs (2e•H⁺, 3b•H⁺) was studied. 
Binding studies were initiated by confirming existence of α and β isomers for analog 
3b•H⁺ in organic solvents. From NMR results, the distinct anion binding patterns of α 
and β isomers were recognized. The involvement of a CH hydrogen of α isomer in 
binding anions was a significant finding. This is the first time that prodigiosenes have 
been shown to employ a CH hydrogen for anion binding. The CHA‾ interaction is an 
important contribution to the study of diverse non-covalent interactions in the ever-






from the data in Figure 4.18. The Cl⁻ anion is smaller in size as compared to the 
MeSO3⁻ anion. Based on computer modeling and NMR data (upfield movement of α-
H1ˈˈ when TBACl is added; trace d-f in Figure 4.18), the α-H1ˈˈ hydrogen is not 
involved in binding Cl⁻. However, due to the bidentate nature of the MeSO3⁻ anion, 
the α-H1ˈˈ hydrogen is able to interact with it. Similarly, it will be interesting to explore 
other polydentate anions such as some of the biologically relevant carboxylate anions 
(for eg. acetate, oxalate, citrate, etc.) and their binding interactions with prodigiosenes. 
In fact, Nager has reported that the gluconate anion can help solubilize prodigiosin in 
aqueous solutions.140 Prodigiosin completely dissolved in a 3% gluconic acid solution 
by forming a gluconate salt. When the solution was freeze-dried under vacuum, 
prodigiosin gluconate was obtained in amorphous form which was readily soluble in 
water. This finding can be applied in biological studies of prodigiosin as it is poorly 
soluble in aqueous medium.141 An investigation of similar anions can be insightful in 
learning more about the involvement of α-H1ˈˈ hydrogen in anion binding. Further, it 
might contribute towards understanding of prodigiosenes solution properties. 
Additionally, it was shown that counter-anions can influence the α/β conformer 
ratio for protonated prodigiosenes in different ways. Solvents can also influence the α/β 
conformer ratio. An α/β ratio of 1:3 is observed in CD3CN, whereas a mixed solvent 
system like CD3CN: D2O (1:1) changes the conformer ratio. Apparently, the presence 
of water provides additional stability to the α isomer, leading to an increase in its 






In conclusion, conformations of prodigiosenes were studied in greater detail in 
this chapter. Computer modeling results coincided with the NMR observations. We 
were able to predict anion binding patterns of prodigiosenes and the factors influencing 









 Chapter 5: Prodigiosin as a G-Quadruplex DNA Binding Ligand 
The 2D NMR experiments were performed in collaboration with Dr. Daoning Zhang 
at the Biomolecular NMR Facility at the University of Maryland, College Park.  
 Introduction 
The goal of the research described in this chapter was to confirm and establish 
binding between G-quadruplex DNA and prodigiosin 1. A hexameric DNA sequence 
(5ˈ-TGGGGT-3ˈ) was used to form a G-quadruplex d[TGGGGT]4 in the presence of 
K⁺ or Na⁺ cations. By 1H NMR spectroscopy, it was found that prodigiosin binds at the 
3ˈ end of the quadruplex DNA. Before describing the studies done to establish 
interactions between G-quadruplex DNA and prodigiosin 1, I first provide a brief 
background on G-quadruplexes, significance of drug-G-quadruplex DNA interactions, 
some selective examples of G-quadruplex binding ligands and previous studies done to 
investigate interactions between prodigiosin 1 and duplex DNA.      
 A background on G-Quadruplex DNA  
In 1960, Gellert et al. first described the G-quartet arrangement adopted in gels 
formed by 5ˈ-guanylic acid.143 By using crystallographic methods, they demonstrated 
the square planar arrangement of four guanosine bases within a G-quartet. Each 
guanosine uses its N1 and N2 amide NH protons as hydrogen bond donors and N7 and 
O6 as hydrogen bond acceptors. A total of eight hydrogen bonds are found in a G-






    
a)                                                  b)                                  c) 
Figure 5.1. a) A G-quartet showing hydrogen bonds between the Hoogsteen and 
Watson-Crick faces of guanosine bases. b) Depiction of a intermolecular G-quadruplex 
5ˈ-d[TG4T]4 formed by assembly of four strands aligned parallel to each other.  c) 
Depiction of an anti-parallel intramolecular G-quadruplex formed by the folding of a 
single-strand of DNA. 
Later, it was found that G-rich sequences are located at the end of eukaryotic 
chromosomes, so-called telomeres. These G-rich telomeric DNA sequences can fold to 
form compact, well-defined and stable intramolecular G-quadruplexes that are 
involved in multiple processes.144, 145 G-quadruplexes are formed due to stacking of G-
quartets on top of each other. The G-quadruplex structure can vary extensively 
depending on the folding, strand stoichiometry, nature and location of loops that link 
the stretches of guanine bases.146 For example, four DNA strands can align in a parallel 






Alternatively, a single-strand with repeating G-rich units can fold to form an               
anti-parallel intramolecular quadruplex such as d[GGTTGGTGTGGTTGG] (Figure 
5.1c). The solution environment, such as metal ions, ligands, molecular crowding 
conditions can affect the stability and topology of quadruplexes.147,148 The stability of 
G-quadruplexes depends on non-covalent interactions such as base stacking, hydrogen-
bonding, hydration and metal ion coordination.146,149  
The higher order structures formed by G-quartets protect the ends of 
chromosomes from damage or attachment to other chromosomes or unwanted species. 
Shortening of G-rich sequences has been shown to trigger cell senescence whereas 
lengthening of the G-rich sequence can lead to cell proliferation as seen in cancerous 
growth.150 Telomerase is an enzyme involved in the synthesis of G-rich fragments of 
DNA. In most cancerous cells, telomerase is highly active. Telomerase requires a 
single-stranded telomeric primer to carry out the replication process. If small molecules 
that stabilize the G-quadruplex are present, the G-quadruplex structure may be stopped 
from unfolding, which subsequently inhibits the telomerase activity.151 Therefore, 
drugs that target G-quadruplexes are seen as a promising way to interfere with 
telomerase functioning and act as potential anti-cancer agents.144,145 
 Examples of G-Quadruplex Binding Ligands 
Although there are hundreds of examples of drugs and dyes that bind G-
quadruplexes,152,153 a few selective examples are discussed here. Thioflavin T 37 
(Figure 5.2) acts as a fluorescent probe that binds with G-quadruplexes, including G-
quadruplex d[TG4T]4.






telomeric DNA sequences. Under certain conditions, ThT 37 can cooperatively 
stabilize a G-quadruplex in presence of K⁺ ions. Interaction of 37 with the G-
quadruplex results in an increase in the dye’s fluorescence emission of up to 2100 fold. 
Depending on the folding topology of  the particular G-quadruplex, ThT can bind at 
the grooves, stack at the top or bottom G-quartet or intercalate between different G-
quartet planes.154  
 
Figure 5.2. Structure of G-quadruplex binding Thioflavin T 37. 
 Most telomerase inhibitors are aromatic compounds with electron-deficient 
heterocyclic rings. Due to their electron-deficiency, these compounds can stack or 
intercalate with the G-quartets. Telomestatin 38, a natural product isolated from 
Streptomyces anulatus (Figure 5.3), is a potent telomerase inhibitor that selectively 
interacts with intramolecular G-quadruplexes.156 In fact, telomestatin can induce G-
quadruplex folding in the absence of monovalent cations.157 Depending on the buffer 
conditions, telomestatin can influence the folding of G-quadruplex into either parallel 
to anti-parallel orientation. This particular ability of telomestatin 38 to modulate G-
quadruplex morphologies extends beyond the usual consequences of ligand binding, 
such as G-quadruplex stabilization and telomerase inhibition.156  
 Distamycin A 39 is another drug that has been extensively studied for its ability 






Two anti-parallel distamycin dimers bind in two opposite grooves of G-quadruplex 
formed by d[TGGGGT]4.
158, 159  
 
Figure 5.3. Structures of quadruplex binding drugs – Telomestatin 38, Distamycin A 
39 and TMPyP4 40. 
Lastly, the porphyrin TMPyP4 40 is another example of a telomerase inhibitor. 
TMPyP4 binding with G-quadruplexes has been tested using different DNA sequences 
that can form intermolecular quadruplexes, including d[TG4T]4, or intramolecular 
quadruplexes (d(G4T4G4)2 and AG3(T2AG3)3). Porphyrin 40 was found to end stack in 
a 2:1 binding mode with d[TG4T]4, whereas it intercalates between two G-tetrads and 
diagonal loop regions of d(G4T4G4)2 and lateral loop regions of AG3(T2AG3)3.
160 
These, and many other compounds, are being engineered for structure specific 
G-quadruplex binding and stabilization. These G-quadruplex binding ligands are being 
studied for therapeutic and diagnostic applications. As shown later in this chapter, we 






G-quadruplex d[TG4T]4. This finding can lead to the study of prodigiosene analogs as 
potential G-quadruplex ligands and telomerase inhibitors.  
 Characterizing Ligand-Quadruplex Interactions 
A G-quadruplex:ligand complex can be characterized by multiple techniques. In 
many studies, there may be a limited availability of the ligand or of the DNA. 
Therefore, the techniques most often used require low quantities of material. 
Additionally, these techniques show sensitivity to changes induced in the G-quadruplex 
structure due to ligand binding. In this chapter, some of the techniques that were used 
include UV-vis spectroscopy, circular dichroism spectroscopy (CD), fluorescence 
spectroscopy and nuclear magnetic resonance spectroscopy (NMR). These methods are 
discussed briefly in the following section. To learn more about other methods used to 
study G-quadruplex:ligand interactions, such as X-ray crystallography, fluorescence 
resonance energy transfer (FRET) assays, isothermal titration calorimetry (ITC) and 
more, the reader is directed to an excellent review written by Gu. et. al.145  
 UV-vis Spectroscopy 
UV-vis spectroscopy is a frequently used method for characterizing G-
quadruplexes and ligand binding. Upon binding with G-quadruplex, the UV-vis 
spectrum of the ligand undergoes a hypochromic shift in its soret band (wavelength of 
maximum absorption) upon binding. The hypochromic effect is due to electronic 
interactions between the DNA bases and a chromophore on the ligand. Figure 5.4 
illustrates the hypochromic effect observed for TMPyP4 40 (structure shown in Figure 






formed by 5ˈ-T4G4-3ˈ. A shift of 12 nm was observed in the porphyrin’s soret band as 
it bound with the G-quadruplex DNA.161 
 
Figure 5.4. UV-vis spectra of TMPyP4 40 in absence (solid line) and presence (dashed 
line) of d[T4G4]4 at a [porphyrin]/[DNA quadruplex] ratio of 8.33. The soret band for 
the porphyrin undergoes a red shift from 422 nm in its unbound state to 434 nm in its 
bound state. Reprinted with permission from Biochemistry 1998, 37 (9), 2709-2714. 
Copyright (1998) American Chemical Society.161  
In order to quantify the impact of binding of a ligand to G-quadruplex 
structures, UV-vis spectroscopy can be used to compare the melting temperature of G-
quadruplex and quadruplex-ligand complex. Nucleic acids give a strong absorbance 
around 260 nm. In quadruplex like structures, the absorbance at 260 nm is reduced due 
to quenching caused by the π–stacking of nucleobases. Upon heating, unstacking of 
these bases leads to a hypochromic effect that can be monitored by UV-vis 
spectroscopy. The melting temperature is determined from a plot of absorbance of the 
G-quadruplex at a fixed wavelength (λmax of a quadruplex) and temperature. Similar 






melting temperature of G-quadruplex:ligand complex is indicative of binding of that 
ligand and stabilization of the G-quadruplex structure.145, 146  
 Circular Dichroism 
G-quadruplexes form helical structures. CD spectroscopy can provide 
information about the conformation and topology of such chiral structures. The CD 
spectrum of a G-quadruplex is dependent on the stacking interactions between adjacent 
G-quartets. Parallel and anti-parallel folded quadruplex structures can be differentiated 
by CD spectroscopy. Parallel intermolecular quadruplex are characterized by a positive 
maximum at 260 nm and a negative minimum at 240 nm. Anti-parallel intramolecular 
quadruplexes exhibit a positive band at 295 nm and a negative band at 260 nm.145, 146   
Many small ligands are achiral and therefore, are CD inactive themselves. 
However, sometimes due to binding interactions, the chiral environment of G-
quadruplex can give rise to an induced circular dichroism in the ligand at its maximum 
wavelength of absorbance.153  
 Fluorescence Spectroscopy 
It has been shown that energy absorbed by a donor DNA base pair can be 
transferred to an intercalated or an end-stacked ligand that serves as an electron 
acceptor. Groove binders, on the other hand, do not exhibit similar energy transfer from 
donor to acceptor.39 Fluorescence spectroscopy is commonly used for screening and 
comparing potential G-quadruplex binding ligands. Certain dyes such as thiazole 
orange 41 (TO; Figure 5.5) bind G-quadruplexes with high affinity. The fluorescence 






fluorescence of 41 increases by many fold.162 Due to this property of TO, it is used in 
ligand displacement assays to screen for G-quadruplex binding ligands.163 
 
Figure 5.5. Structure of thiazole orange (TO) 41. 
When a ligand is titrated into a quadruplex DNA solution, the change in 
fluorescence intensity of ligand is indicative of its binding to the DNA. In cases where 
the ligand is non-fluorogenic, fluorescence resonance energy transfer (FRET) assay can 
be used to detect binding and conformational changes in the DNA assembly. DNA 
strands are tagged with fluorescent dyes at both their 5ˈ and 3ˈ ends.  When the DNA 
strand folds to form a G-quadruplex, the two dyes come in close vicinity to each other, 
leading to energy transfer. Thus, the fluorescence is typically quenched when the DNA 
is in its G-quadruplex state. Upon heating, the G-quadruplex unfolds resulting in 
increased distance between the fluorescent dyes, which then increases the fluorescence 
intensity. This technique is applied to many ligand-quadruplex complexes so as to 
determine their melting temperature and learn about the stabilizing effect of ligand 






 NMR Spectroscopy 
NMR is a versatile technique that gives a wealth of atomic-level information 
about the G-quadruplex structure.  NMR can be readily used to differentiate between 
single-stranded oligonucleotides and higher order structures such as G-quadruplexes. 
It can also be used to study the solution structure of complexes formed by 
oligonucleotides. In a study conducted by Lilley et. al., the quadruplex formed by the 
d[TG4T] hexanucleotide in the presence of 100 mM NaCl, 1mM EDTA, 10 mM 
phosphate buffer (pH 7.1; D2O) was studied by 
1H NMR at variable temperature.165 At 
lower temperatures (30 ⁰C), 6 distinct peaks were observed around 7-8 ppm. Using 2D 
NMR techniques, four peaks were assigned to the H8 proton of four guanosine bases 
and two peaks assigned to the H6 of the two terminal thymine bases (Figure 5.6). As 
the temperature was increased, another set of 6 peaks started appearing. These peaks 
belonged to the aromatic protons on bases in the single-stranded DNA d[TG4T]. At 50 
⁰C, the two sets of peaks were present at 1:1 ratio. When the sample was further heated 
to 70 ⁰C, only the second set of peaks corresponding to the single-stranded form was 
visible. This transition between the two sets of peaks was attributed to a slow exchange 
between the two forms of DNA, namely d[TG4T] and its self-assembled G-quadruplex 
d[TG4T]4. (Figure 5.6). Thus, NMR spectroscopy helped in conducting a real-time 
study of self-association of the d[TG4T] nucleotide. Further, 2D COSY and NOESY 
experiments helped in ascertaining that d[TG4T] forms a parallel stranded tetraplex 








Figure 5.6. 1H NMR stack plot illustrating the slow exchange for single-stranded and 
G-quadruplex forms of d[TG4T]. At 30 ᵒC, d[TG4T] nucleotide exists exclusively in 
the G-quadruplex form. As temperature is increased to 50 ⁰C, the tetraplex starts 
dissociating into single-strands as indicated by the second set of peaks growing in. At 
70 ⁰C, only the distinct set of peaks due to the single-stranded DNA d[TG4T] are 
visible. Reprinted by permission from Nature 1992, 360 (6401), 280-282. Copyright 
(1992) Macmillan Publishers Ltd.165 
More structural information can be obtained by performing 2D NMR 
heteronuclear correlation experiments. Use of sophisticated NMR cryoprobes has 
drastically cut down the amount of sample needed to carry out experiments, thereby 
making NMR an attractive technique for working with relatively large 
oligonucleotides.146 In the studies described below, I have used multidimensional and 







 Rationale for Studying the Binding Interactions Between Prodigiosin 1 and G-
Quadruplex DNA 
As described in Section 1.4, there are two proposed mechanisms currently used 
to explain the ability of prodigiosin 1 to induce apoptosis in cells. The first mechanism 
involves acidification of cell organelles caused by prodigiosin’s ability to catalyze 
H⁺/Cl⁻ symport or OH⁻/Cl⁻ exchange across cell membranes.30 The second mechanism 
suggests that the oxidative cleavage of DNA can be triggered by prodigiosene•Cu2⁺ 
complexes.51 There are additional examples that show that prodigiosin 1 intercalates 
preferably at AT sites of poly d[A-T]2 and calf thymus DNA (ct-DNA).
39,40 With this 
collective evidence, I wanted to explore the possibility that prodigiosin 1 might act as 
a G-quadruplex binding ligand.  
 To first study potential interactions between prodigiosin 1 and a lipophilic G-
quaduplex,147,166,167 I performed a 1H NMR titration with compound 1 and the lipophilic 
G-quadruplex (42)16•3K⁺•4DNP (Figure 5.7) in a 1:1 mixture of CD2Cl2:CD3CN. No 
changes in chemical shifts for the receptor (G-quadruplex (42)16•3K⁺•4DNP) or the 
ligand (prodigiosin 1) protons were observed in the 1H NMR spectra during the titration 
(Figure 5.8c). The absence of interactions between the G-quadruplex 
(42)16•3K⁺•4DNP and prodigiosin 1 were attributed to the lipophilic nature of both 









Figure 5.7. The cation-templated self-assembly of 16 equivalents of 5’-silyl-2’,3’-O-
isopropylidene guanosine (42) gives a lipophilic G-quadruplex (42)16•3K⁺•4DNP in the 
solid state and in solution (green K, blue N, red O). Modified and reprinted with 
permission from Angew. Chem. Int. Ed. 2004, 43 (6), 668-698. Copyright (2004) 
Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.147 
Our hypothesis was that replacing the organic solvent with water might enhance 
the affinity of prodigiosin 1 for G-quartets. For this reason, a known G-quadruplex 
K⁺•d[TG4T]4 DNA assembly was selected for the studies in aqueous conditions.165 By 
using a G-quadruplex DNA assembly (K⁺•d[TG4T]4), I was also able to work more 
closely with the biological conditions. Additionally, at the experimental condition of 
pH 7.0, prodigiosin is in its protonated cation form 1•H⁺, while DNA is anionic. We 






of G-quadruplex DNA assembly, and potentially intercalate with the G-quartets due to 
prodigiosin’s π–conjugation, as well as lipophilicity. 
 
Figure 5.8. A 1H NMR stack plot of a) Prodigiosin 1 (5 mM), b) G-quadruplex 
(42)16•3K⁺•4DNP (5 mM) and c) Prodigiosin 1: (42)16•3K⁺•4DNP:MeSO3H in 1:1:1 
ratio in a 1:1 mixture of CD2Cl2:CD3CN. No changes in chemical shifts of NMR 
resonances for prodigiosin 1 or G-quadruplex (42)16•3K⁺•4DNP were observed in 
NMR spectrum c). 
The ability of prodigiosin 1 to bind G-quadruplexes could lead to another 






describing the work done to establish binding between prodigiosin and d[TG4T]4 
tetraplex, three previous examples of prodigiosin-duplex DNA binding are discussed.  
 Prodigiosin Intercalates Preferably at AT-Rich Sites in Duplex DNA 
 
Figure 5.9. a) UV-Vis spectra of prodigiosin 1 (4 µM) in absence (solid line) and 
presence (dashed line) of 10 bp equivalents of poly d[A-T]2 in 10 mM NaCl-50 mM 
MES buffer at pH 6.5. A bathochromic shift of 20 nm was observed.  b) Fluorescence 
intensity of prodigiosin 1 (4 µM) in the presence of 10 bp equivalent of poly d[A-T]2 
(1), ct-DNA (2) and poly d[G-C]2 (3) 10 mM NaCl-50 mM MES buffer at pH 6.5. The 
maximum increase in prodigiosin’s fluorescence intensity was observed with poly d[A-
T]2. Reprinted with permission from The Journal of Organic Chemistry 1999, 64 (18), 
6861-6869. Copyright (1999) American Chemical Society.39 
Manderville and his group conducted a study to determine the binding 
properties of prodigiosin for three types of DNA – calf thymus-DNA (ct-DNA), poly 
d[A-T]2 and poly d[G-C]2.
39 ct-DNA is extracted from the thymus gland of calf and is 
used in various biophysical and biochemical studies. It has a variable molecular weight 






while poly d[G-C]2 is rich in G and C bases. Manderville et. al. showed that prodigiosin 
binds DNA by intercalating preferably at A-T sites. This finding was based on a series 
of comparative UV-vis absorbance (Figure 5.9a) and fluorescence studies (Figure 
5.9b). The absorbance for prodigiosin underwent a 6 nm bathochromic shift in the 
presence of 10 base pair equivalents of ct-DNA, whereas an even smaller shift was 
observed in presence of poly d[G-C]2. Poly d[A-T]2 induced the highest bathochromic 
shift of 20 nm for prodigiosin, suggesting that 1 prefers to intercalate at A-T base pairs.  
The relative fluorescence intensity of prodigiosin 1 was also compared in the 
presence of the three varieties of DNA. It was proposed that an intercalated 
fluorophore, such as prodigiosin 1 will undergo efficient energy transfer from donor 
DNA base pairs. Indeed, a maximum change in fluorescence intensity of prodigiosin 
was observed in the presence of the A-T DNA polymer. This was another evidence that 
prodigiosin intercalates preferably into A-T sites in duplex DNA.  
 Prodigiosin Inhibits Topoisomerases I and II 
 Montaner and colleagues examined the mechanism of action of prodigiosin 1, 
focusing on its interaction with DNA and its ability to inhibit both topoisomerase I and 
topoisomerase II.41 A single mammalian genome can be approximately 2 meters long, 
but must be squeezed into a cell nuclear volume of approximately 10–17 m3.169 
Therefore, cellular DNA is highly compact and generates many curved DNA domains 
(loops). However, a single-stranded DNA is required for the purpose of replication and 
other biological processes. Topoisomerases are enzymes involved in relaxing DNA 






breaks and are involved in DNA repair, replication, transcription, and chromosome 
segregation during mitosis. Cells that are undergoing rapid proliferation, including 
cancerous cells, have high levels of topoisomerases I and II. As a result, topoisomerases 
have been targeted for chemotherapeutic action.  
 Using a supercoiled plasmid Blue Script cloning vector (pBS) sample and gel 
electrophoresis, it was shown that prodigiosin intercalates with the DNA helix. In 
contrast to Manderville’s observations,39 Montaner et. al. found that prodigiosin 
exhibits some preference for the alternating base pairs, but does not discriminate 
between A-T and G-C sequences. Topoisomerase I and II inhibition was studied by a 
DNA cleavage assay (TopoGEN) in vitro and in cultured cells. The topoisomerases 
form a catalytic tyrosyl–DNA cleavage intermediate, referred to as the cleavage 
complex, by covalently binding with DNA. The assay results showed that prodigiosin 
stabilizes the topoisomerase I and II-DNA cleavage complexes, thereby stimulating 
enzyme-linked DNA breaks. Figure 5.10b shows prodigiosin-treated MCF-7 cells 
where numerous foci appear in nuclei, indicating high level of ds DNA.  
 The authors also studied the ability of prodigiosin 1 to induce copper-mediated 
DNA damage at different pH using a DNA cleavage assay. Their results demonstrated 
that copper-mediated cleavage activity is enhanced at pH 6.8 rather than pH 7.4. The 
cleavage activity is also dependent on Cu2⁺ ion concentration. The authors pointed out 
the therapeutic value of prodigiosin due to its effects on several cellular targets. The 
results from cell assays confirmed the ability of prodigiosin to interact with double-







Figure 5.10. Prodigiosin-induced ds breakage of genomic DNA independent of the 
apoptotic process. MCF7 cells untreated (A), or treated with 2 μM prodigiosin for 3h 
(B) were dual stained with primary antibodies directed against apoptosis inducing 
factor (AIF) and p-H2AX (bar = 20 μm). Reprinted with permission from Toxicological 
Sciences 2005, 85 (2), 870-879. Copyright (2005) Oxford University Press.41 
 Prodigiosin Partially Intercalates into ct-DNA 
This recent study was a multi-spectroscopic approach to investigate the 
potential interactions between prodigiosin and ct-DNA.40 Different techniques like 
UV-vis absorbance (including thermal denaturation monitoring), fluorescence, circular 
dichroism and infra-red spectroscopy were used to study the interaction between 1 and 
ct-DNA. It was found that the melting temperature of ct-DNA increased from 58 to 64 
⁰C in the presence of prodigiosin 1. All these results led towards the assessment that 
prodigiosin partially intercalates into the DNA helix, something that Manderville had 
also previously shown.39  
In the following sections, I report that prodigiosin 1 binds at the 3ˈ end of the 
G-quadruplex generated by intermolecular assembly of d[TG4T] in the presence of K⁺ 






experiments, UV-visible spectroscopic and fluorescence titrations. The experiments, 
observations and inferences made from each experiment are discussed in detail in the 
following sections.  
Results 
 G–Quadruplex K⁺•d[TG4T]4 Increases Solubility of Prodigiosin 1 in Water 
A solution of d[TG4T] was annealed in the presence of 100 mM KCl in a 10 
mM Tris-HCl buffer (pH 7.0) containing 1 mM EDTA in a 90% H2O-10% D2O solvent 
system. This oligonucleotide d[TG4T] has been previously shown to form a parallel-
stranded intermolecular quadruplex with four equivalent grooves in the presence of K⁺ 
ions (Figure 5.11).165, 170 
 
Figure 5.11. An illustration showing formation of G-quadruplex d[TG4T]4 from 






Formation of the K⁺•d[TG4T]4 G-quadruplex was confirmed by CD 
spectroscopy (Figure 5.12) and 1H NMR (Figure 5.15). When the sample was 
annealed in the presence of KCl, the CD spectrum showed a strong peak maxima at 
around 264 nm with a trough around 240 nm. The peak at 264 nm is a characteristic 
peak for G-quadruplexes formed by d[TG4T].
171  
 
Figure 5.12. A CD spectrum showing the characteristic peak for d[TG4T]4 in presence 
of K⁺ at 45 ⁰C. A peak maxima was observed at 264 nm and a trough was observed at 
240 nm. These two peaks are characteristic for K⁺•d[TG4T]4 tetraplex.  
Due to the presence of π-conjugation, prodigiosenes have strong absorption 
bands in the visible regions, which makes it convenient to study their DNA binding 
properties by UV-vis spectroscopy. Moreover, prodigiosin 1 has a low solubility in 
water (18 μmol/L at pH 7.0 at 25 ⁰C).141 UV-vis experiments allowed us to study the 
interaction between G-quadruplex DNA and prodigiosin, even at micromolar 
concentrations of compound 1. To investigate this, a UV-vis titration was performed 
between 1 and K⁺•d[TG4T]4  quadruplex. For this titration, a suspension containing 






insoluble in water and little absorbance was recorded. Then, increasing equivalents of 
K⁺•d[TG4T]4 were added to the sample. The absorbance was recorded after each 
addition of G-quadruplex DNA. As increasing amounts of G-quadruplex DNA were 
added to the cuvette sample containing prodigiosin 1, a distinct increase in absorbance 
of 1 was noticed (Figure 5.13a). This increase in absorbance is presumably due to a 
greater amount of 1 getting dissolved in solution aided by the G-quadruplex DNA. The 
color of the solution also changed from orange to pink, which is a visual indicator for 
the protonated form of prodigiosin (1•H⁺).132  
 
Figure 5.13. A UV-Vis titration plot between prodigiosin 1•H⁺ (~50 µM) and variable 
equivalents of a) K⁺•d[TG4T]4 or b) Li⁺•d[TG4T] at 37 ⁰C. Solutions were made in 10 
mM Tris - 1 mM EDTA buffer solutions containing 100 mM KCl or LiCl in 90% H2O-
10% D2O at pH 7. Addition of G-quadruplex DNA causes increase in absorbance of 
prodigiosin. Soret band of prodigiosin also undergoes a red shift of 20 nm. Addition of 
single-stranded DNA in LiCl buffer decreased the absorbance of prodigiosin. 
Additionally, changes in the Soret band (at 531 nm) of 1•H⁺ were observed in 






almost 20 nm during the titration. A red shift for the ligand in presence of DNA is 
characteristic of DNA-ligand binding.161, 171 As a control, singe-stranded d[TG4T] in 
LiCl buffer was titrated into a solution of 1.  In this case, the absorbance for 1•H⁺ 
decreased initially and became constant later (Figure 5.13b). Addition of single-
stranded Li⁺•d[TG4T] DNA did not assist in dissolving prodigiosin in aqueous buffer 
solution, unlike for the case of the G-quadruplex K⁺•d[TG4T]4. 
 Fluorescence Studies Indicate Interactions Between G-Quadruplex and 
Prodigiosin  
 Fluorescence spectroscopy is a sensitive and an excellent tool to gain 
information about interactions between a G-quadruplex and a binding ligand. 
Prodigiosin 1•H⁺ exhibits a weak emission spectrum by itself in an aqueous solution. 
However, the fluorescence emission intensity of prodigiosin increased in the presence 
of G-quadruplex DNA, presumably due to its interaction with the bases in G-quartets. 
Manderville et. al. have also shown that fluorescence of prodigiosin was enhanced in 
presence of polymeric AT-rich DNA.39     
To study the changes in fluorescence emission intensity of prodigiosin 1•H⁺ in 
presence of G-quadruplex, a fluorescence titration experiment was performed between 
1•H⁺ and K⁺•d[TG4T]4. In a solution containing prodigiosin, varying equivalents of 
tetraplex DNA were added. Fluorescence intensity of prodigiosin was measured after 
each addition of quadruplex DNA. Addition of K⁺•d[TG4T]4 led to a significant 
increase in fluorescence of prodigiosin (Figure 5.14a). When the same titration 






change in fluorescence of prodigiosin was observed. (Figure 5.14b). Thus, 
fluorescence of prodigiosin is only affected in presence of the G-quadruplex DNA. 
 
Figure 5.14. A fluorescence titration plot between 50 µM prodigiosin 1•H⁺ and 
variable equivalents of a) K⁺•d[TG4T]4 b) KCl buffer at 37 ⁰C. Solutions were made in 
10 mM Tris-100 mM KCl-1 mM EDTA buffer solutions in 90% H2O-10% D2O at pH 
7. Addition of G-quadruplex DNA causes the fluorescence intensity of prodigiosin 
1•H⁺ to increase. Addition of KCl buffer, without DNA, caused no change to 
prodigiosin’s fluorescence intensity.  
In his work, Manderville had pointed out that enhancement in fluorescence of 
a ligand upon addition of DNA is diagnostic of binding between the two species. In 
particular, he wrote that the increase in fluorescence is “...ascribed to decreases in 
degrees of freedom of molecular motion, prevention of collisional deactivation, 
restricted conformations, favorable microenvironmental polarity effect, and shielding 
of the excited state from water molecules or other species present in the bulk aqueous 
solution”. Further, energy from a donor base-pairs (DNA) to the acceptor ligand 






the base pairs, which can be monitored by fluorescence measurements.39 This 
explanation and the results from our fluorescence experiments is again consistent with 
the proposal that prodigiosin is interacting with the G-quadruplex, probably by 
intercalation or end-stacking with the G-quartet. 
 NMR Experiments Reveal that Prodigiosin 1 Binds the G-Quadruplex 
K⁺•d[TG4T]4 at its 3ˈ End 
The NMR experiments were initiated by first confirming the formation of G-
quadruplex by the sequence d[TG4T]. Having confirmed that, I next set out to undertake 
certain NMR experiments that might probe binding between the G-tetraplex 
K⁺•d[TG4T]4 and prodigiosin 1.   
 Characterization of the d[TG4T]4 Quadruplex in Solution by 1H NMR 
A solution of d[TG4T] was annealed in the presence of 100 mM KCl in a 10 
mM Tris-HCl buffer (pH 7.0) containing 1 mM EDTA in a 90% H2O-10% D2O solvent 
system. A set of six distinct peaks around the region 7-8 ppm were visible in the 1H 
NMR spectrum at 45 ⁰C (Figure 5.15). This diagnostic pattern of peaks has been 
previously identified for a G-quadruplex structure.165 Four of these peaks belonged to 
the four H8 protons on the guanosine bases and the remaining two peaks belonged to 
the H6 protons on the terminal thymine bases. Since the 5ˈ-d[TG4T]4-3ˈ tetraplex is a 
symmetric tetramolecular assembly, all four guanines from a single tetrad are 
equivalent by NMR. As a result, they resonate at the same frequency, which gives rise 
to only one peak per G-tetrad. Therefore, only six peaks are visible in the aromatic 






for the NH imino proton at N1 position of each of the guanosine bases. These NH imino 
protons are visible in the NMR spectrum because they are involved in G-quartet 
formation and, therefore, they are in a relatively slow exchange with the solvent.  
 
Figure 5.15. A portion of the 1H NMR of K⁺•d[TG4T]4 quadruplex in 90% H2O-10% 
D2O at 45 ⁰C showing six peaks in the aromatic region (δ 9.0-7.0 ppm), corresponding 
to the H8 proton on four guanosines and H6 proton on two thymine bases. Another four 
distinct peaks (δ 12.0-11.0 ppm) are visible for the imino NH protons on guanosine 
bases that are involved in G-quartet formation. Assignments were made from 2D NMR 
and from literature.  
 The peak assignments for aromatic protons were confirmed by 2D-NOESY 
experiment (Figure 5.16) by applying the “sequential walk” technique. Sequential 
walking is used to solve 2D NMR spectra of oligonucleotides. In a DNA sequence, the 
H6 or H8 proton in the aromatic region of each nucleotide is in close proximity to its 
own H1ˈ sugar proton and a 3ˈ neighbor H1ˈ proton, and would therefore, show a 
NOESY correlation. For sequential assignments, terminal nucleotides are identified 
first, depending on different criteria. Sometimes, terminal deoxyriboses are not 
phosphorylated, so they can be identified by the high field shifts of their 5ˈ CH2 or          






deoxyribose exhibit only intranucleotide NOEs, which can be used to identify them.172 
Once the cross-peak for T1 base was determined (Figure 5.16), the next base was 
identified by "walking" across the spectrum (to H8 of G2 base). This process was then 
repeated sequentially until all nucleotides had been assigned. 
 
Figure 5.16. A 2D NOESY spectrum of K⁺•d[TG4T]4 correlating the aromatic protons 
on the bases (top) with the H1ˈ protons on sugars (left) in 90% H2O-10% D2O at 45 ⁰C.  
 NMR Experiments Probing Binding of Prodigiosin 1 to K⁺•d[TG4T]4  
To study the binding properties of prodigiosin, NMR titrations were performed 
between the host (K⁺•d[TG4T]4) and guest (prodigiosin) molecules. These titrations 
were performed using 90% H2O-10% D2O as solvent. Prodigiosin 1 was dissolved in 






31P NMR experiments were performed on the sample to study the interaction of 
prodigiosin with the DNA bases as well as with the phosphate groups.  
 Titration with Prodigiosin 1 in 90% H2O-10% D2O 
 To carry out this experiment, a sample of K⁺•d[TG4T]4 (0.5 mM tetraplex) was 
used. Aliquots of prodigiosin 1 dissolved in d6-DMSO were titrated into this aqueous 
NMR sample. In analyzing the 1H NMR titration, the chemical shifts for the aromatic 
protons of the G5 and T6 bases moved downfield most significantly as increasing 
amounts of prodigiosin was added to the sample (Figure 5.17). The bottom spectrum 
in Figure 5.17 shows that the H6 proton of T6 base had shifted downfield by almost 
0.2 ppm from its original position after the addition of a presumed “3.75” eq of 1. Peak 
for H8 proton of G5 residue moved downfield as well. The change in chemical shift of 
T6 proton was accompanied by the broadening and eventually, disappearance of the 
signal. However, the signal reappeared at around “6 eq” of prodigiosin 1•H⁺. By the 
end of the titration (bottom spectrum in Figure 5.17), a broad but significant peak for 
T6 aromatic proton was observed. A 2D NOESY spectrum was also carried out with a 
NMR sample containing K⁺•d[TG4T]4 and an apparent “4.5 eq” of 1•H⁺ to assign and 
confirm the movement of these signals (Figure 5.18). The two peaks corresponding to 
G5 and T6 aromatic protons were confirmed to have moved farthest downfield as 
compared to the original G-quadruplex sample with no added prodigiosin 1. In contrast, 
the titration indicated that the NMR signals for the aromatic protons for the first four 
residues 5ˈ-T1-G2-G3-G4-3ˈ did not change nearly as much as the G5 and T6 signals 







Figure 5.17. 1H NMR stack plot showing titration of K⁺•d[TG4T]4 with varying 
“apparent” equivalents of prodigiosin 1•H⁺ in 90% H2O-10% D2O at 45 ⁰C. The G5 
and T6 resonances are highlighted in red to show the change in the position of H6 







Figure 5.18. A 2D NOESY spectrum of K⁺•d[TG4T]4 with “4.5 eq” of prodigiosin 
1•H⁺ in 90% H2O-10% D2O at 45 ⁰C. This spectrum correlates the aromatic protons 
on bases (top) with the H1ˈ proton on sugars (left). The experiment confirmed that T6 
H6 and G5 H8 had undergone largest changes in 1H chemical shifts.  
Since the most significant change in chemical shift was observed for the 
aromatic protons on the G5 and T6 bases upon addition of prodigiosin 1, we proposed 
that prodigiosin preferably binds at the 3ˈ end of the G-quadruplex K⁺•d[TG4T]4, 










Figure 5.19. An illustration showing interaction between protonated form of 
prodigiosin 1•H⁺ and G-quadruplex K⁺•d[TG4T]4. Prodigiosin binds at the 3ˈ end.  
 NMR Control Experiments with d6-DMSO and K⁺•d[TG4T]4  
 In a recent publication, Gokel et al. addressed the DMSO-aqueous solution 
conundrum in biological assays.173 While testing a series of pyrogallol[4]arenes and 
antibiotic kanamycin  for their toxicity to E. coli.,  the authors realized that what seemed 
like an enhancement of potency of kanamycin against E. coli was actually due to the 
presence of DMSO in the growth media. There are other instances as well where 
DMSO has interfered in the biological activity with drug testing.174 Therefore, it was 
essential to investigate the effect of d6-DMSO on the G-quadruplex K⁺•d[TG4T]4 since 
we were adding prodigiosin dissolved in DMSO to the G-quadruplex. The control 
titration experiment using d6-DMSO was performed following the same procedure as 






of K⁺•d[TG4T]4 (0.5 mM tetraplex) followed by recording of 1H and 31P NMR spectra 
(Figure 5.20).  
 
Figure 5.20. 1H NMR stack plot showing titration of K⁺•d[TG4T]4 with d6-DMSO in 
90% H2O-10% D2O at 45 ⁰C. The only changes in chemical shifts observed were for 
H6 protons of thymines. 
 Figure 5.20 shows that DMSO has little effect on chemical shift of DNA. The 
observed changes in chemical shifts are different from the changes seen in Figure 5.17 
(1H NMR stack plot showing titration of K⁺•d[TG4T]4 with prodigiosin 1•H⁺). In the 
1H NMR stack plot, the peaks that underwent the most change in chemical shifts were 
of the terminal thymine bases T1 and T6 (Figure 5.20). Due to the quadruplex 
structure, terminal groups tend to be most exposed to the solvent. As a result, addition 
of DMSO caused the peaks for thymine to shift more in comparison to the internal 






and prodigiosin 1•H⁺ (Figure 5.17), the significant changes in the G5 and T6 residues 
are caused by prodigiosin and not added DMSO.  
 31P NMR to Investigate Groove Binding by Prodigiosin 
All these NMR experiments were done at pH 7. As described in Section 2.5, 
prodigiosin has a pKa of 8.2,
114 which means that at pH 7, 1 exists mostly in its 
protonated form (1•H⁺). I wanted to determine if protonated 1•H⁺ might interact with 
the negatively-charged phosphate groups located in the grooves of the G-quadruplex. 
To explore this possibility, separate 31P NMR titrations were carried out with 
K⁺•d[TG4T]4 and prodigiosin 1 (Figure 5.21a) and blank d6-DMSO (Figure 5.21b). 
The titration with DMSO was done to address our concern that the DMSO solvent, 
added along with prodigiosin 1•H⁺ (15% relative to total NMR sample volume by the 
end of the titration), could be causing conformational changes to the G-quadruplex due 
to molecular crowding and water depletion.175 In both the titrations involving 
K⁺•d[TG4T]4 with either prodigiosin (Figure 5.21a) or d6-DMSO (Figure 5.21b), 
peaks for phosphate groups at 1 and 5 positions came close to each other. This effect 
was more pronounced in the case of prodigiosin 1•H⁺ (“15 eq” in Figure 5.21a). 
Conversely, peaks for phosphate groups at 2 and 4 positions behaved differently in 
presence of prodigiosin 1•H⁺ and d6-DMSO. For prodigiosin 1•H⁺, the peaks inter-
changed positions between 0.5 and 4 eq of 1•H⁺. But in the case of d6-DMSO, the peaks 
for P2 and P4 phosphate groups didn’t interchange position until the addition of 5 eq 
of DMSO. The final order of NMR resonances for phosphate groups at “15 eq” in both 






effects on phosphate groups of K⁺•d[TG4T]4 G-quadruplex by both prodigiosin 1•H⁺ 
and d6-DMSO suggests that a) DMSO is not causing any conformational changes to 
the G-quadruplex K⁺•d[TG4T]4 (based on 1H and 31P NMR data); b) prodigiosin 1•H⁺ 
interacts with phosphate groups in the grooves of the DNA assembly. Therefore, the 
ligand binding possibly takes place at two positions in the quadruplex – end-stacking 
at the terminal 3ˈ-G-quartet and/or interactions in the G-quadruplex grooves. 
 
Figure 5.21.  31P NMR stack plot showing titration of K⁺•d[TG4T]4 with a) prodigiosin 
1•H⁺ and b) d6-DMSO in 90% H2O-10% D2O at 45 ⁰C.  
 The peaks in the 31P NMR spectrum were assigned by carrying out a 1H-31P 
HSQC experiments at 0 eq and “4.5 eq” of prodigiosin 1•H⁺ (Figure 5.22). This is the 
first time that the 31P NMR for the d[TG4T]4 nucleotide sequence has been 






sugar 1H signals with 31P NMR signals, the chemical shift assignment and location of 
each phosphate group in the oligonucleotide can be determined. A 1H-31P HSQC 
experiment was also performed with the sample containing K⁺•d[TG4T]4 G-quadruplex 
and d6-DMSO (from Figure 5.21b).  
 
Figure 5.22. A 2D 1H-31P HSQC spectrum of K⁺•d[TG4T]4 in 90% H2O-10% D2O at 
45 ⁰C. This spectrum correlates the sugar protons (H3ˈ, H4ˈ, H5ˈ and H5ˈˈ on top) with 
the phosphate groups (left). 
 Prodigiosin Does Not Bind to Single-Stranded DNA 
Although prodigiosin is known to bind dsDNA,39-41 we were concerned whether 






single-strand. To address this concern, I performed a 1H NMR titration experiment with 
single-stranded DNA. For this purpose, d[TG4T] was annealed in the presence of 100 
mM LiCl (1 mM EDTA-10 mM Tris-HCl buffer; 90% H2O-10% D2O at pH 7.0). As 
Li⁺ does not stabilize a G-quadruplex structure, d[TG4T] exists in the single-strand 
conformation in LiCl solution.165,176 The 1H NMR spectrum for Li⁺•d[TG4T] is shown 
in the top trace of Figure 5.23. Six peaks for aromatic protons from each base were 
visible in the region of 7.5-8.5 ppm. The chemical shifts for each of these peaks have 
been previously assigned and are different for the single-strand as compared to the G-
quadruplex K⁺•d[TG4T]4.164 Moreover, unlike K⁺•d[TG4T]4, no peaks were observed 
for the NH imino protons in the region of δ 10-12 ppm for d[TG4T]. This is because as 
a single-stranded conformation of d[TG4T], the imino NH protons are free to undergo 
exchange with the solvent (H2O).  
A 1H NMR titration was performed between Li⁺•d[TG4T] solution and 
prodigiosin 1•H⁺ (Figure 5.23). Upon adding 1•H⁺ to the NMR sample of DNA, very 
small changes in chemical shifts were observed for all protons in the d[TG4T] single 
strand. Since no major changes in NMR peaks were observed, the conclusion was that 
1 does not interact with the single-stranded DNA d[TG4T].  
From these NMR experiments, two conclusions can be made: a) prodigiosin 
selectively binds quadruplex in comparison to the single-stranded DNA and, b) 
prodigiosin end-stacks at the 3ˈ end of the d[TG4T]4 quadruplex and interacts with the 







Figure 5.23. 1H NMR stack plot showing titration of Li⁺•d[TG4T] with prodigiosin 
1•H⁺ in 90% H2O-10% D2O at 45 ⁰C.  
 NMR Experiments in Mixed Solvent Systems 
Even though binding between prodigiosin and G-quadruplex DNA was 
established by NMR studies in 90% H2O-10% D2O, we were concerned about the poor 
solubility of prodigiosin 1 in aqueous buffer. Additionally, no signals were detected for 
prodigiosin in NMR experiments using 90% H2O-10% D2O as solvent, even when 
excess of 1 was added to the solution. For this reason, a mixed solvent system was used, 
where both DNA and ligand were soluble, to study the binding of prodigiosin 1 and 
K⁺•d[TG4T]4 in solution. A 1:1 mixture of d6-DMSO and 90% H2O-10% D2O was used 
for the experiments described in this section. DMSO was chosen as the co-solvent 
because a) it solubilizes prodigiosin 1 and b) it is miscible with water.    
 NMR Titration in d6-DMSO: 90% H2O-10% D2O (1:1) Mixture 
 Before starting binding studies with the DNA-prodigiosin system, peaks 
assignments were made for prodigiosin in this mixed solvent system. 1D-Selective 






prodigiosin.177 TOCSY is similar to COSY as it allows detection of cross-peaks for any 
nuclei that are directly coupled to each other. Additionally, data from a TOCSY 
experiment also allows one to detect cross-peaks for nuclei that are connected by a 
chain of couplings. Therefore, it is highly useful for identifying large interconnected 
networks of spin couplings.  
 
Figure 5.24. TOCSY NMR showing correlations between ring A resonances (H3, H4 
and H5) in prodigiosin (1 mM) in a 1:1 mixture of d6-DMSO and 90% H2O-10% D2O 
at 45 ⁰C. Strong correlations were observed between all three protons on ring A. 
 As shown in Figure 5.24, peaks for protons belonging to the rings A and B in 
1•H⁺ were identified from these experiments. First, specific peaks for protons in ring 
A were irradiated one by one. The protons that coupled with the irradiated peak showed 






A was irradiated, the peaks for H3 and H4 protons on the ring A gave a positive 
correlation (top spectrum in Figure 5.24 
). Similarly, protons H3 and H4 on ring A and H1ˈˈ were irradiated. All three protons 
from ring A showed correlations with each other.  
Peaks for the G-quadruplex DNA were assigned using NOESY and HSQC 
experiments as described in Section 5.7. Phan et al. have previously shown by NMR 
that certain G-quadruplex DNA fragments can undergo conformational changes under 
conditions of molecular crowding.148,175 We found that the G-quadruplex K⁺•d[TG4T]4 
remained intact in this mixed solvent system. Next, the interactions between G-
quadruplex DNA and prodigiosin were explored in the mixed solvent using a NMR 
titration. A 1 mM solution of prodigiosin 1•H⁺ was taken in the mixed solvent system. 
Variable equivalents of G-quadruplex K⁺•d[TG4T]4 were added to the prodigiosin 
samples (Figure 5.25). Concentrations and stoichiometries of G-quadruplex DNA and 
prodigiosin were determined based on UV-vis absorbance spectra.  As a reference, a 
1H NMR spectrum of a G-quadruplex K⁺•d[TG4T]4 DNA sample by itself in the mixed 
solvent system is shown in the lower trace (Figure 5.25a). The NMR spectrum is 
similar to the peak pattern observed in aqueous buffer (Figure 5.17Figure 5). In the 
presence of 50% d6-DMSO, the peaks for H6 protons of T1 and T6 bases move close 
to each other. To a sample of prodigiosin 1•H⁺, equivalents of tetraplex DNA were 
added (Figure 5.25b-d). Unlike previous titration in aqueous buffer (Figure 5.17), the 
1H NMR signals for prodigiosin could be easily identified in the mixed solvent sample. 






B (Figure 5.25b). As equivalents of tetraplex DNA were added, the peaks 
corresponding to the A and B ring protons of prodigiosin 1•H⁺ shifted upfield (Figure 
5.25b-d). For the 1H NMR resonances belonging to G-quadruplex K⁺•d[TG4T]4, the 
observed changes in chemical shifts were similar to previous titration in aqueous buffer 
(Figure 5.17). NMR signals belonging to H8 proton of G5 and H6 proton of T6 shifted 
downfield indicating binding between the 3ˈ end of the G-quadruplex and prodigiosin.  
 
Figure 5.25. 1H NMR stack plot showing titration of prodigiosin 1•H⁺ (1 mM) with 
different eq of K⁺•d[TG4T]4 in 1:1 mixture of d6-DMSO and 90% H2O-10% D2O at    
45 ᵒC. Bottom trace (a) is of G-quadruplex K⁺•d[TG4T]4 DNA sample. The changes in 
chemical shifts for prodigiosin 1•H⁺ protons has been marked by red dashed lines. The 
changes in chemical shifts of G5 and T6 protons of K⁺•d[TG4T]4 G-quadruplex have 






The 1H NMR titration using d6-DMSO and water as a mixed solvent not only 
allowed the detection of prodigiosin in solution, but also helped in monitoring the 
changes in chemical shifts of some of the aromatic protons on prodigiosin 1•H⁺ upon 
addition of G-quadruplex DNA. These chemical shift changes for prodigiosin 1•H⁺ 
indicate that this ligand can bind to G-quadruplex DNA.  
 Saturation Transfer Difference Experiments Confirm Interaction Between 
Prodigiosin and G-Quadruplex DNA 
 Differential frequency-saturation transfer difference (FD-STD) NMR 
spectroscopy was first introduced in 1999.178 The goal of STD NMR is to screen 
libraries of compounds for their binding activity to proteins. STD NMR spectrum 
shows signals from ligand molecules that have high binding affinity for the protein.179  
Detection of weak binding interactions between ligands and large proteins can possess 
serious experimental challenges, especially at low physiological concentrations. 
Saturation transfer difference experiments can be used for a mixture of potential ligands 
with as little as 1 nmol of protein.178 As the name suggests, magnetization transferred 
from the receptor to the bound ligand is measured by directly observing NMR signals 
from the ligand itself. Low-power irradiation is applied to specific protein signals. The 
magnetization spreads throughout the protein due to spin diffusion and saturates all 
protein NMR signals. Signals belonging to a weakly bound ligand become saturated. 
When the ligand dissociates, intensity of signals decreases as compared to the signals 
of free ligand in solution. Another experiment is performed where the irradiation pulse 






irradiated, the experiment does not lead to saturation transfer to the ligand signals. A 
difference spectrum is obtained by subtracting the two resulting spectra. In the final 
difference spectrum, only signals for the bound ligands are observed.178  
In 2007, Randazzo et. al. used STD NMR to study the binding interactions 
between distamycin A and d[TG4T] quadruplex.
158 These NMR experiments, combined 
with mechanics and dynamics calculations, helped in establishing that distamycin 
interacts with d[TG4T]4 in a 4:1 binding mode, with two anti-parallel distamycin dimers 
binding simultaneously two opposite grooves of the quadruplex.  
 
Figure 5.26. A STD NMR of 1:20 sample of G-quadruplex K⁺•d[TG4T]4 DNA  and 
prodigiosin 1•H⁺ in a 1:1 mixture of d6-DMSO and 90% H2O-10% D2O. When 1H 
NMR resonance of H8 proton of G5 base on K⁺•d[TG4T]4 G-quadruplex was irradiated, 
signals for H1ˈˈ, ring A and B protons of prodigiosin 1•H⁺ were observed. 
Based on previous studies with K⁺•d[TG4T]4  quadruplex and distamycin A, 
STD experiments using a 1:20 sample of G-quadruplex DNA:prodigiosin in a 1:1 






the 1H NMR resonance of H8 proton of G5 residue on K⁺•d[TG4T]4 G-quadruplex was 
irradiated, the resulting spectrum showed distinct signals for the H3, H4, H5 protons 
on ring A, H4 on ring B and H1ˈˈ proton of prodigiosin 1•H⁺. No signals for ring C 
proton or for the C5 alkyl chain were observed. In conclusion, we propose that rings A 
and B of prodigiosin 1•H⁺ are involved in binding to the G-quadruplex K⁺•d[TG4T]4 
DNA.  Ring C of prodigiosin 1•H⁺ is probably projected away from the quadruplex 
assembly with no involvement in binding.   
 Molecular Model Showing End-Stacking by Prodigiosin 
 A molecular model can be an excellent way to visualize the ligand-receptor 
interactions. In order to study the molecular model of K⁺•d[TG4T]4 DNA-prodigiosin 
complex, an online portal was used that allows the docking of ligands onto selective 
DNA G-quadruplexes at specific binding sites. The G-quadruplex ligands database 
(G4LDB) comprises a collection of reported G-quadruplex ligands.180 The goal of 
building the G4LDB was to facilitate the discovery and development of new 
therapeutic and diagnostic G-quadruplex targeting compounds by accumulating 
existing data, including their physical properties and 3D structure of known G-
quadruplex ligands. This accumulated data was combined with web-based tools for 
design of new G-quadruplex ligands.  
 We wanted to study the end-stacking of prodigiosin 1•H⁺ at the 3ˈ end of 
K⁺•d[TG4T]4. But due to the unavailability of the d[TG4T]4 G-quadruplex with the 3ˈ 
end as a ligand docking site in the database, a different G-quadruplex forming sequence 






parallel-stranded assembly similar to that of 5ˈ-d[TG4T]-3ˈ. Prodigiosin was docked at 
the 3ˈ end of the G-quadruplex d[TTAGGGT]4. The 3ˈ ends of G-quadruplexes formed 
by both sequences - 5ˈ-d[TTAGGGT]-3ˈ and 5ˈ-d[TG4T]-3ˈ are similar. Based on the 
model generated by G4LDB, it was found that rings A and B are stacked parallel to the 
G-quartet at 3ˈ end (Figure 5.27). Ring C is orthogonal to the plane containing rings A 
and B, thereby, not interacting with the G-quartet. This preliminary model coincides 
with the results from saturation transfer experiments from Section 5.8.2.  
 
Figure 5.27. Molecular models generated for G-quadruplex d[TTAGGGT]4 and 
prodigiosin 1•H⁺ complex from G-quadruplex ligands database (G4LDB).180 The 
model can be seen from a) top and b) side. Rings A and B in prodigiosin 1•H⁺ are 
stacked parallel to the G-quartet formed by G6 at the 3ˈ end of the DNA. Ring C in 
prodigiosin 1•H⁺ is orthogonal to the plane containing rings A and B. For clarity, the 






 The model described above is an initial attempt to study the G-quadruplex 
d[TTAGGGT]4 and prodigiosin 1•H⁺ complex. More relevant computational modeling 
studies will be performed for d[TG4T]4 G-quadruplex and prodigiosin 1•H⁺ complex 
in the near future.  
  Conclusions  
 The study of binding interactions between natural product prodigiosin 1•H⁺ and 
G-quadruplex DNA has shown significant results. Based on NMR, UV-visible and 
fluorescence spectroscopy, substantial data has been collected indicating that 
prodigiosin 1•H⁺ can bind to G-quadruplex assembly K⁺•d[TG4T]4 in solution. In 
exchange, a hydrophilic and anionic DNA structure helps in solubilizing the lipophilic 
and cationic prodigiosin 1•H⁺ in aqueous systems. The binding results hold 
significance in two ways: 1) for the first time, interactions between prodigiosin and G-
quadruplex DNA have been established. This finding may lead to a potential 
mechanism to explain the potent anti-cancer activity of prodigiosin; 2) these findings 
can serve as a starting point for development of G-quadruplex targeting drugs, based 










 Chapter 6: Conclusions and Future Directions 
 The number of studies done to explore the biological activity of 
prodigiosenes6,42,181 far exceeds the number of studies done to determine the chemistry 
behind prodigiosenes biological activity.36 In order to develop prodigiosenes as 
effective pharmaceutical drugs, it is essential to learn about the mode of action of 
prodigiosenes on its cellular targets. One mode of action is dependent on the ability of 
prodigiosenes to catalyze Cl⁻ transport across membranes,27 which can affect the 
intracellular pH,22 a phenomenon known to trigger apoptosis in cells.29  
 In Chapter 2, I described research done to investigate some of the C-ring 
modified prodigiosenes for their ability to transport anions across lipid bilayers and 
their in vitro anti-cancer activities. An important finding was that the presence of an 
ester on the C ring decreases the pKa and the anion transport rate of prodigiosene ester 
2, even though these compounds are still effective transporters at low concentrations.117 
This finding led to the possibility of regulating anion transport activity of prodigiosenes 
as a function of their basicity and extravesicular pH. The data described in Chapter 3 
indicated that the efficiency of anion transport can indeed be modulated based on the 
electronic nature of the O-aryl substituent on the B-ring. Further, the key factor 
controlling anion transport for this family of synthetic analogs, and presumably for the 
natural product prodigiosin, is the protonation of the prodigiosene. The internal and 
external pH of cancer cells has been shown to be different from that of healthy cells.63 
Therefore, pH switchable chloride transporters have the potential to become promising 






example of such pH switchable transporters whose transport activity can be switched 
depending on the solution pH. The biological relevance of these analogs is further 
enhanced by the knowledge that most prodigiosenes have pKa values in the range of 
physiological pH (6 to 8), therefore, improving the chances of using these analogs as 
anti-cancer agents.  
 Previously, multiple groups have shown that prodigiosenes can transport anions 
across membranes,31, 32 but no experimental proof had been presented so far, to 
demonstrate Cl⁻ binding by prodigiosenes. The studies done in Chapter 4 described 
the distinct anion binding patterns of α and β isomers of prodigiosenes. The 
involvement of a CH hydrogen of α isomer in binding MeSO3⁻ anion was a significant 
finding. It will be interesting to explore other biologically relevant polydentate anions 
such as carboxylate anions (for eg. acetate, oxalate, citrate, etc.) and their binding 
interactions with prodigiosenes. In fact, Nager has reported that the gluconate anion 
can help solubilize prodigiosin in aqueous solutions.140 Another interesting finding was 
the effect of water on population of α isomer in solution. This study supported McNab’s 
theory about a great biological significance of α isomer of prodigiosenes.134  
 Chapter 5 described the study of binding interactions between natural product 
prodigiosin 1•H⁺ and G-quadruplex DNA. The binding results can be potentially useful 
for establishing a possible mechanism to explain the potent anti-cancer activity of 
prodigiosin. Further, the studies can be a starting point for development of 







Figure 6.1. Structures of proposed prodigiosene analogs 43-45 and ester 2a.  
 To confirm the possibility of G-quadruplex as a cellular target for prodigiosin 
1, the ligand-quadruplex assembly interactions will have to be tested in cultured cells. 
Future studies can also explore structural diversity of the prodigiosin scaffold. One 
major problem encountered throughout the course of our studies was the low solubility 
of prodigiosin in water. One way to counter this problem is by generating new analogs 
43 with improved water-solubility. Introduction of functionalities such as carboxylic 
acid on ring C should help improve the water solubility of prodigiosenes 43 (Figure 
6.1). The carboxylic acid derivatives are an initial intermediate in the synthesis of ester 
analog 2. The ester analog 2 can also be explored for its ability to interact with G-
quadruplexes. In analog 2a (Figure 6.1), the ester functional group enhances its 
hydrophilic character which, may help with the DNA:ligand interactions. Other 






polyethylene glycol chain (44). An ammonium group at the terminal end of the alkyl 
chain could help in binding with the anionic phosphate groups (45).  
 
Figure 6.2. Structure of the hexapyrrole 46•2HCl shows two Cl⁻ anions bound to a 
planar S-shaped conformation. Reprinted with permission from J. Chem. Soc., Chem. 
Commun. 1994, (11), 1289-1290. Copyright (1994) Royal Society of Chemistry.182 b) 
Schematic representation of a S-shaped 46•2HCl stacking over a G-quartet.  
 Another possible direction can be exploration of compounds similar to 46 
(Figure 6.2a). Compound 46 is a ‘linear’ hexapyrrole with two prodigiosene units 
connected together in a S-shaped conformation.182 Compound 46 was synthesized by 
Sessler and colleagues to understand the process of anion binding by prodigiosenes. 
Based on X-ray structure, the authors indicated that both prodigiosene units in the 
compound 46 were protonated and each unit was bound to a Cl⁻ anion (Figure 6.2a). 
Having two planar prodigiosene units may give rise to better π–stacking between the 
G-quartet and ligand (as illustrated by a cartoon in Figure 6.2b), leading to a higher 







Figure 6.3. Compound 47 reacts with Cu2⁺ to give prodigiosene-metal complex 
47•Cu2⁺. a) Top and b) side views of the crystal structure of copper(II) complex 
showing a partial labeling scheme. Adapted with permission from Inorg. Chem. 2014, 
53 (14), 7518–7526. Copyright (2014) American Chemical Society.183 The 47•Cu2⁺ 
complex may make a good ligand for stacking on a G-quartet.  
 Prodigiosene 47 was shown to form metal complexes in presence of Cu(II) 
(Figure 6.3).183  G-quadruplexes also require cations (such as Na⁺, K⁺) in order to 
stabilize their structure assembly.146 If the G-quadruplex assemblies are mixed with the 
prodigiosene metal complexes similar to that of 47•Cu2⁺ complex, one might expect 
some DNA-ligand interactions.  
 Further, it will be interesting to perform detailed computational modelling for 
prodigiosin-quadruplex complexes to learn more about the preferred binding 
conformation of prodigiosin 1. Our present knowledge about the conformation adopted 






molecular model (Figure 5.27) and saturation transfer diffusion experiments (Section 
5.8.2). According to the model, prodigiosin adopts an unusual conformation that has 
not been assigned previously. Further, we learned in Section 4.5.2 that water can also 
effect the α/β conformation ratio of prodigiosin in solution (Figure 6.4). It will be 
fascinating to learn the combined effects of water and quadruplex DNA binding on the 
conformation of prodigiosenes in solution. Eventually, the information gained can be 
applied to synthesize new analogs with specific conformations such that the ligands are 
pre-organized to bind with the quadruplex DNA. The experiments described in this 
chapter are only the tip of an iceberg in the development of prodigiosene based G-
quadruplex targeted drugs.  
 
Figure 6.4. The α and β conformations of prodigiosin 1•HA are shown. Different 
factors such as water and counter-anion can affect the α/β conformational ratio. 
 Finally, our studies have been done using a very simple G-quadruplex 
K⁺•d[TG4T]4 DNA. It will be interesting to learn about other G-quadruplex DNAs and 








 Chapter 7: Experimental Procedures and Supporting Information 
 General Experimental 
Materials. Prodigiosin 1 was provided by the Drug Synthesis and Chemistry Branch, 
Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, 
NCI. The series of compounds 2 and 3 were synthesized by our collaborators Dr. 
Estelle Marchal and Dr. Alison Thompson at the Dalhousie University, Canada.  
 Egg-yolk phosphatidylcholine (EYPC) lipid was purchased from Avanti Polar 
Lipids. Polycarbonate membranes and the extrusion apparatus used for making the 
liposomes was also from Avanti Polar Lipids. Salts (> 99% purity) were purchased 
from Sigma-Aldrich and used as received. The fluorescent dye LG was purchased from 
Sigma-Aldrich. Buffer solutions were made using ultra-pure water (distilled and then 
passed through a Millipore filtering system). All pH measurements and adjustments 
were made using an Accumet AR25A pH/ion meter equipped with a Accumet pH 
microelectrode. Calibration was achieved using commercial buffers (Thermo 
Scientific, pH 4.00, 7.00 and 10.00, all ±0.01). All fluorescence experiments were 
performed using a Hitachi F-4500 fluorescence spectrophotometer. 
Preparation of EYPC Liposomes. EYPC lipid solution (~60 mg of lipid) was 
evaporated under reduced pressure to produce a thin film that was then dried in vacuo 
overnight. The resulting lipid film was hydrated with 1 mL of a LG containing buffer 
to be encapsulated inside the liposomes.78,113 After 9 freeze/thaw cycles (thawing and 
then warming to 45°C), the liposome solution was extruded through a 200 nm 






vesicles (SUVs). The liposome solution was then passed through a Sephadex (G-25) 
column to remove any excess LG dye. The isolated liposomes were diluted in 
extravesicular buffer to give a final concentration of 13 mM in EYPC lipid, assuming 
complete retention of lipid during the gel filtration process. The size of the liposomes 
was confirmed using dynamic light scattering experiments. 
Determination of pKa Values. A spectrophotometric procedure described by 
Manderville and colleagues was used to determine the apparent pKa values for 
prodigiosenes.33 The UV-vis spectra were recorded on a Cary 100 UV-visible 
spectrophotometer in Chapter 2 and Shimadzu UV-1800 UV-visible 
spectrophotometer in Chapter 3. Standard 10 mm quartz glass cells from Starna Cells 
Inc. were used. All UV-Vis spectra were recorded at 25 °C with baseline correction. 
Stock solutions (2 mM) of prodigiosenes were prepared in CH3CN. Then, 15 μL of the 
stock solution was added to a quartz cuvette containing 2 mL total volume of 1:1 
CH3CN/H2O (v/v). The ionic strength was kept constant by using 0.1 M NaCl. Acidity 
constants were determined spectrophotometrically by monitoring absorbance changes 
in the UV-vis spectra after additions of dilute HCl or NaOH solutions under constant 
temperature conditions. The pKa values were determined from a plot of ionization ratio 
and pH. Ionization ratio is given by the expression in equation 1; where A is the 
absorbance of the solution containing a certain total concentration of the acid–base 
mixture, Abase is the absorbance of the base form at the same concentration, and Aacid is 










 Experimental Procedures for Chapter 2 
 Anion Exchange Transport Assays 
Chloride-Nitrate Anion Exchange Transport Assay in EYPC Liposomes. 
Liposomes containing 1 mM LG, 20 mM HEPES and 100 mM NaCl buffer (pH 7.4) 
were prepared. In a typical experiment, 0.04 mL of the stock EYPC liposome solution 
was diluted into 2 mL of a solution of 20 mM HEPES (pH 7.4, 100 mM NaNO3) to 
give a solution that was 0.2 mM in lipid. The LG’s fluorescence was monitored for 720 
s with a λex = 372 nm and λem = 504 nm. At t = 30 s, 1 μL of a 0.2 mM DMSO solution 
of the prodigiosene transporter was added to the cuvette containing the EYPC solution, 
giving a 1:2,500 ligand to lipid ratio (or 0.04 mol %). The efflux of Cl⁻, facilitated by 
the transporter was characterized by an increase in the LG’s fluorescence. At t = 660 s, 
0.05 mL of a solution of 10 % Triton-X detergent was added in order to lyse the 
liposomes and maximal fluorescence quenching of LG by Cl⁻ was measured. 
Experiments were repeated in triplicate. 
Determination of EC50 Values for Anion Exchange by Prodigiosenes 1, 2e and 24. 
The Hill equation describes the relationship between the concentration of a substrate 
and an observed effect.184 It is often used in pharmacodynamics to describe the 
relationship between drug concentration (X) and observed effect (Y). A form of the 
Hill equation that is useful in the context of the supramolecular function of ion transport 
is shown in equation 2, where K (EC50) is the transporter’s concentration for which 
50% of maximum transport is obtained, and n is the Hill coefficient of sigmoidality. 






 The Hill equation can be applied to ion transport by examining the effect of 
varying the concentration of transporter [X] on ion flux (Y). In this way, a value of K 
(EC50) can be calculated and used to quantify transport activity; the lower the value of 
EC50, the more potent the transporter. To calculate the values of K and n for each 
compound, the transport assay was repeated for different concentrations of transporters 
with the same batch of EYPC liposomes. The transport experiment was initiated by 
addition of an aliquot of transporter solution at 25 ºC. The fluorescence of intravesicular 
LG was at λex = 372 nm and λem = 504 nm with a 10 nm slit width. At the end of the 
experiment, 10 % aqueous Triton-X was injected to lyze the liposomes. LG 
fluorescence was converted to chloride concentration using the Stern-Volmer constant 
determined under the assay conditions.78, 116 To measure the Stern-Volmer constant, 
liposomes were prepared as above, and then were lysed with Triton-X at t = 30s. 10 μL 
of 2.0 M NaCl was titrated every 30 s via the injection port. The titration was repeated 
three times. A plot of f0/f vs. Cl⁻ concentration was generated (Figure 7.1), the slope 
of which is taken to be the Stern-Volmer constant (‘kq τ0’ from equation 3). The kinetics 
of LG fluorescence quenching process is given by the Stern-Volmer relationship 
(equation 3), where f0 is the intensity of LG fluorescence without Cl⁻, f is the intensity 
with Cl⁻, kq is the quencher rate coefficient, τ0 is the lifetime of the emissive excited 
state of LG without Cl⁻ present and [Q] is the concentration of the Cl⁻.185  
𝑓0
𝑓
= 1 + 𝑘𝑞𝜏0 ∙ [𝑄]                               (equation 3) 
 Using the Stern-Volmer relationship (equation 3), the LG fluorescence intensity 






percentage of Cl⁻ efflux from the vesicles for each transporter concentration at t = 150 
s was calculated. The percentage of chloride efflux vs. log of transporter’s 
concentration was fitted into Hill equation (1) to obtain value for K (EC50) at 150s 
(Figure 7.2-Figure 7.4).  
 
Figure 7.1. Determination of the Stern-Volmer constant. 
 
Figure 7.2. EC50 dose response curve for prodigiosin 1 at 150 s. EC50 value was 
calculated by plotting the percentage of chloride efflux at 150 s vs. the natural log of 







Figure 7.3. EC50 dose response curve for ester 2e at 150 s. EC50 value was calculated 
by plotting the percentage of chloride efflux at 150 s vs. the natural log of concentration 
of prodigiosin 2e and then fitting to Hill equation. 
 
Figure 7.4. EC50 dose response curve for ester 24 at 150 s. EC50 value was calculated 
by plotting the percentage of chloride efflux at 150 s vs. the natural log of concentration 






Receptor Incubation Assay in EYPC Liposomes. Liposomes containing 1 mM LG, 
10 mM phosphate and 100 mM NaNO3 buffer (pH 7.4) were prepared. In a typical 
experiment, 0.04 mL of the stock EYPC liposome solution was diluted into 2 mL of a 
solution of 10 mM phosphate (pH 7.4, 100 mM NaNO3) to give a solution that was 0.2 
mM in lipid. The LG’s fluorescence was monitored for 620 s with a λex = 372 nm and 
λem = 504 nm. For this experiment, two sets of conditions were applied. For condition 
I of “no incubation”, the transporter 2h was added at 0.04 mol% ligand:lipid ratio to 
the liposome sample, immediately followed by addition of a 200 µL pulse of 1M NaCl, 
10 mM phosphate, 100 mM NaNO3 buffer. LG fluorescence was measured. For 
condition II involving “incubation”, 2h was added to the liposome sample and allowed 
to incubate for 300 s, followed by addition of NaCl pulse and measurement of 
fluorescence. The influx of Cl⁻, facilitated by the transporter was characterized by a 
decrease in the LG’s fluorescence. At t = 560 s, 0.05 mL of a solution of 10 % Triton-
X detergent was added in order to lyse the liposomes and maximal fluorescence 
quenching of LG by Cl⁻ was measured. Experiments were repeated in triplicate.  
pH Variation Assay in EYPC Liposomes. Liposomes containing 1 mM LG, 10 mM 
phosphate and 100 mM NaNO3 buffer were prepared. In a typical experiment, 0.04 mL 
of the stock EYPC liposome solution was diluted into 2 mL of a solution of 10 mM 
phosphate (pH 6.5, 7.5 or 8.5) containing 100 mM NaNO3 to give a solution that was 
0.2 mM in lipid. The LG’s fluorescence was monitored for 720 s at λex = 372 nm and 
λem = 504 nm. At t = 30 s, 1 μL of a 0.2 mM DMSO solution of the prodigiosene 2g 






(pH 6.5, 7.5 or 8.5), 1 M NaCl and 100 mM NaNO3 was added at 60 s to get a final 
concentration of 100 mM NaCl in the cuvette. The influx of Cl⁻, facilitated by the 
transporter 2g was characterized by a decrease in the LG’s fluorescence. At t = 660 s, 
0.05 mL of a solution of 10 % Triton-X detergent was added in order to lyse the 
liposomes and maximal fluorescence quenching of LG by Cl⁻ was measured. 
Experiments were repeated thrice. 
 NMR Titrations 
 1H NMR experiments were performed at 25 °C using a Bruker AVIII-600MHz 
instrument. A mixture of two compounds in CD3CN was titrated with acid. 
Methanesulfonic acid (MeSO3H) was used. In a typical NMR experiment involving a 
mixture of two compounds, solutions were prepared containing 1 mM of each 
compound in a total volume of 0.8 mL. If the compound mixture was in the form of an 
HCl salt, then 2 μL of 0.4 M solution of tetraethylammonium bicarbonate (TEAB) was 
first added to the solution to create the free-base form of the compounds. Then, 2, 5 or 
10 μL of a 0.08 M solution of MeSO3H in CD3CN was added to obtain 0.2, 0.5 or 1.0 
eq, respectively of MeSO3H in the NMR tube. After each addition of MeSO3H, a 
1H 
NMR spectrum was recorded. Chemical shifts were referenced to the non-deuterated 
methyl group at δ1.93 in the CD3CN solvent. 
 Determination of pKa Values for Prodigiosin 1 and Prodigiosene Ester 2f 
 Based on the UV-vis titration spectra and ionization plots, pKa values were 
calculated to be 8.2 for prodigiosin 1•H⁺ and 6.5 for ester 2f•H⁺. The UV-vis 






Figure 7.5. A plot of log (ionization ratio) vs. pH for prodigiosin 1 and ester analog 2f.  
 Experimental Procedures for Chapter 3 
 Determination of pKa Values for Prodigiosenes 3b, 3d-f and 3h 
 The pKa values were determined for protonated prodigiosenes 3b, 3d-f and 3h. 
Based on the UV-vis titration spectra and ionization plots, pKa values were calculated. 
The UV-vis absorbance titration was performed in triplicate for each compound.  
 








Figure 7.7. Absorbance spectra and ionization plot for 3h (X = Cl) as a function of pH. 
Figure 7.8. Absorbance spectra and ionization plot for 3b (X = H) as a function of pH. 







 Anion Exchange Transport Assays 
Chloride-Nitrate Anion Exchange Transport Assay in EYPC Liposomes. 
Liposomes containing 1 mM LG, 20 mM HEPES and 100 mM NaCl buffer were 
prepared. In a typical experiment, 0.04 mL of the stock EYPC liposome solution was 
diluted into 2 mL of a solution of 20 mM HEPES (pH 7.4, 100 mM NaNO3) to give a 
solution that was 0.2 mM in lipid. The LG’s fluorescence was monitored for 720 s with 
a λex = 372 nm and λem = 504 nm. At t = 30 s, 1 μL of a 0.2 mM DMSO solution of the 
prodigiosene transporter was added to the cuvette containing the EYPC solution, giving 
a 1:125,000 ligand to lipid ratio (or 0.0008 mol% wrt lipid concentration). The efflux 
of Cl⁻ facilitated by the transporter was characterized by an increase in the LG’s 
fluorescence. At t = 660 s, 0.05 mL of a solution of 10 % Triton-X detergent was added 
in order to lyse the liposomes and maximal fluorescence quenching of LG by Cl⁻ was 
measured. Experiments were repeated in triplicate. 
Initial Rates and Half-Life. For comparative purposes, the relative transport activity 
for various ionophores was expressed as the initial rate of LG fluorescence as chloride 
and nitrate were exchanged across the membrane. Addition of a transporter leads to 
movement of internal chloride across the membrane, which results in increase in 
fluorescence of LG. Rates are obtained by linear fitting of initial slopes of fluorescence 






 Experimental Procedures for Chapter 4 
 NMR Titrations 
 All experiments were performed with the Bruker AVIII-600 MHz instrument. 
1H NMR experiments were performed at 25 °C on 3b. Methanesulfonic acid (MeSO3H) 
was used as the acid source. In a typical NMR experiment, a 1 mM solution of 3b was 
prepared. Then, 1 eq of MeSO3H dissolved in CDCl3, was added to the NMR sample 
After adding 6 eq of MeSO3H, a NOESY experiment was performed. Two sets of 
signals were resolved for each α () and β (*) conformer (Figure 7.10). 1D proton 
spectra of samples were recorded using pulsed-field gradient DPFGSE for H2O 
suppression.186 Phase-sensitive NOESY spectra187,188 were recorded with mixing times 
of 500 ms (T= 25 °C). The relaxation delay was kept at 2s. Experiments were recorded 
using STATES-TPPI189 procedure for quadrature detection. The time domain data 
consisted of 2048 complex points in f2 and 256 fids in f1 dimension. The NMR data 














 Experimental Procedures for Chapter 5 
Materials. The oligonucleotide d(TGGGGT) was purchased from IDT Integrated 
DNA Technologies. Salts (> 99% purity) were purchased from Sigma-Aldrich and 
Acros Organics, and used as received. All fluorescence experiments were performed 
using a Hitachi F-4500 fluorescence spectrophotometer and UV-vis experiments were 
performed on a Shimadzu UV-1800 UV-visible spectrophotometer. NMR experiments 
were performed on different instruments - Bruker AVIII-600 MHz spectrometer at the 
Chemistry NMR facility; Bruker Avance III 600 MHz spectrometer with a CPTCI 
cryoprobe and Bruker Avance III HD 800 MHz spectrometer with a CPQCI cryoprobe 
at the Biomolecular NMR facility.  
Sample Preparation. DNA solutions were prepared by dissolving solid lyophilized 
oligonucleotides in buffered solutions containing either chloride salt of K⁺ or Li⁺. The 
K⁺ buffer used was 100 mM KCl, 10 mM Tris - 1 mM EDTA. The Li⁺ buffer was 100 
mM LiCl, 10 mM Tris - 1 mM EDTA. Both buffer solutions were in 90% H2O-10% 
D2O at pH 7.0. DNA G-quadruplex d[TG4T]4 was formed by heating the solutions to 
95 ºC for 5min. The solutions were then cooled slowly to room temperature and 
equilibrated overnight at 4 ºC. Stock solution of prodigiosin 1 was prepared by 
dissolving it in d6-DMSO. The concentration of oligonucleotide and prodigiosin 
solutions were determined by UV-vis absorption measurements using molar extinction 
coefficient (ε) values of 57,800 (260 nm) and 112,000 (535 nm; 95% EtOH-HCl) M⁻1 






 UV-vis titration 
 Wavelength scans were measured at 37 ºC in sub-micro spectrophotometer 
quartz cells of 1-cm path length from Starna Cells Inc. For UV-vis titrations, the DMSO 
stock solution of prodigiosin was diluted to 50 μM concentration in 200 μL volume in 
a cuvette. Buffer solutions used for dilution were 10 mM Tris - 1 mM EDTA containing 
either 100 mM KCl or 100 mM LiCl in 90% H2O-10% D2O at pH 7.0. The titration 
was performed by stepwise addition of aliquots of DNA solution (0.5 mM in tetraplex).  
After each addition of aliquot of DNA, absorbance of the sample was recorded. Each 
experiment was repeated three times.  
 Fluorescence titration 
 Emission fluorescence scans were measured at 37 ºC in semi-micro 
spectrophotometer quartz cells of 1-cm path length from Starna Cells Inc. For titrations, 
the DMSO stock solution of prodigiosin was diluted to 5 μM concentration in 400 μL 
volume in a cuvette. Buffer solutions used for dilution were 10 mM Tris - 1 mM EDTA 
containing 100 mM KCl in 90% H2O-10% D2O at pH 7.0. The excitation wavelength 
used was 520.0 nm at 5.0 nm slit size. The titration was performed by stepwise addition 
of aliquots of DNA solution (0.5 mM in tetraplex). After each addition of DNA, a 
fluorescence reading was taken. Each experiment was repeated three times. 
 1H-NMR titration 
 All 2D and several 1D NMR experiments were performed in collaboration with 
Dr. Daoning Zhang at the Biomolecular NMR facility. G-quadruplex DNA NMR 






ml (H2O/D2O 9:1) buffer solution having 10 mM Tris, 100 mM KCl, and 1 mM EDTA, 
pH 7.0 or 10 mM Tris, 100 mM LiCl, and 1 mM EDTA, pH 7.0. Prodigiosin stock 
solutions were prepared in d6-DMSO. All experiments with G-quadruplex DNA were 
performed at 45 ºC. 31P chemical shifts were referenced relative to external phosphoric 
acid (> 99%). The acquired NMR data were processed using TopSpin version 3.0 or 
TopSpin version 3.2 software. 
 1D proton spectra of samples were recorded using excitation sculpting with 
gradients for H2O suppression.
186,191 Phase-sensitive 2D NOESY spectra with water 
suppression (pulseprogram: noesyesgpph) were recorded with mixing times of 100 and 
200 ms (T= 45 °C).191 2D NOESY experiments were recorded using STATES-TPPI 
procedure for quadrature detection.189 The time domain data consisted of 2048 complex 
points in f2 and 256 fids in f1 dimension. A power-gated decoupling pulseprogram 
(zgpg30) was used to acquire 1D 31P NMR spectrum. 1H-31P HSQC correlation 
experiments (pulseprogram: na_hsqcetf3gpxy) were recorded using XY16-CPMG with 
Echo/Antiecho-TPPI acquisition mode.192⁻194 1D selective TOCSY spectra using 
MLEV17 sequence were recorded with mixing times of 120 ms.195⁻198 Saturation 
transfer difference experiments (STD, pulseprogram: stddiffesgp.3) used a shaped 
pulse sequence for saturation on f2 channel, alternating between on and off 
resonance.178, 191 A spoil sequence was used to destroy unwanted magnetization and 
water suppression was achieved by using excitation sculpting with gradients. In all the 
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